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Abstract 
The lack of suitable models for prediction of the vertebral body (VB) 
failure load for a variety of pathologies hampers the development of 
indications for surgical and pharmaceutical interventions and the 
assessment of novel treatments. Similar models would also be of benefit in a 
laboratory environment in which predictions of failure load could aid 
experimental design when using cadaveric tissue.  Finite element modelling 
shows great potential but the expertise required to effectively deploy this 
technology in a clinical environment precludes its routine use at the present 
time. Its deployment within the laboratory environment is also time 
consuming. An alternative approach may be the use of composite beam 
theory structural analysis that takes into account both vertebral geometry 
and the bone mineral density (BMD) distribution and they are utilised to 
predict the loads at which vertebrae will fail. 
As a part of this work, vertebrae suffering from three distinct pathologies 
(osteoporosis, multiple myeloma (MM) and metastases) were tested in a 
wedge compression loading protocol (WCF) as a determinant for 
vertebroplasty treatment. MM bone was first tested for changes at the bone 
tissue level by means of depth-sensing micro-indentation testing. In the 
second part more than one hundred VBs were subjected to a destructive in-
vitro WCF experiment, while CT images were used for in-silico structural and 
morphological assessment. In the last part, two vertebroplasty cements, 
calcium phosphate and PMMA, were tested. 
At the tissue level MM bone shows rather moderate changes which are 
of such small magnitude that alone would not be sufficient to change the 
overall vertebral strength. Relatively good predictions of VB strength were 
obtained when using image-based fracture prediction suggesting that bone 
distribution and pathological alterations to its structure make a significant 
contribution to overall VB strength.The results of VB reinforcement using 
either of the cements show increased strength while stiffness was restored 
only when PMMA cement was injected in lower porosity samples. 
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Preface 
Spinal metastases are an increasingly challenging pathology faced by 
clinicians as patient survivorship improves.  A number of these metastases 
are osteolytic in nature and the subsequent fracture is associated with 
significant morbidity. Improved methods of fracture risk and prediction are 
urgently required to aid clinical planning and assessment of the treatment 
outcomes.  
Vertebral compression fractures are currently being treated 
conservatively by a combination of bed rest, braces, pain killers and 
pharmacologic therapy [1]. Minimally invasive treatment such as 
percutaneous vertebroplasty (PVP) shows promising results in terms of pain 
management with considerably lower risk than open surgery. Although PVP 
has been shown to be safe, its biomechanical character is still not well 
understood which may lead to a cascade of alterations in load distribution 
amongst adjacent levels. Moreover, due to heterogeneous changes in bone 
structure such those caused by cancer infiltration, the percutaneous 
vertebroplasty may be different from the one prescribed for osteoporosis. 
For instance, a vertebral body with a lesion-creating cavity may need to be 
treated differently than homogenously deteriorated osteoporotic vertebrae.  
Further, the fact that lesions themselves are more readily identifiable using 
modern imaging techniques and that it may be possible to identify vertebrae 
in the spine at risk of failure brings to the fore the possibility of prophylactic 
treatments. 
There are two essential everyday questions posed in clinical 
environments for treatment of cancer patients: “what to use” and “when to 
use it”. In-silico modelling provides a possible way to provide answers if 
used in appropriate way. Also, models to assess bone quality prior to the 
collapse of the vertebral body would be beneficial both in a laboratory and 
clinical environments.  
For both pre-clinical and clinical applications, there is a strong need for 
an effective experimental design to deploy treatment optimisation studies. 
This design comprises an appropriate and tested laboratory methodology as 
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well as a tool to predict the structural properties of every sample prior to 
testing. Such methods could also be deployed in laboratories providing 
better approaches to experimental design. Previous investigations have 
shown potential for the use of image-derived bone mineral density 
distribution assessment as a deployment of Finite Element modelling but this 
procedure would be time-consuming. Previous research has indicated a 
strong link between bone structure as the disease progresses and the 
fracture [2, 3]. Nonetheless, very little is known about the material laws of a 
bone infiltrated by cancer. In order to help computational models predict 
failures more reliably, an investigation of the affected tissue is required.  
This thesis aims to challenge the lack of basic understanding of 
structure-strength relationship in the biomechanics of spinal metastases. 
Throughout the thesis, its aim and objectives follow the introductory section 
and are followed by a literature review to gather known information from the 
most recent relevant scientific sources. The literature review is followed by 
three chapters to encompass the objectives of this work, each comprising 
Introduction, Methods, and Results sections followed by a Discussion. The 
last chapter of the thesis presents the conclusion reached by this work while 
proposing a future perspective.   
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  Chapter 1
Introduction 
1.1 Clinical drivers – defining the problem 
Vertebral fractures are a significant cause of debilitating back pain, 
particularly in females suffering from brittle-bone disease or osteoporosis. 
One in three women will be affected by osteoporosis and there is a lifetime 
risk that 50% of women and 20% of men will sustain a vertebral fracture by 
the age of 50 [4]. Based on demographic changes, the expenditure 
dedicated to osteoporosis treatments is expected to rise from 30 billion € per 
year in the EU at present to almost 77 billion € per year in 2050 [5].  
Whilst osteoporotic vertebral compression fractures (VCFs) have been 
widely studied both clinically and biomechanically, the fractures arising from 
metastatic infiltration in the spine are relatively poorly understood. Significant 
issues arise from weakening of the bone due to metastatic invasion of the 
vertebral bone causing it to become weak and prone to fracture under loads 
such as those experienced in everyday activities.  
The incidence of vertebral fractures in cancer patients increases as the 
treatment of primary cancers improves due to on-going exposure to the 
progression of the disease. Unlike the vertebral fracture observed in 
osteoporosis, metastatic VCFs are particularly problematic as they have a 
high incidence of spinal cord compression (25% of cases), causing paralysis 
and loss of bowel and/or bladder function, as well as the associated pain [6]. 
Such late stage secondary events are often associated with terminal illness 
in which life expectancy is reduced to perhaps no more than 12 months [7]. 
Thus clinicians and patients have to consider issues concerning quality of 
life as the disease may become debilitating when VCFs occur [8, 9]. 
Current conservative treatment of vertebral compression fractures uses 
a combination of bed rest, braces, pain killers and pharmacologic therapy 
[1]. In osteoporotic patients the therapy primarily consists of drugs promoting 
bone growth such as bisphosphonates, vitamins and mineral nutrients [10].  
However, in cancer patients for whom palliative care is a key issue, pain 
relief is paramount in seeking to provide adequate quality of life for the 
remainder of the patient’s lifetime.  Whilst use of bone-enhancing drugs may 
be beneficial in the medium term, interventions which improve quality of life 
in the short term are paramount,  comprising in the first instance a 
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prescription of analgesics to provide the desired pain relief.  An alternative 
intervention may be required where this treatment is unsatisfactory.  Major 
surgery, in which recuperation would impact severely on the patient’s 
remaining quality of life, is often contraindicated because of both patient 
fragility and poor bone quality arising from the metastatic infiltration itself.  
Minimally invasive approaches which have shown benefit are vertebroplasty 
and kyphoplasty, as they have demonstrated sufficient stabilisation and pain 
relief coupled with little post-procedure pain and/or rehabilitation particularly 
in the osteoporotic cohort [11, 12]. The technique of injecting bone cement 
through a hollow needle without need of open surgery seems to provide the 
desired structural reinforcement with significant and, most importantly, 
immediate pain relief within 24 hours after the surgical intervention. The 
same techniques are currently being utilised on a small scale for the 
treatment of patients with metastatic disease cohort [11-14]. 
Recent studies on the effectiveness of vertebroplasty in the osteoporotic 
cohort [15, 16] initially introduced a controversy to the technique but later 
studies [17], in which more relevant control groups were utilised, have 
shown improvements in the patient outcomes compared to conservative 
cohorts.  Treatment of osteoporotic fractures brings typically excellent results 
with most patients describing the loss of pain as complete or near complete 
within two days with further gradual improvement in the first 6 months [18]. 
Initial results reported for vertebroplasty in cancer sufferers shows similar 
levels of satisfactory outcomes when compared to osteoporotic patients [8, 
19], although the requirements of each patient group are not the same and 
the goals of utilising the technique may not be comparable.  The rate of 
postoperative complications such as leakage of the cement and/or adjacent 
accelerated vertebral fracture may be different in patients treated for 
metastatic fractures due to differences in the systemic and local effects of 
the disease on the bone structure. Osteoporotic degeneration appears as a 
fairly uniform bone loss, although there is an increase in the inter-vertebral 
variability of porosity with age reflecting a reduction in homogeneity [20-22]. 
This is in contrast to vertebral bone loss in metastatic disease in which focal 
lesions are the cause of the structural deterioration of the VB. These 
differences may affect the rates at which complications and treatment 
interventions may occur. 
Key-hole surgery in cancer patients brings the promise of pain 
management with considerably lower risk than open surgery but it has yet to 
be optimised for cement augmentation in which the goals of surgery may be 
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different from that prescribed for osteoporosis. For instance, a VB with a 
lesion that breaches the cortical wall and hence increases the risk of cement 
leakage may have to be treated differently than osteoporotic vertebrae. 
Further, the fact that lesions themselves are more readily identifiable using 
modern imaging techniques and that it may be possible to identify vertebrae 
in the spine at risk of failure brings to the fore the possibility of prophylactic 
treatments. The challenge here is to identify those vertebrae most at risk, 
such that unnecessary procedures are avoided. 
In developing the augmentation procedures in terms of both the cement 
and the delivery process, preclinical studies have an important role to play.  
A number of biomechanical studies have already addressed a number of 
issues arising from use of augmentation utilising both experimental 
investigations [3, 23] and computational modelling, principally using the finite 
element method [24-26]. The volume [27-29] and type of cement [30] as well 
as the method of delivering the cement [28, 31, 32] have been common 
subjects of investigation within osteoporotic models. Here, the use of 
cadaveric material for the in-vitro assessment of this procedure has been a 
key element of these investigations both directly and in the validation of 
computational models. However, little work has been undertaken on 
metastatic bone disease and this has hampered the development of both (1) 
the augmentation techniques for these pathologies and, importantly, (2) 
models with which to predict fracture in a prophylactic setting and their use 
as a measure of outcome.  
Biomechanical in-vitro assessment of these structurally compromised 
specimens is an important method for gaining an understanding of the 
mechanics of structural behaviour under load. Finite element modelling has 
demonstrated great potential but is dependent on a detailed knowledge 
about the properties of bone at a tissue level as well as a solid validation 
methodology in order to be able to demonstrate its full potential. Hence a 
well-established experimental methodology is needed to support a 
development of the computational model and its validation. Secondly, 
despite numerous studies on human bone mechanical properties at a tissue 
level [33-37], very little is known about material laws of bone infiltrated by 
cancer. In order to help computational models predicting failures more 
reliably an investigation of affected tissue is required. 
Currently, biomechanical investigations of vertebroplasty for use in 
cancer patients are few in number and are limited to preliminary studies [38, 
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39]. However the usage of cadaveric tissues arising from these diseases 
within in-vitro experiments is technically very difficult and arises from: 
i. The limited availability of these tissues 
ii. The heterogeneric nature of the infiltration. 
 Therefore an effective experimental design is crucial for such studies. 
This design comprises an appropriate and tested laboratory methodology as 
well as a tool to predict structural properties of every sample prior to testing. 
This tool is essential especially when investigating prophylactic treatment. 
Previous investigations have showed potential of the use of image-derived 
bone mineral density distribution assessment as the deployment of FE-
modelling would be time consuming.  
 From a clinical point of view the essential questions arising from 
challenging metastatic vertebral fracture treatment for treatment of cancer 
patients are “what to use” and “when to use them”. Models underpinning the 
basic science of fracture and the most important parameters that may help 
to restore the compromised vertebral strength would significantly benefit the 
clinical environment. Also, models to assess bone quality prior to the 
collapse of the vertebral body would benefit from both a laboratory and 
clinical environment.  
 In the following sections the anatomy and biomechanics of the spine 
that are pertinent to the problem outlined above are described together with 
their modification following the onset of a diseased state where the focus is 
on the fracture of the infiltrated vertebrae.  Previous models, both cadaveric 
and computational, for understanding and predicting fracture are discussed 
in addition to the use of micro-indentation on elucidating the properties of 
bone at a tissue level derived from these tissues. Finally, vertebroplasty, the 
technique for overcoming both pain and the structural instability arising from 
these fractures, will be discussed. In light of these discussions the aim and 
objectives of the project will be defined in the following section. 
1.2 Aims and objectives of the study 
The overall aim of this project is to investigate the biomechanical imprint 
of bone deterioration due to the presence of structure-changing pathologies, 
explore possible structural biomarkers of weakened vertebrae and 
investigate minimally invasive treatment modalities in such bone where the 
disease weakens the bone and ultimately leads to vertebral fracture.   
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The goals follow the principle stated by WHO: “add life to years, not just 
years to life” and focus on treatments which aid pain-free mobility and 
increase the quality of life for people with bone disease, cancer patients in 
particular.  Following the findings from the literature review, the research 
project focuses on three interrelated areas for which there is limited 
knowledge and understanding (Figure 1). Objectives have been postulated 
as follows: 
i. The development of a model of fracture prediction that can be 
utilised within the scope of data produced through CT imaging 
which will be validated against in-vitro experimental data of 
vertebrae containing osteoporotic and metastatic lesions.  
ii. To perform an assessment of the structural and mechanical 
properties of trabecular bone utilising microCT assessment and 
micro-indentation. 
iii. To investigate the use of vertebroplasty in the augmentation of 
osteoporotic and metastatic lesions. 
 
Figure 1 The aim of this work is to combine knowledge of mechanical 
properties of vertebral bone and experimental testing on both 
tissue and organ level on pathology specific samples for use in 
vertebroplasty. 
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  Chapter 2
Literature Review 
2.1 Anatomy 
 Spine 2.1.1
The spine is a multi-segmental complex mechanical structure which 
forms part of the musculoskeletal unit of the trunk together with the rib-cage 
and the pelvis.  Its functions are to [40]: 
i. Protect the spinal cord  
ii. Provide stability to the upper torso whilst allowing the transfer of 
load  
iii. Aid motion of the upper torso 
iv. Aid motion of the upper and lower limbs.   
The human spine constitutes of 24 non-fused pre-sacral vertebrae.  
They are, as shown in Figure 2, divided into seven cervical, twelve thoracic 
and five lumbar vertebrae together with nine vertebrae fused within the 
sacrum and coccyx.  Each single vertebra is separated from the adjacent 
ones by an intervertebral disc anteriorly and two facet joints posteriorly.  
These joints allow movement between vertebrae and, hence, of the upper 
body, and the discs in particular aid the transfer of load from one vertebra to 
the next downwards to the pelvis [41].  These joints also provide stability 
particularly towards the end of the range of motion and/or where motion may 
be considered detrimental to the surrounding organs or vessels. 
Whilst vertebral pairs in the cervical spine demonstrate the largest range 
of motion for many, if not all, the degrees of freedom, the thoracic spine on 
the other hand is connected to the 24 ribs and has significantly decreased 
mobility [42]. The lumbar spine consists of visually larger vertebrae capable 
of bearing greater loads and moments as well as increased mobility 
compared to the thoracic spine but significantly less mobility than the 
cervical spine. 
Laterally, a non-pathological spine has four main curvatures, two 
kyphotic ones on the thoracic and sacral regions and two lordotic curvatures 
in the lumbar and cervical regions.  In the coronal plane no such curves are 
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noted beyond those as further curvature is generally minor and clinically 
insignificant. 
 
Figure 2 Figure depicting human spine with detail to lumbar and 
thoracic vertebrae. (A- Vertebral Body, B- Vertebral foramen, C- 
Transverse process, D- Lamina, E- Spinous process, F- Pedicle) 
2.1.1.1 Biomechanics of the spine 
The primary function of the spine is to protect the vulnerable spinal cord 
whilst allowing both movement and stability at any given position including 
the upfront position [43]. The spinal cord is protected by the bony structures 
of posterior vertebral elements, including the pedicles and laminar, and 
anteriorly by the vertebral bodies. Between vertebrae the nerve roots 
emanate from the cord through the intervertebral foramen. Any reduction in 
this space through trauma, vertebral fracture and/or degenerative disc 
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disease leads to nerve compression and related pain and/or loss of function 
[44]. From a biomechanical point of view, the spine has to sustain large 
loads as the centre of gravity is shifted from its main longitudinal axis leading 
to forces that are significantly greater than would arise from the weight of the 
upper torso alone [42].  Exercise performed during daily life strongly 
influences loads which vertebrae have to transmit. According to in-vivo 
measurement the lumbar disc pressure measured during bed rest is one 
quarter of that measured  when standing upright [45, 46], suggesting that a 
simple task can significantly increase compressive loads in the spine which 
has to be considered when designing a treatment tool for patients who are 
expected to be discharged from medical care. 
 Vertebra 2.1.2
Vertebrae are the relatively large bony units from which the spine is 
comprised.  A typical vertebra consists of an anteriorly placed vertebral body 
and posterior elements - the vertebral arch enclosing the vertebral foramen 
and processes. The vertebral body is a kidney-shaped structure comprising 
an inner trabecular bone and outer vertebral shell which allows it to transmit 
the majority of the compressive load within the spine [43]. The size of the 
vertebral body varies with level, the largest cross-sectional area being in the 
lumbo-sacral region. The size of the vertebral body is determined by the load 
bearing demands of the upper body above the index vertebra [42]. As noted 
above, the neural arch protects the spinal cord which resides in the spinal 
canal whereas the spinous and transverse processes, which are attached to 
the arch, anchor muscles and ligaments of the spinal musculo-ligamentous 
complex.  
The vertebral body has a thin vertebral shell and an internal structure 
containing cancellous bone which harbours a significant quantity of bone 
marrow.  In keeping with these large amounts of bone marrow the vertebral 
body is well vascularised and this may be a reason why the spine is the third 
most common site for metastatic disease after the liver and lungs.  The 
posterior elements consist mostly of cortical bone and are much less 
vascularised.  As this work focuses strictly on fractures in the thoraco-lumbar 
region only those two regions will be discussed in the following sections. 
2.1.2.1 Thoracic vertebrae 
Between the cervical and lumbar spine, there are 12 thoracic vertebrae 
which are attached to the rib-cage. The T1 vertebra, the closest to the 
cranium, is the smallest and the size of the vertebrae gradually increases 
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down the spine in the caudal direction. The rib-cage is attached by a series 
of articular facet joints (costal facets) and in combination with the associated 
ligamentous structures restricts range of movement; furthermore its larger 
moment of area, arising from the rib-cage which is shifted away from the 
axis of rotation, also contributes to the enhanced stiffness of this region. In 
combination both factors provide increased stability to the whole thoracic 
structure to protect the vital organs inside the rib-cage. 
2.1.2.2 Lumbar vertebrae 
The lower non-fused five vertebrae between the thoracic spine and 
sacral region form the lumbar spine. As loads here are significantly larger 
than those found in the thoracic and cervical regions, these vertebrae are 
correspondingly bigger. The different morphology of facet joints depicts a 
different biomechanical environment with larger ranges of motion in certain 
degrees of freedom but more limited ranges in others e.g. in the axial 
rotation and the translational forward motion.   
 Bone  2.1.3
Bone is a solid living organ. Being constantly modelled and remodelled, 
the bones, to some extent, reflect the needs of the body's biomechanical 
environment. Hard bone tissue forms two microscopically distinct types of 
bone: the cortical (compact) and trabecular (spongy) bone which can be 
differentiated according to their relative density [47]. Micro-composition of 
the bone is depicted in Figure 3. The cortical bone forms the hard dense 
exterior shell around the sponge-like trabecular bone, where spaces 
between the trabeculae are filled with bone marrow and interwoven by a 
vascular system [48]. The remodelling aids bone adaption in response to 
external loads but with age and various pathologies the ability to sustain this 
process is reduced and the equilibrium between absorption and replacement 
of bone decreases along with the quality of the bone structure.  
Apart from mechanical support, bones have several other functions such 
as synthetic (blood production) or metabolic (mineral storage, fat storage, 
acid base balance, storing heavy metals and helping to maintain balance in 
the mineral and hormone levels of the blood). However this study will focus 
only on the mechanical functions of the bone. 
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Figure 3 Schematic figure of a bone structure at different scales – 
organ-, meso- and micro-scale (A- Osteon of cortical bone, B-
Haversian canal, C- Volkmann’s canal, D- Vessels and nerves, E- 
Lamellae, F- Canaliculi, G- Osteon of trabecular bone, H- 
Osteoblasts, I- Osteoclast, J- Osteocytes) 
2.1.3.1 Cortical bone 
The shell surrounding the internal part of the bone and forming its outer 
shape is composed of thin but dense cortical (compact) bone. Regarding 
composition, the cortical bone consists of secondary osteons embedded in 
interstitial tissue made of primary and older secondary osteons (Figure 4). 
An osteon - the fundamental functional unit - is a concentrically layered 
structure where each layer (lamella) is 1-5µm thick [49]. Between some 
lamellae, osteocytes reside within lacunae (10-50µm), and the centrally 
placed canals are called Haversian canals [49]. As published, the density 
and size of the lacunae in human vertebra are similar in both cortical and 
trabecular bone (CS-area 55µm2 in average, density 156/mm2). Counts of 
osteocyte lacunae correspond to the remodelling activity and have been 
shown to be higher in osteoporotic patients [50]. 
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Figure 4 Microscopic image of cortical shell and trabecular bone 
interface depicting difference between cortical shell (left top) and 
notably more porous trabecular bone (right bottom). Cortical bone 
is characteristic of osteons forming around the Haversian canal 
where older osteons are overlaid by new ones. On the contrary 
trabecular bone is characterised by layers of bone where the 
central canal is not present. This is understood to be a reason for 
deterioration of bone emerging from outer layers towards the 
centre (such as thinned trabeculae in osteoporotic patients) 
Modelling (addition or removal of bone to alter shape) and remodelling 
(removal and replacement of bone in a systematic fashion within bone 
multicellular units) are both extremely important parts of the bone life cycle 
which allow responses to changes in mechanical environment or bone 
micro-damage.  The turnover in cortical bone is significantly lower than in the 
trabecular one (3% turnover rate of cortical bone compared to 26% in 
trabecular bone [49]). The cortical bone is remodelled from the bone surface 
through tunnelling resorption by osteoclasts. This cavity is then filled by 
osteoblasts forming a new bone in a lamellar pattern. Every new osteon is 
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enclosed and separated from an old bone by a cement line (0.5-1µm). 
Mineralisation of a new bone is gradual and by the time of formation its 
mineral density is around 70%. In less than six months, the mineral density 
of the newly formed bone increases to 90 to 95% [49]. Studies using 
indentation techniques and ultrasonic experiments on mechanical properties 
of bone at a tissue level have confirmed that trabecular bone is almost 20% 
softer than the cortical material [34, 37, 51, 52], which may arise from the 
greater mineralisation and reduced number of lacunae in cortical bone.  
2.1.3.2 Trabecular bone 
The porous sponge-like structure within the cortical bone is referred to 
as trabecular bone. Similarly to cortical bone, healthy trabecular bone 
remodels to create a well-organized structure which provides an enhanced 
strength-to-weight ratio with space available for other components such as 
bone marrow [53]. The trabeculae are remodelled in a very short timescale 
compared to cortical bone, adapting quickly to changes in a mechanical 
environment.  
The trabecular bone has a very high porosity and comprises 
approximately 20% of the total bone mass. A typical trabecular thickness 
varies between ten and several hundred µm [49]. Usually trabecular bone 
does not contain whole osteons (Figure 5), but rather portions of bone where 
remodelling has occurred in the form of pits rather than tunnels.  
Exceptionally a whole osteon can be seen if the thickness is higher than 
approximately 350µm [49]. This exception aside, trabeculae are either 
cylindrical (rod-like) or plate-like structures which have concentric layers 
(lamellae) around their principal axis without a central canal.  
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Figure 5 Microscopic image of trabecular bone, single trabecula in 
detail: trabecular bone is a very porous structure where each 
trabecula is formed around its main axis composed of layers 
which form externally 
 Morphology and mineral density of human vertebrae 2.1.4
While the external shape of the bone is mainly driven by its kinematic 
purpose and it can be modified in response to external loads, the cancellous 
bone is more readily modified due to a higher rate of bone turnover.  This 
can be seen in the pattern of the trabecular bone accommodating the 
principal directions of stress [53]. 
Histological, and later microCT, assessment of bone has uncovered the 
trabecular micro-structure which is formed from rod-like structures and/or 
plate-like structures. The main structural property indices that are commonly 
used in the description of bone (Figure 6) are denoted by: 
i. Trabecular spacing (Tb.Sp) 
ii. Thickness (Tb.Th) 
iii. Number of trabeculae (Tb.N) 
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iv. Volume fraction (BV/TV) 
v. Connectivity (Conn.D) 
vi. Level of isotropy (Mean intercept of length (MIL)). 
All these variables are modified by the gradual morphological changes 
that occur during ageing. Particularly, a decrease in volume fraction and 
connectivity of the trabeculae and a corresponding increase in spacing are 
observed as a person’s bone becomes osteopenic and then osteoporotic 
[54].  In addition, comparative studies have shown a gradual corresponding 
change from plate-like to a predominantly rod-like structure with increasing 
age [54]. These changes make trabecula more inclined to bend and buckle 
which leads to lower structural stiffness and strength. 
 
Figure 6 Morphometrical indices to qualitatively assess bone structure 
in-situ. Trabecular spacing (Tb.Sp), thickness (Tb.Th), number of 
trabeculae (Tb.N), connectivity density (Conn.D) or level of 
isotropy (MIL) 
Increasing spatial resolution of modern 3D imaging tools allows 
assessing the bone in-situ and non-invasively. Segmenting these images 
can provide morphometrical indices for qualitative assessment. Bone volume 
fraction has been shown to be a better predictor of compressive strength of 
cored trabecular bone when compared to BMD [22, 55]. Investigations of 
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trabecular thickness, number and separation have their roots in histological 
sections [56] but later, in the case of 3D imaging tools, a direct measurement 
method had to be adopted [57]. In theory, the algorithm uses the fitting of 
spheres to or between segmented bone structure using a distance 
transform, which is used to determine the three-dimensional distance 
between each structure. These modern algorithms can minimise the effects 
of partial volumes using a mid-axis transformation method to identify 
trabecular elements. Studies have shown that a single trabecula has a 
thickness (Tb.Th) in the order of 100-200µm leaving the trabecular spacing 
(Tb.Sp) one order higher depending on the anatomical location of the bone.  
The connectivity of bone is defined as the number of struts which have 
to be separated to isolate two nodes of a bone [57]. While the connectivity is 
hard to express as a specific volume, a connectivity density (Conn.D) as a 
value normalised to the volume of interest is widely used. Average 
connectivity density for human bone varies between 2-5mm-3 [54, 58] and 
strongly decreases with age by approximately 15% per decade [54]. 
However cadaveric studies done by Kabel et al. [59] showed that Conn.D 
provides very limited information on material properties of the bone 
structure. 
The remodelling of bone according to Wolff's law causes anisotropy in 
the bone’s structure, particularly of the trabeculae [53].  One way of defining 
anisotropy is through some alignment of the principal axis to the reference 
frame. The most commonly used method is the Mean Intercept of Length 
(MIL).  The principle of this method is based on a count of intersections 
between a linear grid and a segmented material as a function of the grid's 
orientation. The MIL is then the ratio between the total line length and 
number of intersections. Visually, the results can be expressed as an ellipse 
where the major axis (a) corresponds to the principal axis of the bone, the 
minor axis (b) to its perpendicular axis, and the angle from the reference 
frame axis to the principal fabric direction is denoted θ [60] as depicted in 
Figure 6. Even though the trabecular bone cannot be described as an 
isotropic material, recent indentation studies show that the main difference is 
only between the principal trabecular axis and its perpendicular axis, yet the 
difference in helical winding around the main axis remains the same, thus 
one can assume the trabecular bone is transverse isotropic [36, 61]. The 
MIL defining the magnitude of transverse isotropy is then in the order of 1.5 
towards the principal axis [61]. 
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An assessment of trabecular bone quality can be obtained using bone 
densitometry although the increasing sophistication of other tools is reducing 
its dominance as a clinical tool.  In current state-of-art radiography a 
localised bone reduction of an area larger than 1cm2 with a bone loss 
greater than 50% is required for any reasonable surety in identifying 
significant changes in BMD.  Further, the technique is reported to give false-
negative screenings resulting in up to 34% of undetected vertebral 
fractures [62] and up to 40% of undetected metastatic lesions [63].  The use 
of Dual-energy X-ray Absorptiometry (DXA) provides a quantitative means of 
assessing BMD but lacks the resolution to discern non-uniformly distributed 
changes within bone or geometrical aspects that impact on the bone’s ability 
to sustain a load. Whilst biomechanical studies have shown that bone 
mineral content is a good single predictor of trabecular strength, the recent 
consensus is that BMD alone contributes no more than 50% of the vertebral 
strength [55]. It was widely recognised that predictive power can be 
increased by linking assessments of BMD with geometric measurements. 
Initially, these led to investigations of utilising the product of BMD and 
endplate area [3, 64], or BMD and minimal cross-section area [65, 66]. This 
method shows reasonably good predictions when compared to in-vitro 
experiments but requires volumetric CT measurements.  
Several studies suggest that not only BMD but many other bone 
properties have a significant impact on the quality of the bone [2, 55, 58, 64, 
67-70]. These include the architecture of the structure itself, the degree of 
mineralisation, micro-structure damage and accumulation including micro-
cracks within the struts.  However, each of these would rely on techniques 
that are unlikely to be assessable in-vivo within the foreseeable future.  The 
tools that have the greatest potential for use in-vivo are those that 
demonstrate high spatial resolution such as micro computed tomography 
(microCT) which has demonstrated its potential in ex-vivo studies or the 
corresponding, peripheral in-vivo studies which utilise high-resolution 
quantitative computed tomography (HR-pqCT).  
2.2 Pathology 
 Osteoporosis 2.2.1
Osteoporosis is one of the most widespread diseases in the world 
affecting bone tissue in the elderly. Early osteoporosis is asymptomatic and 
results in the reduction of bone mineral density (BMD) which leads to 
increased bone fractures. These fractures are thus called osteoporotic 
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fractures and their treatment imposes an increasing economic burden on the 
health system.  
2.2.1.1 Definition, screening and occurrence of osteoporosis 
Osteoporosis is characterised by the thinning of trabecular elements due 
to bone mass loss (Figure 7). This is related to an imbalanced resorption of 
bone without appropriate bone adaptation. Thinned trabeculae result in 
increased bone fragility which weakens generally strong bone architecture 
and subsequently leads to osteoporotic fractures when the natural load 
exceeds the bone strength. The most common sites of these fractures are 
hip, spine, forearm and humerus [71]. The incidence and mortality of 
vertebral compression fractures (VCF) is not well documented [72] as it is 
believed that only from one fifth to one third of all VCFs are actually 
symptomatic and recognised [73, 74] which accounted for a rough estimate 
of 1.4 million VCF worldwide in the year 2000 [71]. 
 
Figure 7 Comparison of “healthy” high-mineral-density bone (left) and 
low-mineral-density osteoporotic bone (right). Lose of trabecular 
struts in OP bone is predominantly in horizontal direction [21] as 
indicated by red arrow. Structural integrity in osteoporotic bone 
while compromised has been well documented and is believed to 
be related to a simple loss of supporting material, however the 
cancer-bearing bone is yet to be thoroughly investigated  
Clinically the most important goal is to prevent osteoporosis and bone 
fractures, which emphasises the importance of appropriate screening.  
According to guidelines provided by WHO (The World Health Organization), 
osteoporosis is defined as the probability of fracture due to bone quality 
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compared to averaged values obtained from a population. The probability of 
fracture and hence the progress of osteoporosis is measured according to a 
T- and Z-score, where the T-score is a count of standard deviations below 
an average young person at the peak of bone mineral quality while Z-score 
compares the number of standard deviations to an average person of the 
same age. The average density measurements are based on large studies 
conducted worldwide. WHO defines four groups: Normal group (T score<1), 
Osteopenia (1<T score<2.5), Osteoporosis (T score >2.5) and severe 
osteoporosis (when bone contains non-traumatic fractures). Even though 
this method of bone quality estimation is widely spread, WHO currently 
provides data only for Caucasian US North American females. Several 
studies show a variation between different groups, thus a good comparison 
is essential to use the T-score bone quality assessment.  
The average bone mineral density (BMD), which is currently the most 
widely used  predictor of bone quality, is measured either using ultrasound 
with limited usability in the most commonly affected areas such as hip and 
spine or using absorptiometric techniques such as Dual Energy X-ray 
Absorptiometry (DXA) or computed tomography (CT). DXA is the most 
commonly used tool in osteoporosis screening as it provides a cheap, fast 
and robust quantitative measure for clinicians to estimate the potential risk of 
fracture at low radiation dosage (approximately 10µS for spine) [20]. 
However DXA measurements reflect BMD alone, which is only one of many 
contributions to vertebral strength [70] and is insensitive to geometrical 
changes which can lead to up to 70% of fractures remaining undetected 
when only BMD is being assessed [76]. Furthermore, conventional 
standalone DXA shows a significant insensitivity in the screening of a wider 
population [77] and in fact can lead to significant misdiagnosis in cancer 
patients [78] where up to 75% of cancer patients are wrongly diagnosed as 
non-osteoporotic. 
Clinical computer tomography (qCT) shows great potential to provide 
more accurate diagnoses of osteoporosis and fracture risk estimations 
(discussed in the section: 2.6), however its higher radiation dosage (30-
100µS for the spine [20]) is a significant factor to be considered before 
replacing DXA in osteoporosis screening. 
2.2.1.2 Osteoporotic fractures and their systematic clinical impact  
In symptomatic osteoporosis the clinical goals are the prevention of the 
gradual loss of bone quality and treatment of fractures if they occur. The 
spine is one of the most common sites of osteoporotic fractures and 2.35 
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million new VCFs were estimated to have arisen in 2010 in the EU [72], the 
number of which is expected to rise by about 16% by 2020 across most 
western countries [79-81]. Postmenopausal women are more likely to 
develop osteoporosis (increased incidence by 60%), however the age-
standardised mortality and health consequences appear to be higher in 
men [4, 82]. 
Osteoporotic fractures represent a long-life debilitating event which can 
lead to further disability and early mortality, hence efficient prevention of the 
fractures is the stated aim of many biomechanical and clinical studies.  
2.2.1.3 Treatment of osteoporosis 
Treatment of osteoporosis is based on medication to sustain or increase 
the bone mass and hence, restore its natural strength. Maintaining a good 
lifestyle and changing to a healthier one may be recommended.  As the 
patient becomes older, medical treatment to induce and/or maintain bone 
quality may be prescribed such as the use of bisphosphonates.  
 Metastases to bone 2.2.2
Metastases are so-called secondary tumours as they are related to 
another neoplastic disease located elsewhere. They are usually 
asymptomatic until the structure of the surrounding bone is affected, which 
may lead to functional changes and fracture. Changes in bony structure are 
very rarely accompanied by adequate structural adaptation and an elevated 
risk of failure of the bone is often noted [83]. 
2.2.2.1 Metastasis: Definition and occurrence 
The growth of secondary tumours is a malignant process involving 
cancerous cells spreading from their original site [84]. The exact incidence is 
unknown due to difficulties in screening but it is believed to comprise about 
300,000 cases annually in the USA [19, 85]. 
Due to a high vascularisation of the trabecular bone there is a higher 
chance for the cancer cell to infiltrate the vertebral body. Incidence increases 
with age with the highest peak at 50 years but is very rare in children [86]. 
The most common primary tumours to metastasise to bone are breast, 
prostate, lung and thyroid [87]. Spinal metastases occur in more than 30% of 
all cases where the patient died from neoplastic disease, and in almost 80% 
of patients with breast or prostate cancer [9, 85, 88, 89]. The spine is 
affected in more than 50% of patients suffering from prostate, breast or lung 
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cancer. In general, the spine is the 3rd most common site of bone 
metastases.  
Bone metastases can result in three types according to an increased 
(osteoblastic) or decreased (osteoclastic) growth of the native tissue or a 
mixture of these two (Table 1). Bone as a living organ is closely related to 
the remodelling process by exhibiting activity where osteoclasts resorb the 
bone tissue and osteoblasts form new tissue at the same site. However, the 
presence of the cancer tissue creates a hostile environment resulting in the 
uncontrolled behaviour of tissue remodelling. The initial management of the 
tumour has not yet been clearly described, but it is believed that the change 
in the bone tissue is related to a hormonal reaction unbalancing the 
remodelling process in the vicinity of the lesion [84]. This results in most 
cases in osteolytic lesions (~70% of incidences of bone metastases). Purely 
osteoblastic lesions are rather rare (~10%) and mostly develop in breast and 
prostate cancer patients [86] but however dense this new tissue is the 
vertebral strength is unlikely to be increased.  
Cancer type Incidence of Bone 
Metastases 
Nature of Bone Metastases 
Myeloma 70-95%  
Renal 20-25% 
Melanoma 14-45% 
Bladder 40% 
Thyroid 60% 
Lung 30-40% 
Breast 65-75% 
Prostate 65-75% 
Table 1 Incidence of metastases and bone reaction due to presence of 
cancer, ratio between osteoblastic/osteoclastic bone formation [3] 
Multiple myeloma (MM) is a rare type of cancer accounting for about 1% 
of newly diagnosed cancer cases with a very low full recovery rate. The 
survival time is five years in about 15-20% of cases and less than one year 
Osteosclerotic (forming 
lesions osteoblastic in nature) 
 
Osteolysis (forming lesions 
osteolytic in nature) 
- 21 - 
when MM bone lesions are present and untreated [9]. The average age of 
patients with diagnosed MM is 50 years and 2/3 of affected patients are 
men [90-92]. Myeloma is a malignant cancer of plasma cells resulting in 
widespread osteolytic bone deterioration where bone is replaced by a dark 
red gelatinous cancer tissue [93, 94] and the prognosis in developing 
metastases is between 95-100% [9]. Osteolytic effects are caused by an 
osteoclastic/blastic imbalance in the remodelling process where osteoclasts 
are stimulated by cytokines released by plasma cells and resorption 
becomes dominant in the remodelling process. Despite the ubiquitous nature 
of the disease, the osteolytic reaction tends to be confined resulting in 
localised lesions [95]. The structural changes in myeloma patients are in 
general not accompanied by osteosclerotic bone growth but in most cases 
are associated with a generalised osteoporosis. Healing of the bone can be 
observed only in patients who are in complete remission from the 
disease [96]. MM lesions are characterised as irregular in shape and lacking 
a periosteal re-healing effect on the interface between lesion and 
surrounding bone, which results in a reduction of bone structural 
properties [95]. 
2.2.2.2 Clinical and patient related impact due to metastatic infiltration 
– scoring systems 
Structural weakening of the vertebral body can have catastrophic 
consequences on patients’ quality of life. Excluding osteoporosis, the most 
common cause of pathological fractures of a bone is a metastatic disease. 
Up to two-thirds of patients where metastases are already formed will 
experience debilitating skeletal related events (SREs) and related disability 
and severe bone pain [8]. As the occurrence of fractures is higher in patients 
with metastases in general [6] and the risk of fracture is even elevated in 
patients with MM cancer [83], a reliable scoring system and fracture 
prediction tool to assess weakened structure is needed.  
Apart from differentiation based on the nature of bone metastases, more 
complex classifications use information based on the compartmental state of 
the vertebra, whether the cortical wall was breached and the general 
performance of the patient (depicted in Table 2). These scoring systems 
indicate recommended surgical treatments and predicted survival periods 
specific to the patient. The scoring system proposed by Tomita [30] is based 
on three prognostic factors:  
i. grade of malignancy (slow growth, 1 point; moderate growth, 2 
points; rapid growth, 4 points) 
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ii. visceral [internal organs] metastases (no metastasis, 0 points; 
treatable, 2 points: untreatable, 4 points) 
iii. bone metastases (solitary or isolated, 1 point; multiple, 2 points).  
Summation of the score points indicates the life period prognosis (2-3 
points indicates 18-84 months, whereas 6-7 points decreases the prognosis 
to 5-33 months [30]); this demonstrates that for example only a single 
occurrence of multiple metastases decreases the lifetime prognosis by half. 
Surgical recommendation for score groups 2-3 is marginal excision, and for 
groups with 4 to 5 points, intra-lesional or marginal excision is 
recommended. Immediate spinal stabilisation is recommended for patients 
with a prognostic score of 6 to 7 points for short term palliation, whereas 
patients with a higher prognosis score are generally not recommended for 
surgical intervention [30]. 
 
 
Table 2 Classification of the metastatic infiltration (red arrow) to spine 
according to Tomita et al. [30] 
An even more complex scoring system by Takahashi et al. [97, 98]was 
adopted and generally accepted as the current gold standard for both 
medical and scientific purposes when scoring the patient’s survivability. 
Takahashi’s classification combines the previous system with the general 
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performance of the patient, the location, origin and character of the 
metastases, whether the cortical wall has been breached, and most 
importantly how accessible and removable the lesions are. The aim of this 
system is to quantify and classify a survival prognosis and suggest a 
treatment procedure for the patient.  
2.2.2.3 Treatment of secondary tumour to bone - state of the art 
Once the metastasis is present the disease is very rarely treatable to 
complete remission and the focus is often palliative. Apart from the radio-
therapeutic and radio-pharmaceutic palliation for localised metastatic bone 
pain, there is no class of approved drugs for prevention or delay of bone 
metastases and to achieve a complete remission of the metastasis two 
possible options remain: removing the metastases surgically or preventing 
SREs by restoring the natural strength of the bone. Currently the cancer-
related bone complications are reduced through the use of a class of drug 
called bisphosphonates [8, 10, 99]. Subsequent pain management is 
however necessary for the patient with the help of controlled analgesic 
treatment, psychosocial therapy, functional therapy (physiomedical 
rehabilitation or physiotherapy), nerve blockage or epidural therapy.  
However bisphosphonates are not always recommended as a drug as they 
may induce growth of neoplastic tissue [100] and appear to be successful 
only in mid-term treatment [101]. 
Surgical intervention is a solution to be considered when bone pain is no 
longer manageable, to restore stability or to perform decompression of the 
nerves or the spinal cord [102].  The optimal treatment solution is often case-
specific and dependent on the neurosurgeon’s experience and abilities. A 
general approach is hardly to be recommended due to the non-uniform 
nature of the disease. However in younger patients, the tendency to remove 
the tumour completely remains even with a higher risk of complication. This 
can be achieved with en-bloc resection which prevents any possible spread 
of cancerous cells from the tumour site. Stabilisation metalwork tools require 
strong bone to anchor the screws and often cannot be used independently of 
other tools in older patients where the disease is combined with 
osteoporosis with increased bone fragility. In general open surgery is not 
recommended if it is not absolutely necessary due to the potentially 
chronically poor health condition of the patient and an increased risk of 
surgical complications [6, 12, 86, 103, 104]. 
Percutaneous vertebroplasty (PVP) [3, 12-14] and Kyphoplasty 
(PKP) [11, 12] appear to be alternative options in older patients where 
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complete remission of the cancer is unlikely. Vertebroplasty in metastatic 
patients uses synthetic acrylate (PMMA) which results in an ideal curing time 
and additionally its thermo-reaction while curing takes place, next to the 
stabilisation of the fracture, is also often believed to be an additional source 
of good pain relief results. Secondly, the injection of the cement provides a 
tool which non-destructively moves the cancer tumour from the structurally 
weakened site very often without corrupting the integrity of the lesion [12]. A 
further option is to combine the removal of the secondary tumour with 
subsequent augmentation. Biomechanical studies showed lower injection 
pressure is needed after removal with decreased complications due to 
extravasation in laser assisted removal-ablation [105] as well as in 
radiofrequency assisted removal – coblation [38, 104].  Despite its simplicity 
and efficiency, vertebroplasty in SREs related to cancer are still only 
possible with significant resultant complications [13] which are in most cases 
related to leakage [106, 107]. 
All of this, however, produces relatively poor results and leads to a 
significant burden being placed on medical care expenditure. It has been 
estimated that the palliative treatment of bone metastases exceeded almost 
$12.6 billion in the US in 2005, which comprised 17% of the total direct 
medical expenses for oncology [108]. One of the reasons is that up to 75% 
are misdiagnosed in fracture risk predictions based on BMD [78]. Hence an 
improvement in preventing and providing sufficient treatment SREs in 
patients suffering from the metastatic infiltration to bone would bring a great 
benefit on a large scale.  
2.3 Vertebral fractures 
 Definition, occurrence and classification of vertebral 2.3.1
fractures 
The vertebral compression fracture progresses through loads exceeding 
the strength of the vertebra. Such a fracture occurs when the bone structure 
is either weakened by the demineralisation process (general bone loss-
lowered BMD) or the presence of a secondary tumour (localised structural 
changes). The natural strength of the vertebrae is disrupted when the bone 
is replaced by tissue which comes with neoplastic pathology and replaces 
the natural bone. Even though very little is known about the mechanical 
properties of metastases, all types of metastases show a significant 
decrease in strength. Osteoblastic lesions which are defined by the 
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production of a form of compact bone do not appear to increase the strength 
of the bone [95].  
Vertebral fractures are classified according to their gross morphological 
shape change from a radiography examination. The classification comprises 
the severity of collapse and the anterior/posterior location of the compressed 
bone and has a defined height reduction of 20% or more [109]. Classification 
of fractures can be found in Table 3 however more than two thirds are 
asymptomatic and are never detected [74].  
 
 
Table 3 Vertebral Compression Fracture (VCF) classification according 
to Genant et al. [76] 
 Biomechanics of vertebral fractures 2.3.2
Vertebral fractures occur when loading exceeds vertebral strength. A 
typical fracture is a wedge fracture where the anterior wall fails to support 
the load and collapses. The overloading of vertebrae occurs due to either 
exceeding normal physiological conditions or when the bone structural 
properties are weakened due to pathological changes such as generalised 
osteoporosis or cancer infiltration. 
Due to marginal variation in mineral composition of the naturally 
occurring bone [49], the bone structural properties together with bone 
mineral density are believed to be by far the most contributing factor to 
vertebral strength [20, 22, 54, 59, 64, 68-70, 110-112]. Osteoporosis 
appears to have no or very limited effect on the mechanical properties of the 
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bone at the tissue level [21, 36]. This implies that the alteration arises from 
the reduction in bone mass. However it is still debated whether this also 
applies for metastatic tissue [67, 68]. At organ level this type of fracture can 
be reproduced ex-vivo with a combination of compression and bending 
testing. 
 Treatment of vertebral compression fractures - state of the 2.3.3
art 
Treatment of VCF arising from both spinal metastases and osteoporosis 
was traditionally recommended to comprise bed rest, immobilisation and/or 
use of analgesics for pain management. However with increasing life 
expectancy, treatments with an emphasis on an improved quality of life for 
severe osteoporosis or cancer suffering patients have become less 
important and are increasingly supplemented with minimally invasive 
treatment techniques.  
The aim of VCF treatment mirrors the need to protect the patient from 
pain. The secondary aim is to restore stability of movement whilst protecting 
the spinal cord. Principally, management can be classified by three major 
possible solutions: conservative treatment, immediate decompression or the 
stabilisation of the spine. Classic pedicle screws or spinal fusion show good 
results in younger patients, however according to Gebhard [113], in patients 
with generalised and severe osteoporosis, use of cement-augmented screws 
is recommended as the weakened structure can no longer support the 
inserts and becomes susceptible to loosening of the screws.  
In general, open surgery is not recommended in patients with cancer as 
their general condition and lowered immunity increases mortality. On that 
account palliative treatment accompanied by a combination of spinal 
function restoration with minimally invasive surgery would be a great 
advantage. Vertebroplasty (PVP) is increasingly used as such a technique. 
During this key-hole surgery technique a small amount of polyacrilate or 
mineral based cement is injected through an inserted needle directly into the 
vertebral body under fluoroscopic guidance.  
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2.4 Vertebroplasty in VCF treatment 
 PVP in osteoporotic fractures 2.4.1
Indication for treatment of vertebral fractures comes from a detailed 
examination of the patient including identification of localised tenderness or 
severe back pain (localised or in some cases intractable), confirmed by a 
radiographic and/or MRI examination. After careful examination the patient is 
prepared for the operation lying face down either under a full or local 
anaesthesia. Trocar (a cannula with inserted hollow needle) is pierced 
through the skin at such an angle so as to be pointing to the anterior part of 
the affected vertebral body through pedicles. When the trocar is introduced 
through a pedicle under fluoroscopy guidance, the hollow needle is retracted 
and vertebral body is filled through the cannula with slow retraction to 
introduce a sufficient volume of cement without extravasation. Once the 
vertebral body is sufficiently filled, the needle is retracted leaving only small 
signs of the intervention.  
Introducing the cement through both pedicles (bi-pedicularly) compared 
to a single pedicle approach results in higher strength [32], preventing 
collapsing of the vertebra to non-augmented side [31, 32], however as stated 
by Tohmeh et al. [32] even the uni-pedicular approach provides sufficient 
restoration of both strength and stiffness. Injected trans-pedicularly, vertebral 
stiffness is higher compared to the extra-pedicular approach [114] whereas 
no difference was found in restoration of strength.  Although biomechanically 
the aim of the procedure is to prevent further the collapse of the vertebra by 
the injection of a sizable quantity of cement, it has been observed that even 
small quantities of the injected agent may be sufficient for pain relief in the 
near- and medium-term.   
Clinically between 1-6mL (~10-30%) [115] is being injected or the 
endpoint of injection is limited to avoiding possible extravasation [116], 
supported by cadaveric studies suggesting that even small cement volumes 
can restore the vertebral strength depending on vertebral size [28, 29, 117]. 
A study by Molloy [27] suggested 30% vertebral body fill to restore the 
stiffness which is in agreement with a recent clinical study by Nieuwenhuijse 
et al. [118] where 24% vertebral body fill was proven the most beneficial in 
terms of pain relief. Higher volumes are questionable due to an increased 
risk of extravasation [106, 116, 119] without any effect on biomechanical 
enhancement as stiffness and strength were found to be only weakly 
correlated with the volume fill [28, 117, 120]. 
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As the PMMA cement sets in less than thirty minutes the patient can be 
discharged home after a short period of post-operative nursing care when 
the anaesthetic has worn off, usually the same day with rapid pain reduction 
reported within a few days of intervention [121, 122]. For CaP cements the 
length of recuperation may be longer due to the slower setting of this 
cement. 
The exact mechanism of the pain relief is still not adequately reported 
but is believed to be attributed to exothermic reaction (>70ºC) during curing 
of the PMMA, the toxic effect of the monomer on tumour cells and/or 
prevention of micro-fractures in the bone [123]. Both the thermoreaction and 
the toxic effect however only partially explain the pain relief, while non-
thermoreactive, non-toxic calcium phosphate (CaP) cements have also been 
reported to provide satisfactory pain relief [124, 125].  More generally, it is 
believed that the pain relief comes from the stabilisation mechanics where 
the fractured bone (and micro-fractures) are supported and constrained 
against any micro-motion. 
 Vertebroplasty in metastatic bone 2.4.2
Conservative non-operative treatment in cancer patients with bone 
metastases includes drug and hormone treatment as well as extensive 
chemo and/or radiotherapy [126]. However, these modalities usually have a 
slow effect on pain relief (the radiotherapy has a delayed effect of 2 weeks to 
effective pain relief and 12-20 weeks for maximal benefit of pain 
reduction [127]). Open surgery management is often contraindicated by poor 
life prognosis where several guidelines do not recommend operating under 
an estimated life expectancy of three months [104]. Even though comorbidity 
in treatment of spinal metastases is generally accepted, the use of a 
minimally invasive pain reduction tool such as PVP [128] might be advisable 
to improve quality of life in late stages of the disease.  As spinal metastases 
most frequently involve the anterior elements [129], vertebroplasty shows 
very promising results in osteoporotic patients and currently the use of the 
technique is expanding to cover treatment of spinal VCF due to neoplastic 
infiltration. Neoplastic tumours can either be removed using specialised 
approaches [105, 130] or carefully displaced by injecting cement in proximity 
of the lesion, which may however increase the injection pressure compared 
to PVP in osteoporotic bone alone and lead to uncontrolled 
extravasation [106]. 
Studies here listed showed the impressive potential of PVP in providing 
fast and efficient pain reduction treatment with a much lower complication 
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rate when compared to open surgery [104]. However more long-term follow-
ups and randomised controlled trials need to be conducted.  
 Complications and controversy surrounding vertebroplasty 2.4.3
As a relatively young technique (first used by Galibert et al. [131]), 
aspects of the PVP approach are still evolving and the need for randomised 
controlled trials (RCTs) have been sought to ascertain the most effective use 
of this technique. This section though focuses on the possible complications 
and controversies that have arisen from subsequent RCTs.  
2.4.3.1 Controversy of PVP 
Studies by Buchbinder et al. and Kallmes et al. [15, 16] questioned the 
beneficial effect in a sham study comparing PVP and placebo and reported 
no difference between the groups. Buchbinder et al. compared, in a 
multicentre single-blinded, randomised trial, thirty-five patients given PVP 
and thirty-six patients with a sham injection. No benefit was observed 
amongst either group at a 6-month follow-up. Kallmes in a similar study 
compared 68 to 63 patients provided with PVP and sham treatment, 
respectively.  Similarly no beneficial effect was found during the follow-up. 
Even though both studies were very well conducted their results raised 
questions, and yet were at odds with clinical experience from different 
medical centres elsewhere. Both studies were criticised to have imposed a 
number of limitations e.g. exclusion criteria (>50% of patients in Kallmes 
group,>70% of patients in Buchbinder’s), suboptimal treatment (injected 
cement fills <10% VB) and misdiagnosis (MRI not used to confirm acute 
fractures). Further, the sham group was not an approach that could be 
utilised in clinical practice and hence did not allow the surgeon any 
alternative therapy. 
Contrary to studies by Buchbinder et al. and Kallmes et al. [15, 16] 
numerous clinical studies report significant and rapid pain relief in patients 
with osteoporotic (e.g. [17, 18, 89, 115, 118, 123, 132-135]) and/or 
neoplastic disease (e.g. [13, 107, 128, 136])  
However, inconsistency in the beneficial effect shows that more studies 
are required to underpin all aspects of vertebroplasty in its clinical use. 
Biomechanical studies are needed to determine the effect of parameters 
such as volume fill and/or the use of prophylactic augmentation, as well to 
develop and tailor the vertebroplasty materials to provide pathology-targeted 
treatments. 
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2.4.3.2 Complications  
Vertebroplasty currently has three main indications for use in treatment 
of vertebral fractures. These comprise of fractures due to 1) high impact 
load, 2) osteoporotic bone loss and 3) presence of spinal metastases. Each 
indication has, however, a substantial risk of complications. In general, the 
most significant potential complication is damage to neural tissue in 
proximity of the vertebra. PVP in metastatic spine is related with increased 
rate of complications [13] the majority of which are due to leakage [106]. 
The material used can also contribute to an increased occurrence of 
complications. Using PMMA cement can lead to catastrophic effects of 
thermal [137] and mechanical damage [107] to the spinal cord, and is 
believed to be the cause of increased occurrence of fractures in levels 
adjacent to those augmented [119, 122]. The true reason for the adjacent 
fractures is however still unknown as they may also arise from a related 
change in spinal shape after the fracture occurs as well as from the natural 
progression of the osteoporosis.   
Alternative biodegradable bone cements however lack biomechanical 
support with which to augment the weakened structure [138] and are 
currently recommended for fractures of little instability or where stabilisation 
is provided by instrumentation, say, as in a burst fracture.  However, CaP 
cements are of great interest due to their predicted long term outcomes with 
bone remodelling [124].  
The biomechanically related complications arise, in part, from the lack of 
basic science in PVP and several key factors remain to be solved [139]. 
These comprise investigating the importance of cement distribution [28, 
120], biocompatibility/biodegradability [30] of the material used and tailoring 
its mechanical properties [23, 25, 128]. More clinically-focused questions 
include the timing of treatment [3, 140] and long-term outcomes, especially 
those due to the occurrence of an adjacent fracture [122, 141, 142].  
2.5 VCF cadaveric studies 
The biomechanics of osteoporotic vertebral fractures at the organ level 
has been widely studied both clinically and biomechanically [21, 22, 50, 52, 
66, 143], however fractures arising from metastatic infiltration in the spine 
are relatively poorly understood [83, 95, 144, 145]. This section focuses on 
the most essential aspects of designing a study investigating the 
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biomechanics of wedge compression fractures in bone with metastatic 
infiltration. 
 Biomechanics in cadaveric studies 2.5.1
Vertebral fracture occurs when the loading exceeds vertebral strength 
due to either a much higher than normal impact loading in physiological 
conditions [39] or compromised bone quality [1, 75, 87, 146]. Loading occurs 
in the form of compression, rotation, shear or distraction forces or a 
combination of these and can be simulated in-vitro by introducing specific 
boundary conditions applied to the specimen. Here, as the scope of the 
study is to investigate the wedge compression fracture (WCF), the aim is to 
replicate fractures falling into the category of anterior severe fractures 
according to Genant et al. [109] as categorised in Table 3. 
Conditions with which to induce a wedge fracture on a single vertebra 
have been proposed by a number of authors. The generally accepted 
conditions are those in which the specimen is subjected to combined 
compression and anterior bending by means of eccentric loading. In studies 
by Tschirhart et al. [39], Whealan et al. [2] or Windhagen et al. [147], the 
authors used a set of hydraulic actuators to simulate such conditions, 
whereas other authors [3, 29, 38, 65, 66, 144] proposed using a ball joint to 
simulate similar conditions at lower cost where fixed single axis loading is 
desired. 
In all the works mentioned, the preloading cycle (e.g. [64, 66] is followed 
by compression of the specimen to failure [39] or to a predefined reduction 
of the vertebral height [3, 64]. This is usually driven either by subjected 
load [64, 146] or displacement of the cross-head through which the load is 
applied [3, 65, 66] with subsequent unloading.  
Typically the load-displacement curve from such loading consists of a 
non-linear toe-region, followed by a linear elastic region until the specimen 
begins to yield reaching the first peak (zero-slope) fracture load.  This is 
typically followed by post-fracture softening which can be explained by 
broken trabeculae of the cancellous bone sliding along each other, with a 
subsequent secondary increase in resilience due to pore-closure and 
densification of the compressed structure. There are however several 
techniques for ascertaining the stiffness: by using a linear fit within the most 
linear region [3, 29, 65], by qualitatively estimating where the slope appears 
to be at maximum, or as a combination of both where the slope is taken from 
the linear fit of a region with highest slope. Although a discussion around 
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appropriate techniques still persists, it seems that the most reproducible and 
robust is the one based on using a strain window [148, 149]. Such technique 
is discussed in more detail by Buckley [150], who states that despite the use 
of the linear fit within a manually selected region being generally accepted, 
using a 1% strain window approach provides better repeatability and a more 
user-independent tool to estimate the stiffness.   
The composition of testing specimens – i.e. number of levels tested - is 
still being debated from using single vertebra [3, 26, 29, 65, 66, 95, 144], two 
functional spinal units (FSU) [64] or multi-segment spinal specimens [2, 39, 
147]. The single vertebra studies show good consistency in simulating the 
wedge fractures, whereas a multi-segment study provides a more realistic 
loading scheme. In the latter, the adjacent intervertebral disks distribute the 
load more in a manner that is more akin to an in-vivo situation. However in 
this case the control of loading is limited.  
Compared to multi-level segments, a single vertebra embedded into 
PMMA guarantees control of the distribution of the load along the endplate. 
A recent finite element study by Maquer et al. [151] showed a good 
correlation between fracture loads determined when VBs were loaded 
through the vertebral disks and when embedded in PMMA. However, the 
study pointed out a distinct difference in damage concentration compared to 
loading a multi-segment. 
A special type of the single vertebra study with boundaries that are even 
more accurately defined is when both the cortical endplates are fully 
removed in order to create two perfectly parallel surfaces [152]. This was 
later improved to give an accurate description of the boundary states by 
using three differential transformers (LVDTs) attached to the top loading 
plate [66]. Such information was later used in developing more accurate FE 
models with the data providing validation [153].  
 Biomechanical assessment in vertebroplasty 2.5.2
The beneficial effect of PVP has been widely presented in clinical 
studies where pain is substantially reduced usually within days of the 
procedure and key studies thereof were presented earlier in the work. This 
keyhole surgical operation is a cheap and efficient way to reduce pain in 
patients treated for vertebral fractures caused by the presence of 
osteoporosis and collapsing vertebrae when cancer metastases are present 
within the spine. However, very little is known about biomechanical aspects 
of the treatment. 
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 Types of augmentation cement 2.5.3
The decision of which cement to administer to a patient is fraught with 
difficulty and currently often relies on surgeon preference, including selection 
from the numerous new formulations that are put forward by commercial 
companies. 
Ceramic cements show satisfying long term results as they remodel and 
are replaced by the surrounding bone, but are often more difficult to handle 
and have specific uses limited to stable fractures due to their lower strength 
which hence cannot provide the initial supportive effect within days after the 
operation. Hence these CaP cements benefit younger patients with good 
bone quality but would be contraindicated for patients with neoplastic 
disease due to concerns regarding the support of metastatic growth. 
The second type of cement, alternative to the ceramic one, is a much 
stronger acrylic material which is however almost five times stronger than 
natural bone and forms a stiff pillar compromising an unnatural distribution of 
loads with the index and adjacent vertebrae. Hence, a lower-modulus 
cement may help in reducing adjacent vertebral fracture.  Nonetheless these 
polymeric cements treat the condition, but sit unaltered in the bone and 
remain as a foreign body. 
 Prophylactic augmentation 2.5.4
Prophylactic augmentation is a way to reinforce the weakened structure 
before the fracture occurs and saves the patient from experiencing 
debilitating fractures. This intervention has so far provided good 
biomechanical results as it can maintain vertebral stiffness while supporting 
the vertebra to reach higher failure loads (e.g. [3, 154]), but it needs 
thorough investigation as most studies lack multi-segment testing which 
would truly reflect the biomechanics of adjacent levels. Moreover, the 
general tendency in clinical practice is not to use this approach as the state-
of-art prediction approaches lack a robust method in defining the weakened 
vertebrae.   
2.6 Predictions of vertebral compression fractures 
 Clinical models to identify vertebrae prone to fracture and 2.6.1
use of numerical models in clinical practice 
Despite increasingly successful treatment modalities such as 
vertebroplasty, a significant number of patients with osteoporosis or 
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metastatic infiltrations are not treated [155]. One of the main contributing 
factors to missing the opportunity for treatment lies in the failure to identify 
the risk factors for fracture.   
Assessing weakened vertebra or progression of osteoporosis is 
challenging and in clinical application it is currently based on empirical 
modelling such as using DXA based t/z-scores [5], a FRAX prediction 
tool [156], Fracture Risk Index (FRI) [157] or Trabecular Bone Score 
(TBS) [158]. All of the models compare the single subject to a large 
population of epidemiologic statistical models.  However, these models do 
not provide patient-specific pathological assessment such as determination 
of fracture risk in metastatic patients or in general in patients with variance in 
distribution of bone tissue, for example those with large deformities or 
osteophytes. 
 Engineering principles in fracture prediction 2.6.2
As published in 2003 by Bouxsein et al. summarising one decade of 
intensive collaboration of the biomechanical community on vertebral 
morphology-strength assessment: “Despite these new insights, important 
issues remained unresolved” [70], furthermore the same author describes a 
necessity to link clinical models with engineering principals to characterise a 
bone’s ability to resist fracture.  
Here, one of the first models was proposed [64], a simple engineering 
principle taken from a strength assessment gained when subjecting structure 
to compressive loading. The author used the product of the volumetric BMD 
(representing characteristic of the material) and the endplate area. Later the 
model was altered to match engineering structural principles of the weakest 
slice and the product of BMD and minimal cross-section area was 
used [148]. Both methods, using the endplate or minimal cross-sectional 
area, showed good correlation when predicting the vertebral strength 
(˜R2=0.6 for endplate area[64] and ˜R2=0.7 for minCSA [66]). Despite a high 
correlation between predicted and tested vertebral strength, from an 
engineering point of view, this approach is successful only when subjected 
to pure compression with a lack of flexural moment. It is due to this missing 
component of accounting for bending forces that they fail to predict anterior 
compression fractures where eccentric forces are implied. Moreover, despite 
its relatively good results in correlation to in-vitro experiment strength values, 
the method also fails to assess the vertebral weakness qualitatively. 
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The Finite Element (FEA) approach has in the last decade been shown 
to be a useful tool in assessing the behaviour of the bone when subjected to 
extensive load (e.g. [26, 28, 65, 66, 151, 159]). Such models are effective 
tools in underpinning the basic science and have worked well in helping to 
design an appropriate experimental setup prior to cadaver testing. FE 
models have also shown potential in accurate prediction of fractures [66], 
even in samples such as those with metastatic infiltration [160, 161].  
A summary of the different approaches used for predicting 
biomechanics of vertebral bone in Table 4 indicates a widespread range of 
success. Here, beside a more conventional indicator of correlation 
(coefficient of determination (R2)), published data were also reanalysed to 
provide the mean difference and limits of agreements (± 1.96 standard 
deviation) as a measure of the statistical metric of agreement between 
measured and predicted datasets as proposed by Bland-Altman [162]. Each 
dataset was obtained from published predicted-measured plots using plot 
digitising software [163].   
Comparison shows that more sophisticated methods have relatively 
good prediction power (between 0.78 and 0.96) but similarly to other 
methods often do not agree with experimental data also with respect to the 
1-1 line. This is in the majority of cases due to a limited number of samples 
counterbalanced by repeating optimisation of the sample-specific model.  
Even though the FE approach shows promise once the model is 
properly calibrated, it faces challenges such as the fact that it often requires 
(i) well defined boundary conditions; (ii) complex geometry which comes with 
demanding high computational requirements; and (iii) demanding resources 
in terms of high resolution input images. Even though high resolution images 
for voxel based models (e.g. [112, 164]) can be obtained ex-vivo using 
techniques such as XtremeCT (side of an isotropic voxel down to 0.082mm) 
or microCT (down to 0.004mm), in-vivo modelling is limited to homogenised 
FE models [65, 165] from qCT images (2-0.5mm depending on allowed 
radiation exposure). Moreover, due to the challenging computational 
complexity the computational models often have their number of elements 
reduced in order to minimise the computation time required [166]. This 
however results in an influential partial voxel effect where for illustration a 
single trabecula (thickness ˜0.1mm) can fit the voxel in cross-section ten 
times and the cortical shell (thickness ˜0.3mm) almost three times. Despite 
these challenges the FE approach shows promising results even in post-
yield characteristics [153] with accurate input data and boundary conditions. 
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Authors No. of 
samples 
(donors) 
Demog
raphics 
Age of 
donors 
In-silico to experiment strength prediction 
In-silico 
approach 
R
2
 Mean 
[kN] 
LoA 
[kN] 
Boundary 
conditions 
Dall’ara et 
al. [167] 
N=37(10) OP 44-82 analytical: 
minCSA*BMD 
0.70 N/A
‡
 ±1.81 EPs, PEs 
Removed 
Crawford et 
al. [65] 
N=13(13) OP 37–87 analytical: 
minCSA*BMD 
0.65 N/A
†
 ±2.64 EPs Fixed,  
PEs Removed 
Zainali et 
al. [168] 
N=9(3) OP 42
‡
 analytical:  
axial rigidity 
(σuBV/TVmin) 
0.85 -0.85 ±0.68 EPs Fixed,  
PEs Removed 
Buckley et 
al. [148] 
N=27(30) OP 80-97 analytical:  
axial rigidity 
(EAmin) 
0.80 N/A
†
 ±1.28 EPs Fixed,  
PEs Removed 
Windhagen 
et al. [147] 
N=30(30) mixed* 48-99 analytical:  
axial rigidity 
(EAmin) 
0.85 N/A
†
 ±1.18 3 levels 
segment 
Whelean  
et al. [2] 
N=18(34) mixed* 37-102 analytical:  
beam theory 
0.69 -0.43 ±1.24 3 levels 
segment 
Crawford  
et al. [65] 
N=13(13) OP 37–87 linear elastic FE:  
voxel-based 
0.85 -1.3 ±1.86 EPs Fixed,  
PEs Removed 
Dall’ara  
et al. [167] 
N=37(10) OP 44-82 non-linear FE: 
homogenised 
0.78 1.28 ±2.10 EPs, PEs 
Removed 
Pahr  
et al. [169] 
N=37(10) OP 44-82 non-linear FE: 
homogenised 
calibrated 
0.92 0.1 ±0.96 EPs, PEs 
Removed 
Zainali  
et al. [168] 
N=9(3) OP 42
‡
 linear elastic FE:  
voxel-based 
0.82 -0.04 ±0.84 EPs Fixed,  
PE Removed 
Zainali  
et al. [168] 
N=9(3) OP 42
‡
 linear elastic-
linearly plastic 
FE: voxel-based 
0.92 0.86 ±0.53 EPs Fixed,  
PE Removed 
Buckley  
et al. [170] 
N=75(44) OP 54-97 linear el.-perf. 
plastic FE: 
voxel-based FE 
0.80 -0.38 ±1.32 
EPs Fixed,  
PE Removed 
… table continued on following page… 
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Authors No. of 
samples 
(donors) 
Demog
raphics 
Age of 
donors 
In-silico to experiment strength prediction 
In-silico 
approach 
In-
silic
o 
appr
oac
h 
In-
silico 
appro
ach 
In-
silico 
appro
ach 
In-silico 
approach 
Imai  
et al. [171] 
N=12(4) mixed** 31-83 linear el.-perf. 
plastic FE: 
homogenised 
0.90 -0.05 ±0.57 EPs Fixed,  
PE Removed 
Imai  
et al. [171] 
N=12(4) mixed** 31-83 linear elastic-
linearly plastic 
FE: 
homogenised 
0.96 0.25 ±0.51 EPs Fixed,  
PE Removed 
Chevalier  
et al. [172] 
N=12(4) OP 47-83 fabric non-linear 
FE:  
voxel-based 
0.76 1.94 ±2.03 EPs Fixed,  
PE Removed 
Chevalier  
et al. [172] 
N=12(4) OP 47-83 fabric non-linear: 
homogenised 
0.89 1.75 ±1.55 EPs Fixed,  
PE Removed 
Legend: “Mean” - mean of difference between experiment and predicted strength, “LoA” – limits of agreement;  
Demographics: “OP” - healthy or osteoporotic, “mixed*” - simulated lesions, “mixed**” –author’s note gives a list of 
deaths including one from bladder cancer (not distinguished in statistics); Age of donors: “42
‡
” average donor age 
(range not listed); Mean: “N/A
†
” data pooled from retrospective linear fit; Boundary conditions: “EP fixed” - both 
endplates were embedded in parallel PMMA end-caps, “PE removed” - posterior elements were cut/trimmed at 
vertebral body, “Bot EP fixed” - bottom endplate embedded in PMMA whilst PMMA “impression” positioned on top 
endplate, “NU intact” - neural arch was kept intact whilst processes were trimmed 
Table 4 Comparison of assorted in-silico approaches used in vertebral 
body fracture prediction models  
A compromise to the complex FE modelling method is the use of 
engineering principles known as composite beam theory which is then 
applied to the bone structure. Such an approach was for example used by 
Snyder et al. [145] and on whole vertebral bodies by Nazarian et al. [68] 
where cored metastatic samples were subjected to stepwise loading. Here, 
the density information obtained from the tomographic examination is 
converted to a modulus map and the weakest slice is identified as a slice 
with minimal strength. Compared to the complex FE modelling, the limitation 
of this approach is that apart from identifying the weakest slice it lacks a 
qualitative aspect of evaluation. However, the method has been shown to be 
superior in providing better correlation to experimental strength then BMD 
standalone or BMD X minCSA. The full potential of this technique still needs 
to be explored including within the clinical setting.  
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2.7 Morphology and material properties of the bone 
 Material properties of human bone 2.7.1
Bone as a hierarchical material can be investigated on different levels of 
its composite structure. Pooled from literature [55, 173-175], the trabecular 
bone has hierarchical mechanical properties at the following levels: 
i. Macroscale: “At the whole organ” (in order of cm, stiffness ˜1.5kN/mm) 
ii. Mesoscale: At the trabecular bone (in order of mm, Young’s modulus(E)= 
˜0.5 GPa) 
iii. Microscale: Bone structural unit (single trabecula) (order or 100s µm, E= 
˜15GPa) 
iv. Sub-microscale: Single lamella level (2-7 µm, E= ˜30GPa) 
v. Nanoscale: Mineralised collagen fibrils and Hydroxyapatite crystals (order 
of 100s nm, E=˜1GPa and 100sGPa respectively) 
Only limited work has been done to assess the material properties at the 
nano-scale, the undertaking of which remains technologically challenging. 
Experimental challenges were however bypassed using the computational 
approach of multiscale modelling [177-179]. 
At the sub-microscale, the single lamella can again be investigated by 
computational modelling as a composite of a matrix embedded network of 
preferentially oriented fibrils reinforced by apatite crystals [175, 176, 180, 
181] or by means of diamond tip indentation tests adopted to such a small 
scale (nano-indentation) [174, 182].  
Stepping up to mesoscale, the single trabecula can be measured by 
means of micro-indentation; here the hardness and stiffness can be derived 
from indenting the bone tissue with a tip substantially larger than the 
trabecular lamellae. Results show that both the hardness and stiffness were 
independent of age, gender or progress of osteoporosis [36, 183, 184] and 
this was confirmed even at the lamellar level [185, 186]. Even though the 
bone tends to act as an anisotropic material, studies by Wolfram et al., Rho 
et al. [36, 51]describe it as transversally isotropic with a ratio of 
longitudinal/axial anisotropy ranging only from 1.1 to 1.3 (at its largest in 
cranio-caudal bone orientation direction).   
To this point there is only one study in the literature where metastatic 
bone has been assessed. Here, Nazarian et al. [68]reported that both the 
hardness and stiffness measured by means of nano-indentation are half of 
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the values when compared to osteoporotic and healthy patients. However, 
the reported values of the elastic tissue modulus of healthy bone (0.47 GPa) 
are almost two orders of magnitude lower than the ones reported in the 
literature (~10-20 GPa depending on the sample conditions and anatomical 
sites e.g. [184, 187]) This indicates possible problems in their experimental 
procedures or a large effect of damage on the bone indentation 
properties [35] which is typical for bone subjected to yield. This is also later 
contradicted in the same publication when cored samples from the same 
donors were subjected to compression at mesoscale (results comparable 
with those published elsewhere [30, 188, 189]) and it was concluded that 
metastatic trabecular bone biopsies showed similar mechanical properties 
(elastic modulus and yield strength) compared to osteoporotic bone once 
bone density was accounted for [68]. 
 Bone material models for fracture prediction 2.7.2
Bone mechanical behaviour modelling and fracture prediction are for 
obvious reasons strongly dependent on the specified material properties 
(e.g. [190]). The bone material model determines the properties of the 
element and if not set correctly will result in a poor agreement between the 
simulation and the modelled physical situation. By using modern imaging 
tools such as CT, the aspect of variance in porosity can be accounted for; 
nevertheless the bone material model derived from density-based imaging 
tools has still not been adequately investigated. 
This section discusses experimentally obtained material models with a 
focus on using the models from CT-data and the mathematical relation 
between the modulus of elasticity (E) and measured tissue density (ρ). 
Through a series of experiments Kayak et al. [191] reported that hydrated 
tissue mass correlates to the mass of bone tissue when burned to an ash 
and similarly to its density, measured by means of tomography assessment 
with high correlations between all steps reported (ρdry->ρash r=0.996 and   
ρwet->ρash r=0.99, ρash->ρct r=0.98). Although the correlation in the reported 
study was not presented alongside indications of the agreement, the study 
strongly indicates that the non-mineral component of the bone remains 
consistent and therefore the density-based imaging tools, even though 
predicting only the mineral component of the bone, can be used to predict 
material properties of tissue in-situ. To clearly summarise, the definitions of 
the densities used in literature and within this study are defined in Table 5. 
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Nomenclature Abbreviation Units Details 
Apparent 
density 
ρapp 𝑔
𝑐𝑚3
 
ℎ𝑦𝑑𝑟𝑎𝑡𝑒𝑑 𝑡𝑖𝑠𝑠𝑢𝑒 𝑚𝑎𝑠𝑠
𝑢𝑛𝑖𝑡 𝑣𝑜𝑙𝑢𝑚𝑒
, as derived from 
experimental measurement 
Apparent dry 
density 
ρdry 𝑔
𝑐𝑚3
 
𝑑𝑟𝑦 𝑡𝑖𝑠𝑠𝑢𝑒 𝑚𝑎𝑠𝑠
𝑢𝑛𝑖𝑡 𝑣𝑜𝑙𝑢𝑚𝑒
, as derived from experimental 
measurement 
Ash density ρash 𝑔
𝑐𝑚3
 
𝑎𝑠ℎ 𝑐𝑜𝑛𝑡𝑒𝑛𝑡
𝑢𝑛𝑖𝑡 𝑣𝑜𝑙𝑢𝑚𝑒
, as derived from experimental 
measurement 
CT density ρct HU derived from attenuation coefficient (mineral 
component only), calibrated against 
phantom with known density 
Bone mineral 
density 
BMD(vBMD) 
or ρBMD 
𝑚𝑔𝐻𝐴
𝑐𝑚3
 
 
𝑚𝑖𝑛𝑒𝑟𝑎𝑙 𝑐𝑜𝑛𝑡𝑒𝑛𝑡
𝑢𝑛𝑖𝑡 𝑣𝑜𝑙𝑢𝑚𝑒
, units based on calibration 
phantom used 
radiographic 
BMD 
BMD(aBMD) 𝑔
𝑐𝑚2
 
𝑝𝑟𝑜𝑗𝑒𝑐𝑡𝑒𝑑 𝑚𝑖𝑛𝑒𝑟𝑎𝑙 𝑐𝑜𝑛𝑡𝑒𝑛𝑡
𝑎𝑟𝑒𝑎
 
Bone volume 
fraction 
BV/TV 1 𝑠𝑒𝑔𝑚𝑒𝑛𝑡𝑒𝑑 𝑏𝑜𝑛𝑒 𝑣𝑜𝑙𝑢𝑚𝑒
𝑢𝑛𝑖𝑡 𝑣𝑜𝑙𝑢𝑚𝑒
, strongly dependent on 
BMD-to-BV/TV conversion or segmentation 
method used 
Porosity - 1 1 − 𝐵𝑉/𝑇𝑉 
Table 5 Technical annotation of different densities and density-based 
morphological indices 
In order to postulate a relationship between the density and stiffness of 
the bone, experimental testing needs to be performed. This approach for 
assessing the material properties usually comprises platen testing [111, 188, 
191-198], 3 point bending [199, 200] and the use of end-caps [196, 201, 
202].  In the platen test, samples are compressed between two plates and 
the stiffness is derived from the load-deformation curve recorded by the load 
cell. The end-cap method tries to avoid detrimental consequences (artefacts) 
due to structural and frictional end-effects at the interface between the 
sample and platen by casting the bone’s end into a PMMA disk [196]. The 
three-point bending test is predominantly used for long bones but was used 
also by Snyder at al. to investigate stiffness of the cortical bone [200]. 
Supported by the authors listed above the mathematical relation 
between density and modulus can be expressed thusly as a power law (eq. 
(1.1)): 
 𝐸 = 𝑎 + 𝑏𝜌𝐶  (1.1)  
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From the literature, for human trabecular bone “a” generally does not 
notably differ from 0, “b” varies from 0 to a few 10s, and the density powered 
by “c” varies from 0 to ˜3 (an average of 1.76 for pooled literature data). 
The predominant nomenclature has not been agreed on within the 
literature, and the nature of the density used in publication models varies 
from ρapp [149, 165, 194, 195, 197, 199, 200, 202-205], ρdry [188, 193], 
ρash [191, 192, 198], ρBMD [201] to BV/TV [33, 111], with each presenting a 
notably different material model. Any comparison of different models should 
be hence undertaken with appropriate normalisation. For example a 
publication by Helgason et al. [189]provided a comparison of models for 
human bone using known conversions between densities to normalise the 
input variable all to ρapp and normalise strain rates [206]. Such a 
normalisation however still showed a notable discrepancy between the 
results from different publications even for the same anatomical site and 
type of bone. 
The same authors conclude that although normalised, the dataset 
“cannot be assumed equally valid and cannot be pooled together 
statistically, to derive an average elasticity–density relationship”. They 
propose a retrospective numerical material model tuning using a training set 
to extrapolate a representative material model for a specific model. 
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  Chapter 3
Development of a fracture prediction tool 
The first objective of this thesis was to develop a fracture prediction tool 
for laboratory use which would allow improved assessment of vertebrae for 
use in designing experimental studies and potentially as a prophylactic 
augmentation tool where the weakened vertebra is targeted before the 
fracture occurs. This chapter hence focuses on developing such a tool while 
presenting verification and validation studies using cadaver samples 
representing structurally compromised vertebrae. The sections of this 
chapter comprise three distinct subchapters: 
i. Section 3.1 introduces the theoretical approach required to 
underpin the image processing based fracture prediction followed 
by detailed development steps of the composite beam theory 
fracture prediction tool. Moreover this section comprises initial 
validation using historical data. 
ii. Section 3.2 introduces the experimental protocol for testing a 
single vertebra used for structural assessment. This section also 
provides a full list of samples used for the purpose of this study, 
highlights methods of cadaveric testing and scanning and 
includes the initial fracture assessment of pathological samples 
diagnosed as osteoporotic (OP) and multiple myeloma cancer 
bone (MM) as well as samples from spines infiltrated with 
metastases (mets).  
iii. In the final section of this chapter (section 3.3) the proposed 
fracture prediction tool is deployed in order to predict the strength 
of weakened vertebrae in comparison to an actual experiment. 
Furthermore, the fracture prediction tool is tested to observe 
whether the time required for assessment is reduced, followed by 
a calibration of the material-law used. 
Each chapter comprises of an Introduction subsection, putting literature 
findings to appropriate context followed by the methods used, the results of 
the study and a discussion thereof. The entire chapter is then briefly 
summarised in the last section. 
- 43 - 
3.1 Development of an in-silico fracture prediction tool 
 Introduction to vertebral bone fracture prediction 3.1.1
Based on engineering principles, the structural properties and related 
fracture behaviour of a bone are attributes of a geometrical pattern 
combined with material quality. The geometrical disposition reflects the state 
of a bone which is prone to failure due to unnatural morphological 
changes [207] and is often undervalued by studies which present this only in 
the examination of healthy or heterogeneously affected tissue such as 
osteoporotic tissue. The  quality of underlying material properties results 
from the biochemical equilibrium in the microenvironment of the bone [49] 
and is represented by the spatial stiffness and yield potential. When 
combined, these attributes represent the structural rigidity of the organ and 
also, if being analysed quantitatively, contain information about whether 
bone is prone to fracture. 
Although the collagen component of a bone composite cannot be 
assessed using computed tomography (CT) a high correlation between the 
apparent and mineral density has been reported in literature [198]. Human 
bone tissue mineral composition appears in tomography images as a 
attenuation magnitude approximately equivalent to 1.5 gHA/cm3 [49]. Here, 
every prismatic reconstructed image unit (voxel) represents a ratio of mineral 
components within a particular volume which can vary from negative values 
(due to calibration where air appears at approximately -0.1 gHA/cm3) to the 
total maximum density of the bone. Hence, if the scanning resolution allows 
and the voxel is situated entirely inside the bone, a coarsening of the 
resolution will result in a variation between those two values, the so-called 
partial volume effect. This is important to understand in order to distinguish 
between prediction models based on a segmented (BV/TV) image and 
density based modelling. To some extent, the partial volume effect can be 
used as a measure of the porosity of the trabecular bone on a sub-voxel 
scale. This approach avoids a common issue in which the bone is 
segmented in an insufficient resolution but with an appropriate material 
model to represent a conversion between the partial content of the bone and 
the related modulus of elasticity.  
3.1.1.1 Finite Element modelling in WCF  
Mainly due to the recent availability of high performance computers, 
several studies also investigated the use of a finite element approach for 
assessing the material properties of the bone. Such an approach shows 
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substantial potential, particularly due to the convincing physical background 
of the method. This assures robustness and allows for the possibility of 
extending the same principles to different loading conditions. Also, 
compared to more simplistic analytic theories it can help to underline 
damage or fracture localisation and can be also deployed to investigate 
post-yield behaviour of the fractured bone [153]. However, there are many 
limitations to using this sophisticated approach such as well-defined 
boundary and loading conditions or computational time and costs [166]. As 
an example, one study [172] documented the time dependency of 72 
simulations of surface-based models and 12 simulations of voxel model as 
long as 60 days of cumulated processing time. 
3.1.1.2 Fast and simplistic engineering principle models 
This section compares data drawn from literature to find a relatively fast, 
yet reliable, straightforward method which could be used as a fracture 
prediction tool.  
Brinckmann et al. [64] proposed a prediction based on the product of the 
endplate area and BMD, giving agreement between the experimental and 
predicted strengths of R2=0.66 which was later improved by a more 
meaningful model representing the mechanic of solids in which the endplate 
area was replaced by a minimal cross-sectional area of the sample. Using 
this model, various authors [65, 167] observed correlations ranging between 
R2=0.65 and R2=0.70. When accounting for varying densities regardless of 
distribution, different studies [147, 168, 170] obtained even more reliable 
predictions ranging from R2=0.8 to R2=0.85. All three authors, despite using 
different notations, employed the axial rigidity of the weakest slice as the 
measure of the organ’s strength when subjected to compression. Similar to 
the model investigated in this study, Whealan et al. [2] have further shown 
that by adding a parameter accounting for flexural rigidity and incorporating 
both the variations in density together with spatial distribution, the prediction 
correlates much closer with experimental data when the sample is also 
subjected to combined loading. Here, according to physical principles, the 
authors used the engineering composite theory combining axial and flexural 
rigidities using a slender beam approximation, which resulted in a more 
robust structural assessment which is applicable to different test sets and 
loading conditions compared to pure compression models. 
Here, the composite beam theory has already been proven [65] to be 
competitive to computationally demanding finite element (FE) modelling 
where the requirement for high precision scanning as a precursor to FE 
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modelling still hampers clinical usability. This engineering beam theory has 
also been suggested to be superior to those methods based on BMD of the 
bone used in clinical practice [2]. However, this methodology has never been 
robustly validated against a wider range of neoplastic pathologies. This 
section aims to encompass a solid theoretical background for the proposed 
fracture prediction tool. It describes the development of the tool and presents 
subsequent verification and validation on historical data. Later this method 
will be used in a cadaveric study comprising three morphologically distinct 
pathologies. 
 Methods used in development of the fracture prediction tool  3.1.2
3.1.2.1 Composite theory approach 
The theoretical approach for determining strength comes from a coarse 
simplification based on the assumption that the whole spinal structure is a 
single unit. Based on the Euler-Bernoulli beam equation, the stresses in 
such a construct can be analytically assessed to determine its strength. A 
long thin unit under combined loading such as compression and bending can 
be simplified to a single slender beam. Then the stress is linearly distributed 
from the neutral axis to the most distant point on the beam’s surface. In the 
region of linear stress-strain curve, where the simplified Hooke’s law is still 
valid, the stress (σ) is proportional to the product of strain (ε) and elastic 
modulus (E):  
 𝜎 = 𝜀𝐸 (1.2)  
In the case of combined compression and bending, the strain (ε) at a 
particular distance from the bending (neutral) axis becomes: 
 𝜀 =
𝐹𝑍
𝐸𝐴
±
𝑀𝑦𝑐
𝐸𝐼𝑦
±
𝑀𝑥𝑑
𝐸𝐼𝑥
 (1.3)  
Here Fz corresponds to the compression loading whereas EA and EI 
represent the axial and bending rigidity and My is a measure of loading 
corresponding to moment loading. The maximal strain occurs at the most 
distant point from the neutral axis. Here, the theoretical assumption 
determines that the point of the highest strain will be positioned directly on 
the axis of symmetry which intersects with the load axis. This results in the 
assumption that “c” represents the distance between the point of highest 
strain and the neutral axis, whereas “d” is to be substantially lower allowing 
the contribution of the moment Mx to be disregarded (more on bi-axial 
eccentric loading and asymmetric beam theory can be found in Appendix G: 
Bi-axial eccentric loading) 
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Hence for a known strain at which the fracture starts to propagate 
(component ε) and at a given geometrical distribution (components “c”, “A” 
and “Iy”) with known material properties (E), a maximum load at this strain 
can be established. Furthermore, a strong relation between the measured 
mineral density and its material properties suggests that the spatial elastic 
modulus (E(x,y)) at every element of the tissue can be related to density from 
tomography images following a power law material model (eq. (1.4)): 
 𝐸(𝑥,𝑦) = 𝑎 + 𝑏𝜌(𝑥,𝑦)
𝐶  (1.4)  
Subsequently, the bending stiffness component can be assessed 
according to equation (1.5): 
 𝐸𝐼𝑦 = ∑ 𝐸(𝑥,𝑦) 𝑥𝑖
2 𝑑𝑎 −  𝐸𝐴𝑥𝐸𝑐𝑒𝑛𝑡𝑟
2
𝐴
𝑖=1
 (1.5)  
Here the second term translates as the second moment of area 
weighted by the spatial elastic modulus from the spatial coordinate system 
axis into the neutral axis. As the neutral axis is assumed to be identical to 
the modulus weighted centroid, its position is defined by: 
 𝑦𝐸𝑐𝑒𝑛𝑡𝑟 =
∑ 𝐸(𝑥,𝑦)𝑦𝑖 𝑑𝑎
𝐸𝐴
 (1.6)  
 𝑥𝐸𝑐𝑒𝑛𝑡𝑟 =
∑ 𝐸(𝑥,𝑦)𝑥𝑖 𝑑𝑎
𝐸𝐴
 (1.7)  
Together, this represents an analytical approach which can be adapted 
to any structure where material properties and geometrical distributions 
under certain loads are known (Figure 8). 
 
 
Figure 8: Engineering beam theory principles used in predicting 
vertebral strength during the wedge compressing fracture 
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3.1.2.2 Implementation of the composite beam theory into a 
comprehensive computational package 
Structural analysis used in this approach combines CT images with 
minimal user interference estimates of the vertebral body strength. Firstly 
data taken from scans is loaded and converted into bone density. Secondly 
the vertebral body is masked from the surrounding areas. Finally a structural 
assessment, where the estimated bending and axial stiffnesses are 
combined using the beam theory, is used to estimate the minimal load 
required to induce fracture to the sample under given conditions. The 
detailed flowchart presented in Figure 9 illustrates blocks of operations 
delivered, from acquiring the CT images to reporting the predicted vertebral 
body strength.   
A number of theoretical assumptions have been implemented as 
described in the previous section. Each axial image is considered as a 
cross-sectional cut of a slender beam with a modulus map defined directly 
by its local density distribution. In summary, the approach combines the 
bone strain (ε), axial rigidity (EA), bending rigidity (EI), geometrical distances 
between the neutral axis and load axis (a) and the most distant anterior point 
(c) and the body mask described in detail in section 3.1.2.3. The loading axis 
position and mid-sagittal plane orientation are derived from the experimental 
setup once defined by the user.  
The bone strain (ε) corresponding to the fracture was set to 1% 
according to Keaveny et al. [195]. EA is estimated as a sum of all the 
density-based elastic moduli over the cross-section of the vertebral body, 
whereas EI is based on the moment of inertia which is obtained from a 
relationship of the voxel’s normal distance to the axis perpendicular to a mid-
sagittal plane intersecting the modulus weighted centroid squared.  
To minimise an error due to misalignment, the script was adapted to any 
possible position of the image and hence the neutral axis does not have to 
align to the image matrix and is defined according to the anatomical plane of 
the measured specimen in general. The predicted fracture force is 
equivalent to the uniaxial force needed to induce the fracture at the same 
loading point as in the experimental setup. Here, the weakest slice is 
identified by analysing axial slices one by one, giving the estimated load, 
hence the one with the lowest Fz is the predicted fracture load of the sample.  
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Figure 9 The fracture prediction tool developed in this work comprises 
steps in which VB cross-sectional boundaries are obtained by a 
series of morphological operations, then each voxel within this 
mask is converted to an elastic modulus with which to create a 
series of modulus maps of the axial slices. Vertebral strength is 
taken as yield load of the weakest slice 
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The output of the tool is presented as the predicted fracture load, 
bending rigidity and axial rigidity and represents the area of the weakest 
cross-sectional slice. A Graphical User Interface (GUI) has also been 
developed (depicted in Figure 10). The output results are saved to a 
separate file together with a modulus map of the weakest slice highlighting 
the position of the modulus weighted centroid, the load axis and the most 
anterior and posterior points of each particular slice.  
 
Figure 10 Graphical User Interface (GUI) designed for purposes of the 
fracture prediction tool 
3.1.2.3 Vertebral body image segmentation (masking) 
A series of binary image processing morphological operations has 
shown to provide a good compromise in terms of defining sufficiently 
accurate border detection (volume estimation) in a sufficiently short time, 
even when using a standard desktop PC. This approach was hence adopted 
in order to allow the tool to detect the vertebral body to minimise the length 
of calculations and to establish the most distant point in the vertebral cross-
section. This approach was tested on different pathologies to assess its 
versatility and was validated experimentally against volume estimation. The 
following section details the particular background of such an approach.  
A CT image can be represented as a three-dimensional array of 
attenuation coefficients expressed in grey-scale values. The spatial unit of 
the image-voxel (a three-dimensional pixel) comprises isotropic single value 
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information of a specific dimension depending on the scanning parameters 
and the resolution. Volumetric measurements are derived from the known 
voxel volume. Secondly, using the simple isometric voxel edge size, the 
distances and area measurements can be similarly derived.  
To define the VB mask (i.e. to define a cross-sectional area slice-by-
slice) and to automatically identify the most distant point of the vertebra, a 
semiautomatic subroutine was compiled in a computational environment 
using MATLAB [208]. The cross-section of a VB was established using two 
distinct sub-programs with additional subroutines. In the first program, the 
image in every slice was binarised based on a histogram cut and then 
filtered to remove disconnected elements with sequential flood fill 
morphological operations such as extrusion and dilation. All variables here 
listed are first predefined by the user according to the scanning resolution 
used and the quality of the bone, where for resolution of 70.8μm voxel edge 
size typical values may vary from 400-700mgHA/cm3 and 10-50 voxels for 
flood fill operations and increasing with increased resolution (due to lower 
partial volume effect). This step was repeated until the surrounding noise 
was removed providing clear and smooth boundaries of the vertebral body, 
as seen in the example in Figure 11 which shows the development and 
validation of the approach using porcine samples. Consecutively, this was 
repeated for every slice from the top to the bottom vertebrae with minimal 
intervention from the user.   
However, as the tool is dependent on the difference between the degree 
of density inside the bone and the background, the automatic boundary 
estimation can be hampered for samples with a very low bone density or 
large lesions. The degree of rectitude is automatically assessed by 
comparing an area in the current slice to the area of the previous slice and if 
the criterion falls out of the tolerance area specified by the user, the border 
line is replaced by the one from the previous slice. This approach was 
shown to be sufficiently expedient and useful in non-uniform pathological 
samples and especially in samples with a high degree of lytic infiltration. In 
some cases the boundaries needed to be corrected manually. The manual 
correction (Figure 13) combined with the previously described self-correcting 
routine (Figure 12) have been proved to be suitable in all cases where the 
automatic tool failed to provide the boundaries independently. This 
subroutine significantly minimises pre-processing time with minimal effect on 
the final modulus map differences and needed to be deployed only on the 
more morphologically altered vertebrae.  
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Figure 11: Vertebral body boundary estimation: a microCT image is 
first taken and binarised according to a pre-set histogram 
threshold value, this is followed by a number of morphological 
operations such as filling the gaps and removing disjointed 
particles before the final mask is obtained (A). As shown in the 
GUI snapshot (B) this method can account even for more 
challenging low density human cadaver samples 
B.) 
A.) 
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When the fracture prediction tool is used, the defined boundaries are 
displayed for every slice indicating the proposed edge as a thin white line 
superimposed on the original image (such as depicted in Figure 11 and 
Figure 13 (C)).  The user can then determine if the boundaries have been 
estimated correctly, apply the self-correction subroutine, change the 
parameters for both subroutines and either re-run the analysis or perform a 
manual correction. However, it was found that the manual correction was 
needed only for analysis of the historical data where samples had been 
scanned in air without removing the air-bubbles. Since then, the self-
correction subroutine was shown to be a sufficient tool for capturing 
incorrectly proposed boundaries.  
 
Figure 12 Manual correction of the VB boundaries combined with area-
based filtering algorithm. The area-based filtering algorithm 
identifies slices where the pixel count of the masked area 
suddenly changes with respect to the previous slice. If such a 
step change occurs, the border is replaced with the previous one 
until the slice where the border area falls back into a user-
specified difference between calculated cross-sectional areas is 
reached  
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Figure 13 Manual correction of boundary outlines. In case of a 
“morphologically challenging” sample (e.g. very low trabecular 
bone density or metastasis), manual correction is required. Such a 
problem can occur due to a low density gradient between the bone 
and the background (A). In such cases manual correction (B) 
allows the user to correct the boundaries to include the whole 
vertebral body (C) 
3.1.2.4 Analytical verification and surrogate model validation 
In order to verify the tool, a comparison to a simplified scenario was 
conducted. Verification consisted of comparing estimated strength, axial and 
bending stiffnesses. In-silico and analytical values were compared firstly on 
samples of a simple homogeneous shape and later against a simple shape 
consisting of a non-homogeneous sample of up to six different material 
stiffnesses (Figure 14).  
The results of the comparison are reported in Table 6 and show only a 
small difference found in EIy and Fz. This was attributed to an error 
introduced by a user-based definition of the most anterior and most posterior 
points. This was further verified by setting the points as precise coordinates, 
which resulted in diminished difference between both values. The results 
presented here match the output values from the script, hence the script can 
be considered to be verified.  
A.) B.) 
C.) 
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Figure 14: Analytical verification of the fracture prediction script. A 
false image of a sample consisting of composite layers of varying 
stiffnesses was imported as a simulated CT image. Points defining 
the AP-axis were imported manually (green markers at the margin 
of the composite) and load axis was defined at 25% of the AP axis 
(green “o” marker) 
The script has been further validated using a set of surrogate models 
manufactured to represent infiltrated metastatic vertebra in which the 
strength was compromised due to location of the lesion (Figure 15). Tested 
plastic models were manufactured using two different prototyping methods, 
Stereo-lithography (SLA) and Selective Laser Sintering (SLS) prototyping 
methods in which the position of lytic infiltration has been altered according 
to a range of lesion locations. The gross vertebral body measures were 
taken from literature [209] and as further depicted in Figure 15 the lesion 
was represented as an empty void located anteriorly, anterio-laterally and 
posterio-laterally. The last model represented a non-infiltrated vertebral body 
without any lesion. 
As a result, the predicted values strongly correlated with the 
experimental data (also depicted in Figure 15) for the whole range of 
experimentally obtained strength values (from 1.6 to 18.4kN). The strain at 
yield had to be adjusted to that prescribed for the Nylon 12 material (=22%) 
according to technical specification. However, no uniaxial tests to establish 
this value independently were carried out. For adjusted strain the mean 
difference was found to be -2.92kN with limits of agreement of ±2.39kN. 
Despite the lack of accurately measured material properties, this study 
showed two important findings: (1) despite the notable offset of the predicted 
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values, most probably due to incorrect yield strain for the particular 
polymeric material, it has been shown that the in-silico tool accounts for 
macroscopic imprint due to the presence of metastases with a strong 
correlation and (2) in agreement with other authors [210, 211], the position at 
which the lesion occurs leads to a significant effect in terms of the strength, 
which is implied by a strong correlation between predicted and experimental 
strength distributed from strongest (no lesion) to weakest (anteriorly-located 
lesion).  
The experimental part of the work has been carried out by 3rd year 
project student, Eveline Sleiman [212]. The results have been implemented 
into the script and reanalysed by the author of this work. Here the 
experimental model has been compared to the in-silico approach in which 
the weakest slice, fracture load [kN], axial rigidity [kNm2] and bending rigidity 
[kN] were estimated.  
 In-silico Paper 
calculated 
EA [kN] 2.7106 x105 2.7106 x105 
EIy [kNm
2] 2.2430 x102 2.2534 x102 
Fz [kN] 7.4963 x10
2 7.5139 x102 
Table 6: Analytical verification of the mathematical solution which was 
used in the fracture prediction tool. Results show very negligible 
difference even when manual definition of AP points has been 
conducted (when defined numerically with pixel precision, the 
results were identical) 
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Figure 15 Validation study of the fracture prediction tool using 
surrogate plastic models representing different scenarios of 
metastatic infiltration. The blue arrow indicates metastatic 
infiltration in the human vertebral body modelled as a void in a 
simplified vertebral body. Models are listed from left to right 
according to their strength (anteriorly positioned vertebrae 
resulted in the highest strength compromise compared to healthy 
vertebrae on the right) 
Here, finding (2) suggests that the anterior lesions have the greatest 
effect on vertebral strength in all investigated scenarios whereas posterior 
lesions have minimal or no effect on vertebral strength compromised for the 
investigated loading condition. These results are in accordance with the 
occurrence of vertebral collapse observed in-vivo [211]. Here both findings 
suggest that accounting for bending rigidity in the beam theory principle has 
a strong potential in vertebrae with an osteolytic reaction. 
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3.1.2.5 Fracture prediction tool validation using historical data 
Initially, the developed fracture prediction tool was tested on samples of 
subjects with varying BMD distribution. This was done in order to verify the 
usability of the approach on oncological samples. This subsection describes 
data collection and retrospective use of the tool on historical data.  
Fracture data and microCT images were pooled from previous studies 
where single vertebrae were experimentally tested to induce fracture. The 
collection criteria were defined thusly:  
i. A single vertebra compression wedge fracture conducted on 
human samples 
ii. Use of the same scanning protocol  
iii. Use of the same compression testing procedure with 
comparable output in terms of strength estimation 
 More specifically, samples were collected from studies in which all 
specimens underwent testing based on a single vertebra model used by 
Oakland, Furtado et al. [3, 38]. In this protocol, samples were disarticulated 
and freed of soft tissue through sequential trimming of the processes but 
preserving the integrity of the spinal canal by keeping the neural arch intact. 
All samples underwent initial microCT scanning and were subsequently 
fractured. 
 Collected historical samples used for validation 3.1.2.5.1
Pooled samples consisted of three morphologically distinct pathologies: 
osteoporosis, bladder cancer and multiple myeloma cancer. All specimens 
used for this retrospective assessment were rendered anonymous and 
checked for eligibility for use in this study in terms of the ethical 
considerations (ethical approvals 09/H1306/1, 10/H1306/60 
and 10/H1306/83).  
The final dataset consisted specifically of forty-one osteoporotic samples 
(OP) from a total of eleven spines, twelve samples from one spine from a 
donor diagnosed with bladder cancer with metastases to spine (mets) and 
finally of forty-four samples from three spines diagnosed with multiple 
myeloma (MM). 
 Historical data - Scanning procedure 3.1.2.5.2
All collected samples underwent scanning in microCT (uCT80, Scanco 
Medical AG, Bassersdorf, CH). The osteoporotic and bladder cancer 
samples underwent the assessment at a resolution of 148x148x148 µm3 
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voxel size and scanned in air, whereas the multiple myeloma samples were 
scanned with a final voxel size of 70.8x70.8x70.8 µm3 and scanned while 
submerged in water without applying vacuum prior to the scan. Furthermore, 
in all three cases the scanning parameters remained unaltered: 250 
projections were used (70kV, 114mA, and 300ms) and reconstruction took 
place with the use of an in-build 200mgHA/cm3 beam hardening correction 
provided by the manufacturer (Scanco Medical AG, Bassersdorf, CH). All 
images were then converted to ρBMD using Hydroxyapatite phantom.   
 Historical data - Wedge compression fracture 3.1.2.5.3
 The first and second datasets (OP, mets) were fractured in a custom-
built testing rig and subjected to compression in a single axis compression 
machine (AGS-10kNG, Shimadzu Corp.). The third dataset (MM) was tested 
using the enhanced rig developed as a part of this work as per testing 
protocol described in subsection: 3.2.2.4: “Single vertebra Wedge 
Compression Fracture rig”. In all cases the vertebral strength was taken from 
the first peak on the load-displacement curve (zero-slope). 
 Predicting historical data - beam theory and BMD-based 3.1.2.5.4
method 
All collected microCT images were assessed using the beam theory 
fracture prediction tool discussed previously. Where necessary, given the 
complex nature of the deterioration, a manual correction of the detected 
boundary was undertaken, in which case every fifth slice was corrected.  
For the purpose of developing the model, multiple material laws 
suggested in relevant studies [200, 204, 213] have been initially tested for 
comparison with the model proposed by Kaneko et al. [198, 214], obtained 
based on metastatic and osteoporotic cored samples. The initial test was 
performed on a smaller number of samples (training dataset) and extended 
to the full population once the model with the closest agreement had been 
chosen. 
In addition, the metastatic samples were reanalysed afterwards 
excluding the extra-vertebral body formations from the fracture prediction 
modulus map. Figure 16 depicts one of the samples containing such 
formations, comparing the morphological imprint of the lytic and blastic 
tumours. To exclude these formations, a similar tool to the one used to 
manually define vertebral body outlines was used to define the body without 
the external lesions.  
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The theoretical background of this assessment is that the structure is 
firmly attached to the vertebral body, hence is assumed to contribute to 
vertebral strength. According to engineering principles the osteo-sclerotic 
nature of the structure and its anterior position suggest that the structure will 
be expected to support the loads. This assumption is supported by the fact 
that, if the yield of the healthy and osteo-sclerotic tissue remains the same, 
than the bending stiffness - a significant contributor to the strength of the 
vertebra (subsection “Composite theory approach”, eq. (1.3)) - is in fact a 
product of Young’s modulus (density dependent variable) and distance from 
the neutral axis squared (eq. (1.5)). However, in tools such as those using 
standalone BMD without accounting for density distribution, this sclerotised 
tissue would not be considered, hence the strength predictions would be 
hampered. 
Moreover, excluding (masking) of the mineralised tissue from the 
modulus map will decrease both the axial and bending stiffness in the 
fracture prediction equation. The comparison before and after the masking of 
the tissue from the prediction with sequential comparison to the 
experimentally obtained value can be then used to investigate whether the 
tissue is more likely to be mechanically supporting the vertebra and hence 
enhancing the vertebral strength.  
The results of predicted strength prior to and after alteration of the 
masks were compared to those obtained experimentally and will be 
discussed in the results subsection. 
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Figure 16: Example of microCT vertebral body assessment depicting 
severe metastatic infiltration.  An axial slice obtained from 
microCT (above) shows a notable influence on the internal 
structure when mixed lesions are present. Beneath is a 3d 
representation of the infiltrated vertebra 
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 Results in predicting historical data 3.1.3
3.1.3.1 Historical data – Collected osteoporotic samples 
In total forty-one scans and experimental data of osteoporotic samples 
matching the criteria were collected for this retrospective analysis. Data from 
microCT scans were used to estimate fracture load based on a product of 
BMD and cross-sectional area and using a beam theory approach. The 
results of both methods were then compared to experimental compression 
test output. A typical output of the fracture prediction tool is shown in Figure 
31, where the first slices clearly overestimate the strength due to the 
presence of the cortical wall. However, as the analysis takes into account 
only the weakest slice, an overemphasis on the strength of the bony 
endplates is irrelevant.  
The dataset also consisted of 6 samples which showed unexpected 
strength (exceeding 3.9kN and up to 6.4kN). These samples were each 
treated in the same way in order not to bias the fracture prediction tool 
validation study.  
With regards to the structural analysis compared to experimental data, 
the mean difference was -0.25kN, the limit of agreement was ±0.91kN 
(depicted in Figure 17) and the coefficient of determination R2 was 0.93 
(p<0.001). In terms of accuracy, the mean difference was found to be 
sufficiently close to zero. The reason for discrepancy in the stronger samples 
originates in the nature of the location of high density bone, where the 
weight of each voxel of every pixel contributing to flexural rigidity is a product 
of density and distance from the bending axis squared. Sensitivity to any 
impairments of the density-to-modulus relationship or misalignment with 
bending rigidity is then overwhelmed by these osteophytes.   
The results of the analysis based on the product of BMD and cross-
sectional area proposed by Brinckmann [64] with the same apparatus show 
the adjusted linear interpolation coefficients (a=0.32 and b=0.00308; 
conducted by a former researcher from the University of Leeds using the 
same methodology and apparatuses [95]) to be significantly poorer in terms 
of both agreement and association (mean diff -0.7kN; limits of agreement  ± 
2.78kN; coefficient of determination R2 of 0.16 (p=0.011). The comparison of 
both methods in Figure 18 displays data from which a number of 
observations can be made.   
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Figure 17 Bland-Altman analysis of predicted and experimentally 
obtained fracture loads for collected osteoporotic samples. The 
difference between both datasets indicates modest limits of 
agreement lower than ± 1kN  
Firstly, despite the high correlation in the structural analysis, the model 
tends to overestimate the failure load for small loads; nevertheless this is 
reversed for larger ones.  The analysis based on Brickmann/Oakland’s 
prediction [64, 95] tends to overestimate the failure loads for all samples 
except those where osteophytes are present. 
In an attempt to discern the reasons for the discrepancy between the 
two models, the presence of osteophytes was investigated. First, three 
samples with clearly enlarged osteophytes (strength exceeding 5kN) were 
excluded, which altered coefficients of determination from R2=0.93 to 
R2=0.83 for the beam theory based method and from R2=0.16 to R2=0.27 for 
the BMD based method. Bland-Altman’s mean difference and limits of 
agreement were found to be -0.31 ± 0.81 kN and -1.02 ± 1.7 kN for the beam 
theory and the BMD based method respectively.  
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Excluding additional stronger vertebrae (smaller osteophytes) altered 
the correlation, mean difference and limits of agreement to R2=0.75; -0.39 
and ± 0.6 kN for the beam theory and R2=0.4; -1.2 and ± 1.14 for the BMD 
based method. It is interesting to note that despite the reduction in R2, the 
limits of agreement became narrower, which highlights that the use of R2 
alone is an inappropriate measure of accuracy and/or precision. 
 
Figure 18 Plot of the predicted versus experimentally determined 
failure load. Beam-theory method (red “o” marker) shows good 
agreement and correlation in comparison to the formerly used 
product of BMD and cross-sectional area (blue “Δ” marker), with 
the example in the bottom right corner depicting a sample 
reaching 6.03kN strength most probably due to the presence of  
extra-vertebral body formations. In fact, all samples in the red-
dashed area contained similar osteophytes 
3.1.3.2 Historical data - Collected metastatic samples 
This section introduces a retrospective assessment of twelve samples 
from one donor with diagnosed bladder cancer. A study in which the set of 
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samples was used [95] identified a notable compromise in the strength of the 
vertebral body, however has not adequately underpinned a relation between 
this and the internal structure prior to the testing and the experimental data.  
The qualitative assessment of microCT images confirmed the presence 
of mixed lesions of severely infiltrated metastases, the majority of which 
appeared as an osteolytic cavity. In many cases the bone was malformed by 
the presence of enlarged extra-vertebral body formations such as those 
depicted in Figure 19. In four out of twelve specimens, notably enlarged 
lesions were present, in all cases in an anterior part of the vertebral body. In 
four other cases the osteoblastic reaction was smaller, but again present in 
the anterior part. In fact, the spine was affected by metastatic infiltration at all 
spinal levels (vertebrae) but three.  
Quantitatively, the bone quality in terms of the Bone Mineral Density 
ranged from 78.1 to 136.1 (an average of 98.6 ± 18.1) mgHA/cm3. The 
vertebral body strength was unexpectedly high considering the eccentric 
loading and the bone quality and in terms of the zero-slope yield ranged 
from 1.4 to 4.2 kN (an average of 2.2 ± 0.8kN) where the stiffness was 
assessed ranging from 1.0 to 2.9 kN/mm (an average of 1.9 ± 0.6kN). The 
BMD as a standalone predictor failed to correlate with the fracture load 
(R2=0.09, p=0.349). In addition, although the product of BMD and minCSA 
increased the prediction power, it still remained far below the correlation 
level (R2=0.16, p=0.197). 
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Figure 19 Example of a severely infiltrated sample containing multiple 
osteoclastic lesions together with extra-vertebral body formation 
in the anterior part of the vertebral body 
Initial fracture predictions using the beam theory on average not only 
strongly overestimated the experimental data but also failed to correlate with 
the actual values. Assessment using the Bland-Altman method estimated 
the mean difference at -1.2kN with the limits of agreement at ± 2.7kN, 
together with R2=0.18 (p=0.167). This peculiar overestimation was in fact 
consistently present in specimens with a significantly enlarged extra-
vertebral body formation. This was however not unexpected due to the 
relatively good results obtained for osteophyte formations discussed in the 
previous section. 
A further analysis was undertaken to exclude the extra-vertebral lesions 
from the modulus maps which resulted in an improvement in the results. As 
depicted in Figure 20 the coefficient of determination improved from R2=0.18 
to R2=0.64 (p=0.02), together with statistical results narrowing the limits of 
agreements to ±0.96 and resulting in a smaller mean difference of -0.41 kN. 
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Figure 20 Twelve samples infiltrated by bladder cancer were subjected 
to an experimental compression test following a microCT 
assessment. The initial fracture prediction (red) failed to correlate 
with experimental values; however the correlation improved after 
removing the extra-VB formation (blue) from assessment 
3.1.3.3 Historical data - Collected multiple myeloma samples 
Analysis of the microCT assessment provided a quantitative measure of 
the bone quality BMD which ranged from 63.1 to 252.6 mgHA/cm3 (an 
average of 127.0 ± 54.7 mgHA/cm3).  
When fractured, the zero-slope yield ranged from 0.3 to 7.1 kN (an 
average of 2.5 ± 2.1 kN), coupled with corresponding stiffness from 0.4 to 
7.3 kN/mm (an average of 2.6 ± 1.9 kN). As a standalone predictor, both the 
BMD (R2=0.07, p=0.088) and the product of BMD and minCSA failed to 
show any correlation to the experimental data. As a matter of fact the 
minCSA together with the BMD even lowered the coefficient of determination 
down to R2=0.03 (p=0.277). 
As depicted in Figure 21 the fracture prediction based on the beam 
theory shows a significant discrepancy between the spines and fails to 
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predict fracture with a sufficiently high correlation. In fact, the coefficient of 
determination for all samples altogether was R2 = 0.6 (p<0.001) with Bland-
Altman’s mean difference and limits of agreement of -1.05 and ±2.61 kN 
respectively. 
 
 
Figure 21 Experimental and predicted values of vertebral strength 
based on beam theory prediction. Contrasting colours indicate 
different spines which highlights a possible peculiarity of Spine 2 
MM which has been notably and consistently overestimated 
Detailed qualitative assessments of all images uncovered morphological 
changes in the bone structure of one outlying sample which was notably 
similar to the pre-existing fracture. This particular sample (Spine MM 2 - L5, 
indicated by the blue arrow in Figure 21) showed almost double the 
predicted strength at the “weakest slice” (the site at which the fracture was 
predicted) when comparing to experimental data (Figure 22 (a.)).  
Following manual exclusion of the fractured part of the vertebral body 
depicted in Figure 22, fracture load decreased by 20% to 6.3 kN moving 
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towards the experimental data and the linear regression line of the whole 
dataset (increase of R2 to 0.62, mean diff -1.01, lim. of agreements ± 2.52), 
which underpins the necessity to carefully check samples for possible pre-
existing fractures.   
  
Figure 22 Initial scan of sample “Spine 2 MM L5” and modulus map 
masking. (a.) Possible pre-existing (not cured) fracture resulting in 
a disconnected piece of bone. (b.) In-silico masking of the 
disconnected element (indicated by the red arrow) enabling an 
assessment of the contribution to the strength of the sample 
 Initial validation using historical data - Discussion 3.1.4
3.1.4.1 BMD based prediction used on historical data 
In agreement with data presented by other authors [170, 215], the 
preliminary data presented in this work indicated that using simplistic 
principles of the mechanics of solids such as those proposed by Brinckmann 
et al. [64] is not sufficient for any investigated loading scenario which 
introduces large bending moments. The prediction of vertebral strength 
based on a sample of averaged trabecular bone mineral and endplate area 
represents, from an engineering viewpoint, a model that is more adequate 
for an accurate assessment of the compression strength because it does not 
account for flexural stiffness. Unlike similar data reported while exhibiting a 
minimal cross-sectional area [65, 167], data presented here did not correlate 
with experimental data, which can again be explained by the fact that the 
experimental setup substantially contributed to bending. Moreover, since 
bone quality declines preferentially in the central region of the bone [216], 
the fact that the relative thickening of the cortical bone was not accounted for 
in this simplistic model hampers predictions in subjects with (1) higher bone 
(a.) (b.) 
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mass [217-219], (2) osteophytes as presented in this study, and (3) i non-
uniformly distributed bone deterioration such as oncological patients.  
3.1.4.2 Image processing and density-to-modulus material model 
The structural assessment tool proposed in this work consisted of a 
series of steps which have been previously discussed. Prior to the strength 
assessment, each slice was masked to determine the boundaries of the 
vertebral body. Here, a series of documented morphological operations 
which processed the binary image have shown to provide a good 
compromise in terms of boundary detection which is sufficiently accurate in a 
sufficiently short time in terms of volume estimation, even when using a 
standard desktop PC (detailed flowchart can be found in Appendix H: Image 
processing: vertebral body boundary estimation). 
Compared to other possible solutions using masking such as edge 
detection, gradient based masking or shape recognition [220-222], the 
approach used in this work has been found to be computationally 
straightforward with a relatively low time dependency. In fact, the time 
required in order to provide an estimation of the vertebral body boundary 
used in this work has been optimised and reduced to less than 2 minutes per 
sample, and additionally validated for accuracy and precision in a buoyancy 
experiment. Nonetheless, as presented here, the user here needs to rely 
purely on a GUI providing a slice by slice assessment to show whether the 
cross-section of the vertebral body has been estimated correctly or whether 
the secondary filtering based on a step-change in the cross-sectional area is 
accurate. Furthermore, this work has presented a manual correction which 
has been demonstrated to be particularly useful in morphologically deformed 
samples where the lesion has breached the cortical wall. Despite provision 
of this alternative, the use of a GUI and secondary filtering seemed to be 
sufficient for the majority of the close to two hundred samples presented in 
this study. 
Throughout this work it has been hypothesised that the bone quality 
remains unambiguous throughout the organ and hence the density-to-
modulus material model does not need to be adjusted. As presented by 
Wolfram et al. [36], who experimentally investigated osteoporotic bone by 
means of micro-indentation, the micro-properties of the bone correlate 
weakly in respect of their position within the vertebra as well as between 
different vertebral levels. The unambiguousness of cancer bone however 
remains unknown and will be verified later in Chapter 4 independently of the 
development of this fracture prediction tool.  
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3.1.4.3 Validation of the fracture prediction tool on historical samples 
The model presented in this study was used throughout the initial 
testing and structural assessment of human vertebrae with three different 
pathologies sampled from other investigators (not published). Here, the 
assessment of the complete dataset has shown that the strength of the 
vertebral body can be predicted with a relatively high correlation and 
sufficiently narrow limits of agreement. A structural compromise (strength) 
was predicted in axial slices obtained from a tomography assessment. 
Similarly to previous investigators [2] it has been hypothesised that fracture 
would occur when the bone yields under compression by more than 1%, as 
has been measured by Keaveny et al. [195] and that this would occur at the 
structurally weakest slice, determined by the stress distribution exhibited 
under the effects of the Euler–Bernoulli beam theory. To the author’s 
knowledge, this is the first work to adopt the use of a composite engineering 
principle on isolated vertebrae with a wide variety of experimental datasets 
and exhibiting different types of cancer.  
For osteoporotic samples the image-derived prediction was able to 
account for as high a variation as 93% in results in which predicted strength 
was the independent variable, which is in a range comparable to 
sophisticated FE models [168, 169]. The prediction in metastatic samples 
was initially hampered by the presence of both osteolytic and osteoblastic 
lesions which has been overcome by removing the osteoblastic lesions from 
the modulus maps. These improved results have shown that the developed 
tool can account for 64% of the variability of fractures in samples with severe 
metastatic infiltration due to bladder cancer. Despite the need to predict the 
wide range of possible causes of failure, the model has proved to 
demonstrate a good precision in terms of the limits of agreement which have 
been maintained for both pathologies under ± 1kN, which is in range of 
many sophisticated models (see Table 4, literature review section 2.6.2). 
The range of R2 is understandable given the range of experimental strength 
and is below presented elsewhere. The state of deterioration however 
hampers the possibility of comparing the results as such samples have, to 
the author’s knowledge, never been predicted for fracture using FE or any 
other engineering model.  
An assessment of historical samples from patients with diagnosed 
multiple myeloma cancer proved to be far less successful compared to an 
assessment of osteoporotic samples. Here, the dataset which consisted of 
three spines showed that the strength of the regression of the predicted 
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forces contributed to a moderate 62% in the variability of the results, and 
despite strong inter-patient variability the data remained within the limits 
agreement of ± 2.5kN which is lower than most of the compared models 
(Table 4 in literature review section 2.6.2), but in the same range as the very 
sophisticated FE model [172] and the minCSAxBMD model proposed by 
Crawford et al. [65]. An over-predicted spine denoted as Spine 2 MM did not 
in fact show any peculiar morphology and its increased BMD, appearing as a 
notable thickening of the trabeculae, could not be considered sufficient 
reason to exclude the spine from analysis. Here only one sample could be 
justified to be reanalysed with caution and manually improved for accounted 
boundaries due to the discovery of a pre-existing fracture. The possibility to 
thoroughly investigate the nature of the discrepancy was hindered due to the 
retrospective nature of the dataset and the fact that they had been scanned 
with a lower number of projections.  
In terms of accuracy, the predicted strength in all three pathologies 
was found to be in relatively good agreement with experimental testing. In 
particular, the osteoporotic and metastatic datasets were found to have been 
predicted with mean differences of -0.25 and -0.45kN respectively. The most 
notable difference in mean has been found in the multiple myeloma dataset, 
again due to the presence of Spine 2 MM.  
Based on these initial results three assumptions have been made: (1) 
the material model proposed by Kaneko was adopted and thereafter used in 
all three studies with a sufficiently good outcome in terms of prediction, 
suggesting that it can be also used further; (2) the use of microCT 
assessment of 0.148mm edge voxel size and lower produced sufficiently 
accurate predictions when accounting for both geometry and the BMD; and 
(3) the dataset should not contain samples with pre-existing fractures. 
3.2 Commissioning of cadaveric Wedge Compression 
Fracture testing rig 
 Introduction to cadaveric testing of human samples 3.2.1
This section describes an in-vitro approach to induce a vertebral fracture 
similar to fractures found in-vivo (illustrated in Figure 24 (A)). Wedge 
compression fractures are categorised as anteriorly collapsed vertebral 
bodies [109] and are characterised by a decreased vertebral height in the 
anterior region of the vertebral body. Using imaging tools such as CT, X-ray 
or DXA, the fracture is also visible as a densified region of bone where 
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trabeculae have compacted, locally increasing the volume fraction (Figure 
23).  
To reproduce the fracture, the vertebral body needs to be compressed 
by applying an eccentric axial load (Figure 24). This can be achieved using a 
single axis compression device with a ball-joint loading plate compressing, 
eccentrically, one of the endplates at a constant low speed displacement 
(quasi-static testing).  
 
 
Figure 23 Wedge compression fracture in-vivo and in-vitro simulated 
WCF. All fractured vertebrae found in spines had a 
characteristically deformed vertebral body towards the anterior 
side (example in A). This type of fracture (WCF) is typical for 
osteoporotic/metastatic bone 
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Figure 24: WCF type of fracture can be obtained experimentally where 
an intact bone is compressed eccentrically. This figure illustrates 
a sagittal slice of vertebra scanned in microCT image before and 
after inducing the fracture 
 
 Wedge compression testing - Methods 3.2.2
3.2.2.1 Cadaveric sample selection and preparation  
Samples used in this study comprise of three distinct pathologies. The 
first comprised samples without any signs of neoplastic pathology 
(considered by the GIFT bank as osteoporotic), the second comprised those 
diagnosed with multiple myeloma cancer and the last came from patients 
with cancer with a high probability of osteolytic infiltration to the spine. In 
total, one hundred and ten samples were used in this study, all of which 
were acquired from a non-transplant tissue bank (GIFT, Leeds General 
Infirmary, UK and Science Care®, AZ, USA) following ethics committee 
approval (NRES, UK). More specifically, thirty-two samples from three 
osteoporotic spines were collected for PVP-CaP study (Ethical approval: 
10/H1306/83), and twenty-five samples from five osteoporotic spines and 
twenty-four metastatic samples were collected for PMMA study (Ethical 
approval: 11/YH/0002). An additional ten samples from metastatic spines 
were harvested and used for morphology and fracture prediction 
assessment (Ethical approval: 10/H1306/83); and finally, nineteen samples 
from four spines with diagnosed multiple myeloma cancer were collected 
and used for morphology and fracture prediction assessment (Ethical 
approval: 10/H1306/60). The two metastatic spines were collected from 
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donors with (j) metastatic inflammatory carcinoma (breast cancer) and (ii) 
metastatic lung cancer. In total four single vertebrae samples needed to be 
excluded, more specifically one due to loss of measurement data during the 
experiment, two due to pre-existing fractures sustained after harvesting and 
one due to technical difficulties experienced during the re-fracture 
experiment. To clarify, a list of all studies and number of specimens used is 
included in Table 7 while Table 8 presents the list of all used spines together 
with their properties.  
Study Pathol
ogy 
Number 
of 
spines 
Number 
of 
samples 
collected 
Number 
of 
samples 
excluded 
Number 
of 
samples 
used in 
fracture 
prediction 
Number of 
samples 
used in PVP 
PVP-CaP OP 3 32 3 29 29 
PVP-PMMA OP 5 25 1 25 24 
 mets 2 34 0 34 24 
Fracture 
prediction 
MM 4 19 0 19 0 
Table 7 Cadaveric samples collected and used for wedge compression 
fracture testing 
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  Spine gift 
bank name 
Levels used Age Gender  Weight Height  
SpineBS 1 Gift 29/11 T7, T8, T9, T10, T11, 
L1, L2, L3, L4 
88 F 54 kg  170 cm  
SpineBS 2 Gift 13/11 T8, T9, T10, T11, T12, 
L1, L2, L3, L4, L5 
82 F 51 kg 160 cm 
SpineBS 3 Gift 32/11 T6, T7, T10, T11, T12, 
L1, L2, L3, L4, L5 
72 F 51 kg 168 cm 
SpineGo 1 S091157 T7, T8, T9, T10, T11, 
T12 
66 F 36 kg 157 cm 
SpineGo 2 C100098 T7, T8, T9, T10, T11 93 F 68 kg 168 cm 
SpineGo 4 S091223 T7, T8, T9, T10, T11 102 F 61 kg 168 cm 
SpineGo 5 GIFT 20/11 T7, T8, T9, T10, T11 74 F 108 kg 170 cm 
SpineGo 6 GIFT 23/12 T7, T8, T9, T10, T11 77 F 38 kg  171 cm  
Spine 1 mets C121608 T1, T2, T3, T4, T5, T6, 
T7, T8, T9, 10, T11, 
T12, L1, L2, L3, L4, L5 
41 F 73 kg 170 cm 
Spine 2 mets C121562 T1, T2, T3, T4, T5, T6, 
T7, T8, T9, 10, T11, 
T12, L1, L2, L3, L4, L5 
85 M 43 kg 168 cm 
Spine 4 MM C101540 T5, T7, T8, T9, T10, 
L2, L5 
68 M 68 kg  170 cm 
Spine 5 MM S101357 T8, T10, L2, L5 82 M 77 kg  178 cm 
Spine 6 MM S110132 T5, T7, T8, T9, T10, 
L2, L5 
90 M 67 kg  170 cm 
Spine 7 MM S110807 L5 60 M 113 kg  175 cm 
Table 8 List of all spines used for wedge compression fracture testing 
3.2.2.2 Tissue collection, dissection and storage 
Work done by Panjabi et al. [223] showed little or no influence of 
freezing on the change in quality of the cadaver tissue, hence all samples 
were kept frozen before dissection, after dissection and during every longer 
period between treatments. Human cadaver samples were either collected 
from the local GIFT bank, frozen and stored at -80C or in the case of an 
- 76 - 
overseas donor tissue bank (ScienceCare, USA), samples were collected 
from a sealed parcel covered in dried ice. For long term storage, the 
samples were kept deep frozen at -80C, while for imminent use the 
samples were placed in a freezer at -20C and later defrosted overnight for 
either dissection or testing. For storage, every sample was fully wrapped in a 
purified water-soaked paper tissue to retain moisture and was sealed in a 
labelled plastic bag before being returned to the freezer. Samples were 
harvested from thawed spines where every sample was carefully 
disarticulated (Figure 25) using standard dissection and operation tools. The 
samples were then initially measured with Vernier callipers (part no. 50590, 
Draper, UK) and prepared for scanning.  
 
Figure 25: Harvesting of vertebral samples. The figure depicts 
disarticulation of levels T10, T11, T12 (from left to right) with 
enlarged bridging osteophytes (“Spine 2 mets”) 
3.2.2.3 Cadaveric sample scanning 
 Prior to scanning every sample was separately placed in an 
appropriate scanning container fully submerged in purified water under 
vacuum for 5 minutes to remove any possible air-bubbles trapped in the 
bone marrow (CCL-31 vacuum pump [Javac, UK]). Using the vacuum pump 
prior to scanning and increasing the scanning resolution compared to 
previous studies was necessary in order to increase the spatial information 
obtained from the scanner especially for the morphology assessment and 
also as it was found that air bubbles trapped in the vertebral body strongly 
hamper accurate BMD measurements.  Where necessary, the facets were 
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removed to allow the sample to remain anatomically horizontal during the 
scanning, but the neural arch remained intact.  
 All samples in this section underwent scanning in the most up-to-date 
microCT apparatus (microCT100, Scanco Medical AG, Bassersdorf, CH) at 
medium resolution of 70.8x70.8x70.8 µm3 voxel size with 500 projections(at 
70kV, 114mA, and 300ms), with subsequent 1200mgHA/cm3 beam 
hardening correction provided by the manufacturer (Scanco Medical AG, 
Bassersdorf, CH). All images were then converted to ρBMD using 
Hydroxyapatite phantom ranging from -200 to 800mgHA/cm3. 
3.2.2.4 Single vertebra Wedge Compression Fracture rig 
The wedge compression testing rig was designed to produce fractures 
similar to the methods of previous investigators [3, 28, 29, 38, 66].  In 
addition displacement transducers were added based on the SpineFX 
collaborating partner TUVienna [66]. The rig was designed to fit the Instron 
uniaxial compression testing machine (model 3366, Instron, MA, USA), 
which was firmly attached to the frame to allow the maintenance of a fixed 
loading axis during testing. This design enabled more accurate positioning 
and a repeatable and stable mounting protocol.  Further, the design allowed 
a quantitative measure of the boundary conditions through the attachment of 
three linear variable differential transformers (LVDT).  According to Dall’Ara 
et al. [66]the more accurately known boundary conditions are of a great 
value when combining experimental data with numerical approaches such 
as FEA. Nevertheless in this study, the LVDTs were used only to verify 
whether the inclinations of the sample remained within the safe limits for the 
duration of the testing procedure.  
The enhanced rig comprises of a base mounted to the testing machine, 
three LVDTs (ACT1000A, RDP Electronics Ltd, UK), a recess where the 
sample is positioned and a steel loading plate compressed by a ball-joint 
attached to the cross-head of the machine (depicted in Figure 26 (A)). The 
axial load was measured using a 10kN load-cell (Part no. 2530-443, Instron, 
MA, USA) fitted between the ball-joint and the cross-head of the 
compression machine. 
The loading scenario combined an axial compression with bending by 
introducing an eccentric loading. Therefore, the bottom of the vertebra was 
firmly embedded whereas the top endplate was covered by a PMMA 
impression to compress the sample without inducing tension on the back of 
the vertebral body (depicted in Figure 26 (B)). 
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After the sample preparation described previously each specimen was 
prepared for testing by partial embedding to increase the reproducibility of 
the experimental setup. In order to position and embed the sample a 
custom-built rig was designed (Figure 27 (A)). This rig allows the positioning 
of the loading axis of the compression device with a point on the top 
endplate of the vertebral body representing 25% of the anterio-posterior 
vertebral depth without the offset. Adjustable screws were used to restrain 
the sample in an aligned position (Figure 27 (B)) and it was later placed into 
a DELRIN ring and using a dental plaster (Suprastone, Kerr, CA, USA), 
embedded to the level of the plastic ring corresponding to submerging the 
samples 5mm into the plaster (Figure 27 (C)). When cured, the sample was 
turned and dipped into semi-cured PMMA (WHW Plastics, Hull, UK) to make 
a loose impression for the top contact (Figure 27 (D)). 
The embedded sample was positioned into the compression rig (model 
3366, Instron, MA, USA) and the crossbar with fitted pointer was lowered to 
verify the correct position of the loading. Later the pointer was replaced with 
a ball-joint and the vertebra was covered by the PMMA impression with the 
top loading plate placed over the top. In order to allow unrestricted 
movement of the two surfaces over each other, a thin layer of grease was 
inserted between the PMMA and the steel plate. Figure 28 illustrates the full 
experimental setup during the compression testing. 
The testing machine was controlled using software provided by 
Instron [224].The protocol consisted of preloading the sample by 50N for 5 
minutes with subsequent compression at a 1mm per minute stroke to 75% of 
the average height of the original sample. When reaching the pre-set 
deformation, the sample was released at 1mm per minute stroke until 
reaching 50N again and held in that position for an additional 10 minutes 
before the test was finished. Once removed from the compression rig, the 
plaster base was removed with subsequent measurement of the VB 
dimensions taken before freezing.  
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Figure 26: The enhanced single vertebra compression rig, an 
illustration of a CAD model (A). The rig consists of a base fitted 
into the frame of the Intron testing machine  and 3 precisely 
positioned LVDTs to capture the change in inclination of the top 
loading plate, compressed by the ball joint driven by the cross-
head. The bottom figure (B) illustrates schematically the 
positioning of the sample. The sample is aligned in the recess 
using a Delrin fitting and dental plaster embedding. The top PMMA 
imprint allows loading of the sample without introducing tension 
on the posterior part of the vertebral body 
A.) 
B.) 
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Figure 27: Single vertebra mounting rig. The top illustration (A) 
represents a CAD model of the mounting rig designed to position 
and embed the sample prior to testing. Subsequent images 
represent positioning which allows aligning with the loading axis 
(B), embedding of the bottom endplate (C) and making an 
impression of the top endplate (D) 
C.) D.) 
A.) 
B.) 
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Figure 28 Testing rig mounted to uniaxial compression machine 
(Instron). Sample wrapped in a purified-water-soaked tissue is 
compressed between the top loading plate and the bottom part of 
the rig. While the bottom of the sample is partially embedded and 
the coupling between the cross-head and the loading plate is 
performed by a ball joint, the loading axis remains at the same 
position while the loading plate is allowed to tilt around this axis 
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Vertebral stiffness was defined as the maximum slope within the elastic 
region of the load-displacement curve from the experimental data post-
processed in a custom-compiled MATLAB code [208]. The slope was 
defined using a 1% strain window approach based on the previously 
validated method proposed by Buckley et al. [148], whereas the vertebral 
strength was ascertained using a proof-load approach at 1% of the total 
strain.   
 Fracturing of cadaver samples - Results 3.2.3
Following the microCT assessment all samples from the previous 
section underwent experimental testing to induce WCF. This section aims to 
present the cadaveric experiment in detail for each of the three pathologies 
tested. 
3.2.3.1 WCF in osteoporotic samples  
The average specimen height was 22.9 (±4.9), 25 (±3.8), 23.5 (±4.2), 
and 23.1 (±3.7) mm at anterior, posterior, right and left margin of the 
endplate respectively, while the average width was measured as 39.1 (±8.2), 
34 (±6.3) and 42.1 (±8.6) mm at superior, middle and inferior levels 
respectively. The anterior-posterior length of the endplates was 31.5 (±3.8) 
for superior and 32.1 (±3.2) for inferior. Lastly the offset (overhang) was on 
average 3.1 (±1.7) mm.  
A typical single vertebra wedge compression fracture experiment lasted 
1 hour for embedding followed by an imminent compression experiment 
lasting on average 20 minutes during which the specimen was kept 
moistened by paper soaked in purified water resulting in a typical 
experimental output as depicted in Figure 29.  
To induce the wedge fracture by compressing each vertebra by 25% of 
its average height, the specimens were compressed on average by 5.9 (±1) 
mm. The average strength was measured as 1.35 (±0.91) kN and  ranged 
from 0.34 to 3.55 kN. The average stiffness was 2.2 (±1.0) kN/mm and 
ranged from 0.7 to 5.3 kN/mm.  
 
- 83 - 
 
 
Figure 29 A typical vertebral compression test data readout as a 
function of time (a.) later compiled in a form of load-displacement 
curve (b.). The curve is characterised by an initial ramp-up 
sequence reaching a load of 50N which is maintained for 5 
minutes to simulate preloading conditions and allow the specimen 
to settle in the mould. When loaded at constant rate, the sample 
typically remains in the elastic region until yielding to the plastic 
region where fracture is followed by a short softening. The end-
point of the experiment was at 25% strain followed by a 10 minute 
relaxation period at 50N (initial fracture, sample Spine BS 3–T10) 
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As verified by post fracture measurement, the reduction of the height 
remained over 20% even after the relaxation period, which resulted in an 
increase of the angle between superior and inferior endplates from 3˚ to 11˚ 
(note that the anterior height was in most cases smaller compared to 
posterior height, which is typical for osteoporotic samples).   
For samples SpineBS 3 - T09 and T08 the initial scan identified possible 
pre-existing fractures. Both specimens were hence dissected, cleaned and 
measured following the same protocol as for the other samples. As shown in 
Table 9, the anterior height of the fractured T09 was notably lower than other 
specimens from the same spine (namely specimens from levels T06, T07, 
T10, T11, T12, L1, L2, L3, L4 and L5), however the second sample with a 
possible pre-existing fracture (T08) had been fractured to such an extent that 
no vertebral body could be used for measurement as both endplates 
separated immediately after dissection.  
 Height 
anterior 
Height 
posterior 
Height 
left 
Height 
right 
Width 
superior 
Width  
middle 
Width 
inferior 
Ant-Pos 
superior 
SpineBS 3 
- T09 
8 20 17 13 37 32 41 30 
Spine BS 3 
average 
T6-L5 
22.7 
(±4.3) 
24.8 
(±2.8) 
22.8 
(±2.9) 
22.8 
(±3.1) 
42.9 
(±10.2) 
39.5 
(±8.3) 
46.8 
(±9.3) 
33.3 
(±5.1) 
Table 9 Cadaveric VB outer morphology measurement – sample with 
pre-existing vertebral body fracture 
3.2.3.2 WCF in multiple myeloma samples 
 Eighteen samples from four spines with diagnosed multiple myeloma 
cancer were disarticulated and underwent compressive testing in the same 
conditions as the other pathologies. Here, the average strength was 
2.73 (±1.17) kN, ranging from 1.31 to 5.47 kN. The average stiffness was 
3.46 (±0.96) kN/mm and in range from 2.13 to 5.06 kN/mm.  
3.2.3.3 WCF in metastatic specimens 
 Metastatic samples in this study consisted of 2 spines and were 
disarticulated into a total of thirty-four single vertebrae. The average 
specimen height was 22.8 (±5.2), 23.2 (±4.2), 22.3 (±4.3) and 22.8 (±4.5) 
mm in the anterior, posterior, right and left sides of the endplate respectively, 
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while average width was measured as 36.2 (±10.0), 32.4 (±7.4) and 38.5 
(±10.7) mm at superior, middle and inferior levels respectively. The anterior-
posterior length of the endplates was 29.6 (±7.6) mm for superior and 30.5 
(±7.5) mm for inferior. Lastly the offset (overhang) was on average 4.1 (±2.8) 
mm.  
To induce the wedge fracture by compressing each vertebra by 25% of 
its average height, the specimens were compressed by an average of 
5.7 (± 1.1) mm. Following the strength and stiffness assessment, the 
average strength was measured as 2.86 (± 1.33) kN and ranged from 1.02 
to 5.57 kN. The average stiffness was 3.57 (± 1.40) kN/mm and ranged from 
1.24 to 6.60 kN/mm, as shown for the example of Spine mets 1 in Figure 30 
describing strength and stiffness for each corresponding level (other tested 
spines in Appendix E: Cadaveric testing: Strength/stiffness per level).  
 
Figure 30 Spine 2 mets: Initial strength and stiffness for corresponding 
spinal level 
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 Initial fracture of tested samples - Discussion 3.2.4
3.2.4.1 WCF testing protocol  
The eccentric loading used in this work may also have introduced out-of-
axis parasitic loads and moments which might have impaired the measured 
uniaxial load used to estimate the fracture load, although a uniaxial load cell 
is a reliable means of measuring load. For future experiments it is highly 
recommended to use a six-channel load cell which is to be attached from 
underneath the testing base to capture and quantify these loads.  
Uniplanar motion which is expected during the wedge compression 
failure has been incorporated by a strongly eccentric anteriorly-located 
loading axis, ensuring that the axis of the minimum principal moment of 
inertia is closely aligned in the sagittal plane. In addition LVDTs were used to 
record any extensive tilting which did not occur in any of the 107 samples 
tested. Moreover, the anterior fracture was visually confirmed after 
completion of the test and the deflection of the endplate towards the anterior 
cortex was measured by the change of height of the anterior part of vertebral 
body by callipers. Contrary to the FE analysis, this is a necessary 
requirement for the beam theory principle as the most distant fibre is 
theoretically expected to be most subjected to yield. For example, as noted 
by Dall'Ara et al. [167]from their samples: only “most of the vertebrae 
underwent an anterior wedge-shape fracture” which could lead to a 
decrease in the prediction power of the beam theory, however it remains 
relatively easy to capture using the FE model presented in the study. This 
limitation can be avoided when considering bi-axial eccentric loading and 
asymmetric beam theory (discussed in Appendix G: Bi-axial eccentric 
loading)  
3.2.4.2 Limitations of the sample population and treatment history of 
the donors 
In the study presented here, the test population consisted of an 
osteoporotic group of relatively elderly patients (median 79.5±12), where all 
eight spines were from female donors, contrary to the multiple myeloma test 
group where all four relatively elderly donors (median 75±13) were male. In 
fact, the metastatic group consisted of only two donors, a relatively young 
female (aged 41) and an 85 year-old male. Although this is a relatively 
narrow demographic, osteoporosis predominantly affects women. Selecting 
a wider demographic in oncological pathologies is a challenge shared by 
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many other oncological studies [2, 67, 147, 198, 225] due to the limited 
availability of samples.  
Concerning the level selection, the samples were harvested only from the 
thoraco-lumbar region due to clinical evidence proving that vertebral 
fractures typically occur between T6 and L3 [1, 226]. In fact, the samples 
discarded from this study due to the presence of pre-existing fractures 
(Spine BS 3: T8, T9) can confirm findings presented in a previous study [1] 
which reported that T8 and T9 are the most common levels on which 
fractures can develop. This study consisted of one hundred and seven 
vertebral bodies from which nearly 80% were between the range of T6 and 
T10, which is in fact more than in many other studies [167, 169, 170, 172]. 
The major limitation of the dataset population presented here is the 
limited information available about treatment history prior to the death of the 
donor. Each GIFT bank provided samples together with a tissue transfer 
agreement containing basic information such as primary cause of death and 
basic information of the most important treatment modalities used. The 
current standard of collecting the data however does not cover the 
requirement of recording all drugs administered prior to tissue collection, 
including drugs promoting bone growth such as bisphosphonates (list of 
available information for this study is provided in full in Appendix C: Donors’ 
medical records available for this study). This limitation including a link to 
bisphosphonates will be later discussed in the micro-indentation study 
(section 4.2.4). 
3.3 Fracture prediction tested on large sample population: 
three pathologies 
 In-silico vs. experiment strength comparison 3.3.1
This section presents the results of the composite beam theory fracture 
predictions and compares these in-silico predictions to the results of the 
cadaveric testing discussed in section 3.1.  
The intention of this study was to investigate the vertebral strength in 
terms of the comparison between predicted and real experimental data. 
Although beam theory has already been used in previous studies, it has 
never been tested on a large data population comprising different 
pathologies. In this section the vertebral strength of each sample has been 
predicted in a reduced range of vertebral body height (80%) with a material 
model identical to one which is used in historical data assessment. MicroCT 
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scanned images (described in section: 3.2.2.3) were processed individually 
providing the predicted strength. This value was then compared to the 
experimental strength obtained per protocol described in 3.2.  
3.3.1.1 Reducing fracture prediction range to a single slice  
Although the principle of the beam theory is based on selecting the slice 
with a minimum predicted fracture load (weakest slice), the preliminary 
results discussed previously (section 3.1) have shown a notable pattern in 
the location of the weakest slice in a majority of cases (as shown in the 
illustrative Figure 31 in which different assessment ranges are defined). 
Structural weakening, which was observed as a fall in predicted strength, 
was appearing consistently in the middle section between cranial and caudal 
endplate. This in fact can be explained by the presence of increased bone 
density around posterior elements and closer to both endplates.  
 
Figure 31 A characteristic slice-by-slice fracture load prediction 
identifying the weakest slice where each step on the y-axis 
represents analysis of one axial CT slice. It should be noted that 
the weakest slice appears predominantly in the mid cranio-caudal 
section of the vertebral body which allows minimising of the range 
of analysis excluding bony endplates. The typical prediction curve 
is characterised by the low degree of variability of predicted 
strength within the vertebral body. Mid-slice analysis could then 
provide sufficient illustration of degree of vertebral strength 
compromise with minimal time and scanning effort 
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This section aims to investigate the possibility whether one-slice 
analysis could predict vertebral strength with relative success under an 
assumption that deterioration of bone is heterogeneously distributed. 
Whether the degree of decreased prediction success falls in a reasonable 
range remains dependent upon a specific use, but could be highly beneficial 
in cases where exposure of the sample should be minimised from the whole 
vertebral body scan to a single slice. This preliminary investigation can be 
potentially useful in clinical application due to radiation safety requirements. 
Moreover, the mid-slice is relatively easy to identify with a relatively high 
repeatability in a very short time.  
3.3.1.2 Density-to-modulus model calibration 
The material model of the relationship between microCT derived density 
(ρBMD [mgHA/cm
3]) and elasticity modulus (E [GPa]) is an important factor in 
the calculation of both the axial and the flexural rigidity and hence the 
predicted fracture load. Correlation has been proved in numerous 
publications and was thoroughly discussed in the literature review, however 
as noted for example in literature review by Helgalson et al. [189], finding an 
appropriate material model from literature data remains challenging as 
authors state: “The proposed relationships are substantially different one 
from the other”. The preliminary stage of this work was conducted on five 
different material models from literature [149, 198, 200, 204, 205, 213] 
comparing the difference in agreement to the respective dates of the 
literature. The best agreement for converting CT density to Young’s modulus 
was found by far to be the use of the model in the form described by Kaneko 
et al. [198] to eq. (1.8) and eq. (1.9). This model in fact seemed to be 
appropriate as the same author compared osteoporotic and metastatic 
tissue to find no significant difference between the two pathologies.  
 ρ𝑎𝑠ℎ = 69.8 + 839 ∗ ρ𝐶𝑇 [g/cm
3] (1.8)  
 E = 10.88 ∗ ρ𝑎𝑠ℎ
1.61 [GPa] (1.9)  
Nonetheless, this section aims to expose this model to a sensitivity 
study in order to calibrate the density-to-modulus in terms of agreement 
between predicted and experimentally obtained data. Such a procedure is a 
common tool to deploy and show full potential of a proposed model [169, 
189, 227].  
In summary, the density-to-modulus model (in form of eq. (1.4)) 
described in subsection: 3.1.2.1 was tested on the full sample population 
used in the main framework of this work while varying the linear coefficient 
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“b” and power-law coefficient “c” from 1-11 and 1-3, respectively. Over one 
thousand models have been tested in one-slice-analysis discussed later (in 
total over one hundred thousand single vertebra fracture predictions) and 
compared to the experimental data. Each dataset has been tested in respect 
of coefficient of determination, mean difference and limits of agreement. The 
proposed model was considered as the one which fits the criteria of 
exhibiting the lowest mean difference and limits of agreement with respect to 
“c” in a range not extensively varying between the three tested pathologies.  
 Comparison between predicted and experimental data – 3.3.2
Results for three pathologies 
3.3.2.1 Predicted osteoporotic samples  
 Weakest slice selected from 80% of vertebral body height - OP 3.3.2.1.1
For the in-silico analysis, no sample exhibited notable difficulties in 
automatically recognising vertebral body boundaries as is made clear by the 
example in Figure 32 depicting the initial scan of the weakest slice coupled 
with the modulus map. Despite a two-fold increase in resolution (74µm voxel 
edge size) compared to the historical osteoporotic dataset (148µm voxel 
edge size), all samples were processed in a relatively short time (~5 minutes 
per sample using a personal laptop computer).  
 
 
Figure 32 Structural assessment of the osteoporotic sample. On the left 
is a microCT image of the weakest slice identified by the fracture 
prediction tool. On the right is the corresponding modulus map 
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The predicted values were in the expected range between 1.24 
to 8.85 kN (mean 3.28 ± 1.62 kN). With respect to experimental data as 
shown in Figure 33 and Figure 34, the mean difference between the 
predicted values and actual yield strength was -1.93 kN, with limits of 
agreement ± 2.02 kN and coefficient of determination R2=0.66. Flexural and 
standalone compressional rigidity were found to only weakly correlate with 
the strength (R2=0.4 and R2=0.38 respectively). All evident outliers from 
Figure 33 and those confirmed from the Bland-Altman plot (Figure 34) 
consisted of samples from SpineGo 4.  
 
Figure 33 Fracture prediction - osteoporotic samples: Eight spines 
(fifty-four samples) were experimentally tested and compared to 
the predicted vertebral strength 
Here, in an attempt to discern the causes of poor correlations, each 
spine and all coefficients of determination for Fz, EI and EA were examined 
separately. A statistical analysis of SpineGo 4 by itself showed a relatively 
high coefficient of determination (R2= 0.75, p= 0.057), but with a substantial 
mean difference of -4.59 (limits of agreement ± 2.31 kN) compared to the 
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rest of the spines (on average -1.61 and ± 0.89 for mean difference and 
limits of agreement respectively).  
By removing SpineGO 4 from the overall analysis, the R2 increased to 
0.75, and the mean difference improved to -1.66 together with decreasing 
the limits of agreement back to the expected ± 0.97 kN. 
 
 
Figure 34 Fracture prediction - osteoporotic samples: Bland-Altman 
plot indicating a large discrepancy due to outliers belonging to a 
single donor (SpineGo 4). Peculiarity of SpineGo 4 could not be 
assessed but was believed to come from presence of healing 
woven bone which appears high in mineral component but lacks 
the structural integrity of fully healed bone (typical for early stage 
of healing) 
 Single slice analysis tested on osteoporotic samples - OP 3.3.2.1.2
In the second step, the range of slices used to determine the vertebral 
strength was reduced to a single slice in the middle section of the vertebra. 
The merit of this step was to reduce the time required as well as the need for 
computational power, which has resulted in less than 1 minute per sample 
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as only one set of two-dimensional image data was processed at one point. 
Compared to the “weakest slice” approach, the coefficient of determination 
was reduced by 12% (R2= 0.58 (p<0.001)) with a moderate shift in mean 
difference by 25% remotely from a 1-1 agreement, along with widening the 
limits of agreement to ±2.97 kN. This again was improved by removing 
SpineGo 4 from the assessment (R2=0.64, mean difference: -2.07, limits of 
agreement: ± 1.47).  
 Material model calibration in osteoporotic population 3.3.2.1.3
When the whole dataset has been reanalysed to identify the pathology 
specific material model the R2 ranged between 0.59 and 0.67 and the mean 
difference between -4.7 and 1.1kN while limits of agreement was limited to 
between ±1.0 and ±4.2kN. The calibrated model has been selected as 
b=3.5, c=1.25 to meet agreement criteria with the same “c” coefficient. This 
resulted in R2=0.66 with a mean difference of -0.14 kN and limits of 
agreement at ±1.03kN.  
3.3.2.2 Predicted multiple myeloma samples 
 Weakest slice selected from 80% of vertebral body height - 3.3.2.2.1
MM 
A qualitative assessment of the microCT images uncovered a wide 
range of localised trabecular bone deterioration from smaller confined 
lesions (Figure 35) to a complex corrosion of the internal structure (Figure 
36). Despite the compromised bone quality, the automatic vertebral body 
assessment was in most of the cases suitably efficient in estimating the 
outer boundaries which helped to process the images in a much shorter time 
(~7 minutes per sample).   
Despite the compromised quality of the bone, the predicted values were 
notably higher in comparison to osteoporotic samples and ranged between 
1.86 to 8.56 kN (mean=4.57 ± 1.93 kN). With respect to the experimental 
data, the mean difference between the predicted values and actual yield 
strength was -1.84, with limits of agreement ±1.94 kN and coefficient of 
determination R2=0.83. Flexural and standalone compressional rigidity were 
found to correlate with strength, with coefficients of determination R2=0.62 
and R2=0.73 respectively. As depicted in Figure 37 the data were equally 
spread along the range without any obvious outliers however suggesting a 
systemic error in the agreement between predicted and experimental 
strength.  
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Figure 35 Structural assessment of a multiple myeloma sample. On the 
left is a microCT image of the weakest slice identified by the 
fracture prediction tool. On the right is the corresponding 
modulus map. The arrows indicate widespread multiple myeloma 
lytic lesions. Here the lesions filled with material with low mineral 
density result in a low modulus (E=f(ρ)) hence negligibly 
contributing to the wedge compression strength 
 
 
 
Figure 36 Structural assessment of multiple myeloma bone with severe 
infiltration causing disintegration of the natural structure of the 
trabecular bone  
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 Single slice analysis - MM 3.3.2.2.2
Markedly, the reduction of the analysed range of slices to a single slice 
assessment did not impair the R2 (single slice R2=0.82), and despite altering 
the mean difference by 21% to -2.24 kN, it altered the limits of agreement 
only moderately to ±2.18 kN. 
 
Figure 37 Predicted strength compared to experimental data in multiple 
myeloma sample set 
 Material model calibration - MM 3.3.2.2.3
This retrospective material model sensitivity study selected b=2.5, 
c=1.25 which resulted into to R2=0.83, with a mean difference of -0.09 kN 
and limits of agreement at ±0.96kN.  
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3.3.2.3 Predicting fractures in metastatic specimens   
 Weakest slice selected from 80% of vertebral body height - 3.3.2.3.1
mets 
In the last pathology dataset, 2 spines were assessed and their 
predicted strength was compared to the experimental data. The qualitative 
assessment uncovered a significant imprint in the bone tissue (Figure 36), 
however only 3 samples exhibited signs of notable infiltration, whereas the 
remaining tissue appeared to be unaffected by the presence of the disease 
in terms of lesion presence (Figure 40).  
 
  
Figure 38 Structural assessment of a sample with osteolytic infiltration 
to the vertebral body. The lesion (indicated by a blue arrow on the 
left) replaces the natural trabecular bone with a highly 
vascularised but low density tissue which results in an almost 
negligible contribution to the strength (the red arrow on the 
corresponding modulus map with automatically detected VB 
boundaries). Despite the confirmed metastatic infiltration, only 
three samples exhibited a morphological alteration due to the 
presence of cancer 
In respect to fracture prediction, the strength was estimated to range 
between 1.45 and 7.36 (mean=3.54 ± 1.63 kN). A later comparison showed 
moderate correlation with the experimental data (coefficient of determination 
R2=0.77, Figure 39), a low mean difference (-0.69 kN) and the narrowest 
limits of agreement (±1.55) of all the three pathologies. Flexural and 
compressional rigidity alone were found to correlate with strength, with 
coefficients of determination R2=0.8 and R2=0.75 respectively.  
- 97 - 
 
Figure 39 Fracture prediction of metastatic samples. This diagram 
presents in-silico predicted fracture loads compared to those 
derived from the cadaver testing 
  
Figure 40 Structural assessment of a sample from a spine with 
metastatic infiltration but without presence of a lesion in the 
vertebra 
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 Single slice analysis - mets 3.3.2.3.2
Similarly to the previous examples, the reduction of range of slices to 
one representative slice did not substantially reduce the prediction success, 
but instead impaired the correlation by 20% (single slice R2=0.62), together 
with worsening the mean difference by 36% and limits of agreement by 38% 
to -0.94 and 2.14 respectively. 
 
Figure 41 Bland-Altman plot indicating relatively good agreement 
between predicted and experimental strength in an assessment of 
the metastatic samples 
 Material model calibration – mets  3.3.2.3.3
For the last pathology material model tuning ranged in terms of the R2 
from 0.44 to 0.70,the mean difference ranged from -3.6 to 2.7kN while limits 
of agreement were limited to between 1.4 and 3.8kN. The calibrated model 
resulted in b=6, c=1.25, meeting the criteria of a fixed “c” coefficient. Results 
for this particular model were R2=0.67, with a mean difference of 0.13 kN 
and limits of agreement at ± 1.52 kN.  
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 Fracture prediction tool used in three distinct pathologies - 3.3.3
Discussion 
The structural analysis conducted in the second stage using samples 
from this study proved to demonstrate a relatively strong association 
between the predicted and experimental results, particularly in oncological 
pathologies where strengths have been predicted in both datasets with 
results varying by more than 77% without undertaking any additional 
corrections to the samples. The prediction of a particular osteoporotic 
dataset however appeared to be more challenging, resulting in a modest 
R2=0.66. The possible reason for this discrepancy between the OP and 
other two datasets is that the OP dataset has clearly been affected by inter-
spinal variability, in that by removing SpineGO 4 from the overall analysis, 
the R2 increased to 0.75. The reason for the discrepancy could not be tested 
however is believed to be related to the presence of woven bone which 
despite its high mineral composition remains significantly weaker compared 
to mature lamellar bone. Woven bone is formed by fast activation of 
osteoblasts as a process of bone healing following a fracture. This is 
characterised by a lower degree of alignment of collagen fibres and the bone 
tends to be mechanically weak until replaced by lamellar bone [228]. In 
healthy tissue this would be a natural process of healing, which is however 
unlikely to happen in all tested samples in a single donor. An alternative 
explanation would be the presence of asymptomatic Paget’s disease [229] 
which is characterised by enlarged bone structures with limited strength of 
the structure due to presence of woven bone. This however has not been 
confirmed in patient history details, unless it remained undiagnosed. As 
provided (listed in full in Appendix C: Donors’ medical records available for 
this study), donor’s history details state only mild scoliosis which is not likely 
to be linked to weakening of bone as observed here. Interestingly the 
morphology assessment of the particular spine (in “Appendix D.1: 
Osteoporosis”) highlights increased bone mineral density together with 
notably high connectivity density (almost twofold the average of other 
spines). Neither trabecular spacing and thickness nor the number of 
trabeculae were found to be notably different. 
Despite unexplained over-prediction in one spine, fracture prediction 
has shown a sufficient success rate when compared to experimental data.  
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3.3.3.1 Single slice analysis 
In the subsequent step the hypothesis was that a single 
representative slice would reflect a weakening of the whole organ. Similar to 
the findings of previous investigators [147, 151], who also tested a reduced 
number of analysed slices, this has significantly reduced the time 
dependency of the complete analysis, in case of this study from one hundred 
slices to a single slice, progressing from a matter of minutes to seconds per 
sample. Such an approach is comparable to that presented by Windhagen et 
al. [147], where the representative slice was however selected intuitively and 
where a simulated lesion removed most of the original bone structure. 
Contrary to Windhagen’s analysis, in this study the slice has always been 
selected from the central region between both endplates which is easy to 
identify from the anatomical reference scan (scout view). The correctness of 
this approach is of course only valid if the weakening is homogenous in 
nature, such as in OP and MM where the lesions do not seem to follow any 
particular pattern.  
A notable impairment of correlations between the range of slices and 
one-slice analysis was however observed in the metastatic dataset. Here, 
the most affected sample was tested whether the size and position of the 
lesion with respect to mirror symmetry could hamper the use of the simplified 
beam theory. Asymmetric beam theory has been deployed resulting in 
marginal difference between the two methods. (more in Appendix G: Bi-axial 
eccentric loading). This hence suggests that the structural compromise has 
been located remotely from mid-slice along the cranio-caudal direction. 
Therefore either wider slice range assessment or combination with pre-
screening lesion-detection should be considered once the vertebra is 
severely infiltrated.  
Despite the issues in the metastatic dataset, the structural 
assessment showed promising results in terms of correlation; however the 
same results showed complications in terms of the agreement of the 
predicted and experimental strengths. Despite a relatively high correlation 
within all three pathologies, the model showed much lower precision and 
accuracy than was initially expected, based on the preliminary experiment. 
The discrepancy which was identified did in fact correlate with experimental 
strength leading to a notable over-estimation of the specimen’s structural 
properties which was not observed in the assessment of historical data 
(section: 3.1.3). One possible explanation was a use of new scanning 
apparatus (microCT100 in this study compared to microCT80 in the previous 
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study). Unfortunately for this study, the transition from the use of microCT to 
assess the historical data and the use of microCT in the more recent study 
could not be accomplished using a proper scientific method due to a sudden 
breakdown of the previously employed machine. It is however believed that 
the inbuilt non-adjustable beam hardening (BH) correction algorithm could 
have contributed to this discrepancy. While the initial datasets were treated 
with a BH correction of 200mgHA/cm3, the more recent scans were treated 
with a BH correction six times higher for samples of similar size.  A similar 
effect has been reported by Fajardo et al. [230] who identified not only the 
BH, but also the size and density distribution of the samples as notable 
contributors to the discrepancy in measurements. In fact, the mechanism of 
BH phenomena is in agreement with reported discrepancies, as it biases 
predicted densities in favour of the margins of the sample [230, 231]. Due to 
the fact that a moment of inertia accounts for the square of the distance from 
the neutral axis to each voxel, the difference in density with respect to the 
distance from the centre of each sample increases the weight of the 
spatially-dependent density-to-modulus bending rigidity. This in fact leads to 
an increase in the predicted strength of the sample as presented above.  
Nonetheless, the two sets of sufficiently close correlations mentioned 
here suggest that the discrepancy between the scanners does not affect the 
correlation between data, and hence the relative comparison of strength is 
not impaired. This leads to the conclusion that the discrepancy, and hence 
the resulting accuracy and precision of the prediction, can be adjusted by 
choosing an appropriate material model.  
3.3.3.2 Retrospective density-to-modulus model fit 
Using a complete dataset calibration of the material model, which is a 
common approach for finite element methods used in previous studies [169], 
a notable improvement in the predictions of one slice analyses was 
demonstrated. Although the main criteria for the density-to-modulus power-
law model were to adjust the results in terms of agreement with the 
experimental strength, the R2 in the osteoporotic and metastatic samples 
improved by 14% and 8% respectively, together with maintaining a similarly 
superior R2 in the multiple myeloma dataset. In terms of accuracy as defined 
by Bland and Altman [162], the models were calibrated so that even the 
lowest mean difference in the osteoporotic samples was found to be lower 
than 0.15kN. The largest scatter in terms of the limits of agreement has been 
observed to reach 1.52kN in the metastatic dataset.  
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The optimal material models were found to differ between datasets and 
although the power coefficient (“c”) could remain fixed between pathologies, 
the linear coefficient (“b”) required adjustment. Only a marginal difference 
between optimal models was found, which confirmed the findings from a 
recent micro-indentation study presented in this study. In the case of 
osteoporotic and multiple myeloma bone, the difference between the “b” 
coefficients of the tested power-law was found to be marginal, indicating only 
trivial differences in the properties of the micro-material. In contrast to these 
two datasets, the same linear coefficient of the material power-law for the 
metastatic bone has been found to be twofold that of the osteoporotic bone. 
This can be either explained as a result of the weakest slice contributing 
significantly more to raised levels of strength - hence the middle slice 
analysis could not account for structural changes in metastatic samples - or 
due to underlying differences at the tissue level. 
Observed differences in the metastatic bone are rather surprising as this 
conflicts with studies by Kaneko et al. [198] and von Stechow [67], where 
both studies reported that the presence of metastases does not impair the 
estimation of the stiffness modulus gained from the density of the mineral 
component.  
In fact, another study [225] disagrees with all of these findings, reporting 
that both lytic and blastic lesions are significantly less stiff than normal 
tissue. Hipp et al. [225] in their study also noted that although the apparent 
wet density of osteoblastic lesions in cancer specimens is greater than their 
ash density, they are less stiff than normal bone. The study thus concluded 
that fracture prediction tools based on a density-to-modulus model should be 
adjusted to take into account the effects of the metastases.  
While all three contradicting studies [67, 198, 225] were conducted on 
cored trabecular samples, those conducted by Kaneko and Hipp were 
limited by the low number of samples available (three and two metastatic 
subjects in each of the studies respectively), while the study by von Stechow 
was conducted on ten subjects, without however distinguishing the primary 
cancer or the nature of the lesions. To the author’s knowledge, there is only 
one study which has been conducted where the cancer-affected (metastatic) 
bone was evaluated at the bone tissue level [68]. However, in that study 
authors reported values of an elastic tissue modulus of the healthy bone 
derived from nano-indentation (0.47 GPa) which were almost two orders of 
magnitude lower than the ones reported in the literature (~10-20 GPa) [36], 
indicating a possibly significant disparity in their experimental procedures or 
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a considerable detrimental effect of damage on the bone indentation 
properties [35]. Despite the systematic difference to values reported by other 
investigators, Nazarian et al. [68] reported the elastic modulus and hardness 
of the metastatic cancer bone as more than twofold lower than that of non-
oncological tissue. Normal and osteoporotic indentations were not found to 
exhibit significant differences. Yet the actual potential variance between 
osteoclastic and osteoblastic lesions remains unclear as the researchers 
reported only primary cancer diagnoses and reported neither the presence 
of the lesion, nor the specific location of the indents.  
Nonetheless, the inconsistencies between all the aforementioned 
studies, including this more recent one, raises concerns that the material 
properties of bone may be different with respect to the cancer type. Hence, 
to produce reliable data a calibration material model study should be 
conducted when testing different cancer samples. 
3.3.3.3 Structural assessment in predicting OP, MM and mets – 
comparison to sophisticated FEA models 
In contrast to the most recently developed finite element models used to 
provide an assessment of vertebral strength, the simplistic one-slice-analysis 
model has proved superior in terms of both accuracy and precision [65, 148, 
167, 169-172]. In fact, only three studies [168, 169, 171] have been superior 
both in correlation and in agreement with measured data. Zeinali et al. [168] 
and Imai et al. [171] both tested models were modelled as linear elastic as 
well as improved linear elastic-linear plastic constitutive models, which were 
tested in homogenised and voxel-based models consisting of limits of 
agreement lower than 0.85kN, however both studies were limited in the 
number of samples tested which may have impaired the results which were 
obtained (N=9 and N=12 respectively).  Pahr et al. [169] on the other hand, 
reused 37 samples earlier processed by Dall’Ara et al. [167] and reported 
that by calibration of the model on the same dataset, both accuracy and 
precision can be improved to an impressive mean difference of nearly zero, 
with ± 1kN limits of agreement together with an impressive correlation of 
R2=0.92. These in fact are quite comparable data in terms of agreement 
when comparing to the calibrated one-slice analysis, however R2 is more 
difficult to compare as the range of experimentally obtained strengths was 
up to twofold larger in the finite element study mentioned (6.9kN in favour for 
FE [167] versus experimental ranges in this study: 3.2, 4.16 and 4.55 kN for 
OP, MM and mets respectively). 
- 104 - 
When considering the time dependency of the model used, literature 
very often lacks any indication of length of processing time which is however 
a significant factor in both the experimental and clinical environment. 
Although it is generally known that FEA is often limited by requirements 
consisting of preparation of the modelled sample prior to analysis, resulting 
in a lengthy modelling procedure and a reduced number of samples being 
able to proceed to testing. Considering the computational time alone, the 
models presented here could in theory be compared to coarsen 
homogenised models [167, 171] where the lower computational time and 
cost are counter-balanced by the lengthy effort required for the material 
mapping, segmentation and meshing, which all need to be adjusted 
separately for each sample. Even here, the one-slice-analysis is hardly 
comparable due to the fact that the time required performing an image-to-
strength assessment, including data handling and preparation of the image, 
has been reduced to less than one minute. There is a strong potential in 
automatised fabric homogenisation which has been recently used to 
minimise the computational time required to approximately 30 minutes [169], 
but still requires well-defined boundary conditions and has been tested only 
in a pre-clinical environment.   
3.3.3.4 Comparison of fracture prediction tool to other analytical 
models 
In contrast to the work presented in this thesis, Whealan et al. [2] and 
Windhagen et al. [147] tested multiple segments, an analysis which probably 
represents the in-vivo state more accurately, but which hampers a 
methodological approach to understanding the load management within an 
isolated organ. In fact, the sample was tested in forward flexion, where the 
presence of intervertebral disc and posterior ligaments causes the load to be 
distributed more uniformly across both vertebral endplates towards 
compressional loading and is strongly dependent upon the pathological state 
of the soft tissue.  Moreover, both studies have in reality covered predictions 
for particularly cancerous samples by pooling samples from donors without 
any oncological pathology and creating spherical cavities to simulate lesions. 
This however leads to an artificially distributed prediction across the range of 
experimental strengths and may have facilitated the acquisition of 
correlations of R2=0.69 and R2=0.85 respectively. The higher correlation in 
Windhagen’s study can be explained by placing the simulated lesion always 
within the central region of the vertebral body, hence minimising the need for 
a flexural rigidity component.  
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3.3.3.5 Limitations of fracture prediction used in this study 
The major limitation of this approach is that the outcome lacks any 
indication of fracture propagation or even of the relative position of the 
fracture. Although the slice-by-slice analysis can be used to predict the 
weakest slice, i.e. the site which is most prone to fracture, it lacks the ability 
to derive the relative stress distribution. Moreover, the linear elastic model 
which is the basis of the model proposed in this study cannot be used to 
quantify post-yield behaviour in any way. On the other hand, results 
suggested by Hong et al. [232] suggest that the model could easily be 
adjusted also for torsional loading, improving its versatility.  
At last, it must be noted that the final results were calibrated using the 
entire dataset. Such simplification may offer a distorted interpretation of the 
performance of the developed model and lacks an engineering approach as 
data have not been delivered experimentally. Finally it is not guaranteed that 
this material model would work on different subsets.  
Despite these limitations, the results are similar to those presented by 
Whealan [2], Windhagen [147] and many finite element approaches 
(e.g. [65, 167] and more). Even without adjusting the material model, it 
provides accurate information about the relative strength of the bone 
compared to other samples tested with the same model (Table 4, literature 
review section 2.6.2), which ensures a fast and robust benchmarking tool for 
use in a laboratory environment.  
3.4 Commissioning of the fracture prediction tool – Summary 
The fracture prediction tool adopted for purpose of this thesis and 
discussed in this chapter was initially tested using a dataset of osteoporotic, 
metastatic and multiple myeloma samples which matched testing and 
scanning criteria for the single vertebra study. 
At first, the model was validated for use using historical data which 
showed promising results in terms of predicting the fracture based on the 
assessment of mineral component distribution using microCT images. In 
short, a relatively good agreement in terms of mean difference and limits of 
agreement was found (-0.25 ± 0.91 kN, -0.41 ± 0.96 kN and -1.01 ± 2.52 kN 
for OP, metastases and MM respectively), together with an indication of 
good correlations (up to R2=0.93, 0.64 and 0.62 for OP, mets and MM 
respectively). This initial analysis underpinned two important findings: first, a 
strong necessity to identify any pre-existing fractures and also the existence 
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of possible differences in bone material properties; second, multiple 
myeloma bone predictions show large discrepancies in terms of both 
accuracy and precision, probably due to changes not only on a structural but 
also material level which should be further investigated. 
Recent analysis of samples tested for the purpose of this thesis 
comprised altogether more than a hundred samples which have been 
collected, dissected and scanned before being subjected to an eccentric 
wedge compression fracture test. Here, samples were tested separately 
according to the nature of the bone disease (OP, MM and metastases). The 
results presented here underpin the overall stiffness and strength 
assessment used for the validation of the image-based fracture prediction 
tool in the following sections.  OP bone was found to be both the weakest 
(1.35 ± 0.91 kN) and the least stiff (2.2 ± 1.0 kN/mm) from the investigated 
groups. From the other two tested pathologies, MM and metastases were 
found to be relatively comparable in terms of both the strength (2.73 ± 1.17 
kN and 2.86 ± 1.33 kN respectively) and stiffness (3.46 ± 0.96 kN/mm and 
3.57 ± 1.40 kN/mm respectively). 
The results of the fracture prediction presented for each of the three 
pathologies were with relatively good correlation (R2=0.66, 0.83 and 0.77 for 
OP, metastases and MM respectively) with however a wider range of 
agreement and considerable change in agreement compared to the initial 
study. The mean difference was found to be relatively poor when no 
samples were excluded from the study (-1.93, -1.84 and 0.69 kN 
respectively) with relatively wide limits of agreement (±2.02, ±1.94 and ±1.55 
kN respectively). Calibrated one-slice-analysis ranged in terms of multiplier 
of the material model from 3.5, 2.5 and 6 with limits of agreement ±1.03, 
±0.96 and 1.52kN (for OP, MM and mets respectively). The mean difference 
for all three pathologies was <0.15kN.  
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  Chapter 4
Determination of the mechanical properties of trabecular 
bone utilising microCT assessment and micro-indentation 
The second objective of this thesis was postulated regarding the limited 
understanding of underlying material properties of the cancerous bone. The 
necessity to underpin the alteration due to the presence of neoplastic 
pathology encompasses whether the deterioration of bone relates to 
changes at the meso- or micro-scale of trabecular tissue.  
Section 4.1 focuses on the investigation of changes at the meso-scale 
level by means of image-derived assessment which was carried out by 
comparing morphology indices compared to the biomechanical metrics of 
each sample.  The latter - the investigation at the micro-scale- was 
investigated in the following section 4.2 by means of micro-indentation 
assessing bone quality change in patients with diagnosed multiple myeloma 
cancer.     
4.1 Pathology specific morphology 
 Introduction to assessment of micro-properties of the bone 4.1.1
The use of areal-BMD consistently fails to diagnose osteoporosis in the 
wider population (e.g. [62, 83, 226]). This could be explained by the fact that 
areal-BMD is based on accumulative planar X-rays and hence is dependent 
on the general size of the vertebra and mineral mass in the direction of the 
scan. Nevertheless, the size of the subject is not taken into account and 
hence can result in a systemic under-classification of osteoporosis. Despite 
its increasing general acceptance, the volumetric BMD used in this study is 
still considered more as a pre-clinical measure of bone quality due to the 
necessity of CT scanning and issues arising from relatively high radiation 
dosages, which increase with resolution together with the lack of proof, to be 
deployed purely as a measure of the weakening of the vertebral bone.  
The objective of this study was to conduct a pre-clinical experiment 
that would provide a better understanding of the morphological nature of the 
tissue in combination with biomechanical testing that would assist in the 
development and optimisation of a treatment technique in pain management 
and techniques to prevent debilitating vertebral fractures. Volumetric BMD, 
as a mineral content per volume, provides measures which are corrected for 
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the volume of mass, however it lacks the large statistical data required to 
establish a precise threshold in clinical practice. 
In this study the relative contributions of bone mass and trabecular 
microarchitecture to biomechanical metrics have been determined in a more 
complex loading scheme. The relationships between bone mass indices and 
trabecular morphometry on one hand and strength and stiffness on the other 
have been investigated. Pathologically unique samples have been examined 
by means of microCT assessment and later statistically compared to the 
complete organ wedge compression testing. This is in fact more clinically 
relevant [76, 233] than a similar assessment done on samples compressed 
axially [69, 234]. The consequences for the stiffness and strength of the 
organ have been presented earlier in this work in the fracture prediction tool 
development.  
 Methods used in morphology assessment 4.1.2
4.1.2.1 Sample population 
Samples used for the morphological assessment study undertaken in 
this section comprised of the same samples used in the development of the 
fracture prediction tool, section 3.3. This more specifically comprised of fifty-
four osteoporotic samples, thirty-four metastatic samples and nineteen 
samples from donors diagnosed with multiple myeloma. Details of the 
sample population together with basic donor information are listed in section 
3.2.2.1. The same CT images as those used for beam theory-based 
predictions were treated in this analysis allowing a direct comparison with 
the previous data.   
4.1.2.2 Morphology image processing 
Scans were first carefully checked manually for scanning artefacts which 
would hamper the assessment and checked if all the slices have been 
reconstructed properly. The volume of interest (VOI) was chosen according 
to the SOP suggested by previous investigators [38]. In this protocol, 
trabecular BMD is evaluated safely within the inside volume of the bone as a 
specimen-specific cylinder with  its cross-sectional base centred on the 
sagittal plane with a diameter of 60% of the anterio-posterior vertebral body 
length and 80% of vertebral body height, defined by the first appearance of 
the cortical endplate on the axial slices (VOI depicted in Figure 42). The VOI 
(file extension GOBJ) was defined in the scanner evaluation program for 
later use within Image Processing Language [235]. 
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Figure 42: Protocol defining the VOI within the trabecular structure.  
An overview of the steps taken to perform this basic morphometrical 
analysis is depicted in Figure 43. Prior to segmentation a measurement 
noise was partially suppressed within the VOI using a 3D Gaussian filter 
(filter width 1.2, filter support 2) followed by binarisation to differentiate 
between bone and the background. This method is often performed 
manually by selecting the threshold according to the researcher’s best 
estimate. However, this technique, when tested on sensitivity to different 
microCT users, showed insufficient consistency between researchers. As an 
alternative method an iterative selection method proposed by Ridler et 
al. [236] was adopted. The method for selection of the threshold is based on 
an iteration to the weighted equilibrium of a density histogram as shown as 
“X” in Figure 44. To do so, the scanning density data (file extension ISQ) 
together with the volume of interest defined in the microCT scanner (file 
extension GOBJ) were simultaneously loaded and processed by a custom-
build code [208] prior to derive the single threshold value (GUI depicted in 
Figure 45). 
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Figure 43: Single step flowchart of the Morphological assessment. (ISQ 
- microCT scanning file; GOBJ - microCT file defining ISQ specific 
volume of interest mask; SEG_CYL – 3d binarised image stack of 
representative trabecular bone region; BMD,BV/TV, Tb.Sp, Tb.Th, 
Tb.N and Conn.D represent morphological indices discussed in 
the text) 
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Figure 44: Principle of iterative selection thresholding technique 
proposed by Ridler and Calvard [236] and adopted to microCT 
measurements performed in this study 
 
 
 
 
Figure 45: Graphical User Interface (GUI) of a custom-compiled script 
used to view the ISQ scanning files, to estimate the BMD, BV/TV 
and optimal threshold within the desired VOI (based on GOBJ). 
Subfigure (A) shows an example of vertebra scanned in 
microCT100, a program which allows a slice by slice list, is able to 
adjust brightness and highlights segmented bone according to the 
estimated threshold detailed in subfigure (B) 
A.) B.) 
- 112 - 
The binarised stack was later filtered using a ranking filtering approach 
which identifies and removes significantly minor disjointed elements. 
Subsequently, a morphological assessment was performed using a distance 
transform algorithm to deliver direct measurements of trabecular spacing 
(Tb.Sp), thickness (Th.Th) and number of trabeculae (Tb.N). Connectivity 
was performed using a ranking method whereas density was normalised to 
the size of the VOI. All these morphological indices were obtained using 
Image Processing Language [235]. 
4.1.2.3 Comparing the morphology to cadaveric testing 
The trabecular microarchitecture indices were furthermore combined 
with measures obtained from the fracture prediction tool described 
previously in subsection 3.3: ”Fracture prediction tested on large sample 
population: three pathologies” and compared to experimental data obtained 
from mechanical testing described in section 3.2: “Commissioning of 
cadaveric Wedge Compression Fracture testing”. 
Statistical analysis was performed using the computing environment 
R [237]. Morphological indices were compared to experimental data in terms 
of coefficient of determination (R2) based on linear fit and multivariate 
regression between the selected variables. 
 Morphology of human bone - Results 4.1.3
4.1.3.1 Morphology assessment 
 Morphology of osteoporotic bone 4.1.3.1.1
 With regards to the most commonly used bone quality indicators, the 
Bone Mineral Density (BMD) in this dataset was found to vary from 56.7 to 
204.7 mgHA/cm3 (mean 124.6 ± 39.9 mgHA/cm3), whereas the bone volume 
fraction (BV/TV) varied from 0.1 to 0.23 (mean 0.17 ± 0.04). The trabecular 
structure indices Tb.Sp, Tb.Th, Tb.N and Conn.D varied from 0.9 to 2.07 mm 
(mean 1.31 ± 0.3), 0.26 to 0.42 mm (mean 0.3 ± 0.03), 0.97 to 2.07 per mm 
(mean 1.36 ± 0.28) and 0.29 to 1.62 per mm3 (mean 0.81 ± 0.4) respectively.  
 Morphology of multiple myeloma bone 4.1.3.1.2
 An assessment of the multiple myeloma samples revealed that the 
Bone Mineral Density (BMD) varied from 100.4 to 194.3 mgHA/cm3 (mean 
124.1 ± 28.3), whereas the bone volume fraction (BV/TV) varied from 0.1 to 
0.22 (mean 0.15 ± 0.04). The trabecular structure indices Tb.Sp, Tb.Th, 
Tb.N and Conn.D varied from 0.95 to 3.84 mm (mean 1.68 ± 0.82), 0.27 
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to 0.53 mm (mean 0.32 ± 0.06), 1.05 to 3.76 per mm (mean 1.75 ± 0.8) and 
0.22 to 1.13 per mm3 (mean 0.67 ± 0.29) respectively.  
 Morphology of metastatic bone 4.1.3.1.3
Morphology alone in metastatic samples provided an assessment of 
Bone Mineral Density (BMD) varying from 109.3 to 239.9 mgHA/cm3 (mean 
152.3 ± 34.2), whereas the bone volume fraction (BV/TV) varied from 0.18 
to 0.34 (mean 0.27 ± 0.05),The trabecular structure indices Tb.Sp, Tb.Th, 
Tb.N and Conn.D varied from 0.69 to 1.15 mm (mean 0.8 ±0.11), 0.28 to 
0.37 mm (mean 0.31 ± 0.02), 0.8 to 1.2 per mm (mean 0.9 ± 0.09) and 0.77 
to 2.88 per mm3 (mean 1.91 ± 0.68), respectively.  
4.1.3.2 Morphology as a fracture prediction and comparison to 
composite beam theory fracture prediction tool 
Generally speaking, fracture prediction using the beam theory has 
provided promising results when assessing the weakening of the vertebra. 
This section aims to establish the relative links between the vertebral 
biomechanical behaviour of the bone-mass coupled with an assessment of 
the trabecular micro-architecture in comparison to image-based beam theory 
fracture prediction.  
Multivariate correlation was possible due to combining the previously 
presented morphological indices, beam theory fracture predictions and 
experimental data. Table 10 details results from a number of observations 
which have been made. Stand-alone morphology indices were found to 
weakly correlate with the experimental data, here only BMD and BV/TV were 
found to correlate with the vertebral strength but only with moderate success 
given their different pathologies. Tb.Sp and Tb.N were found to correlate 
weakly or not at all with strength and stiffness. The beam theory was found 
to strongly correlate with the biomechanical testing in both cases, using the 
representative range of images and also in the case where only one slice 
(Fz.OneSlice, EI.OneSlice and EA.OneSlice) has been used. 
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Multivariate regression - part correlation 
Composite Beam Theory 
Dependent variable Strength 
Independent variable Fz.ran
ge 
EI.rang
e 
EA.ran
ge 
Fz.OneSli
ce 
EI.OneSli
ce 
EA.OneSli
ce 
P
a
th
o
lo
g
y
 
Osteoporosis 0.81 0.61 0.63 0.76 0.7 0.67 
MM 0.91 0.79 0.86 0.91 0.88 0.86 
Metastases to 
spine 
0.88 0.87 0.90 0.79 0.78 0.86 
All 0.77 0.63 0.69 0.68 0.64 0.64 
Dependent variable Stiffness 
Independent variable Fz.ran
ge 
EI.rang
e 
EA.ran
ge 
Fz.OneSli
ce 
EI.OneSli
ce 
EA.OneSli
ce 
P
a
th
o
lo
g
y
 
Osteoporosis 0.73 0.78 0.82 0.67 0.67 0.63 
MM 0.64 0.49 0.57 0.63 0.62 0.65 
Metastases to 
spine 
0.73 0.78 0.82 0.66 0.67 0.74 
All 0.65 0.58 0.63 0.58 0.57 0.57 
Morphology indices 
Dependent variable Strength 
Independent variable BMD BV/TV Tb.Sp Tb.Th Tb.N Conn.D 
P
a
th
o
lo
g
y
 
Osteoporosis 0.55 0.73 -0.68 -0.06 -0.68 0.81 
MM 0.79 0.30 0.16 0.53 0.15 0.02 
Metastases to 
spine 
-0.23 0.21 0.04 0.62 0.09 -0.16 
All 0.36 0.51 -0.22 0.30 -0.20 0.38 
Dependent variable Stiffness 
Independent variable BMD BV/TV Tb.Sp Tb.Th Tb.N Conn.D 
P
a
th
o
lo
g
y
 
Osteoporosis -0.38 0.08 0.16 0.53 0.22 -0.25 
MM 0.44 0.05 0.37 0.50 0.36 -0.22 
Metastases to 
spine 
-0.38 0.08 0.16 0.53 0.22 -0.25 
All 0.27 0.44 -0.17 0.26 -0.15 0.30 
Table 10 Pearson’s Correlations (r) between the biomechanical 
experiment and the image-based analysis 
 When combined together, the correlation with biomechanical 
assessment significantly improved for all pathologies, in terms of both the 
strength and the stiffness (Table 11). This suggests that despite their weak 
correlation as standalone predictors, all parameters in some measure 
contribute to the organ’s mechanical resilience. However, statistically only 
trivial contributions to the correlation were found in the spacing index (Tb.Sp) 
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and number of trabeculae (Tb.N) for all three pathologies. By excluding the 
two indices from the multivariate regression, the correlation coefficient 
decreased only marginally (by 4.1, 1.2 and 0.9% for strength in OP, MM and 
mets respectively and by 2, 13.7 and 5.8% for stiffness in OP, MM and mets 
respectively).  
Multivariate regression - final correlation 
Dependent variable Strength 
Independent variable Morphology indices 
combined 
Morphology + 
Beam theory 
P
a
th
o
lo
g
y
 
Osteoporosis 0.84 0.90 
MM 0.88 0.98 
Metastases to 
spine 
0.76 0.97 
All 0.66 0.92 
Dependent variable Stiffness 
Independent variable Morphology indices 
combined 
Morphology + 
Beam theory 
P
a
th
o
lo
g
y
 
Osteoporosis 0.74 0.80 
MM 0.81 0.96 
Metastases to 
spine 
0.70 0.89 
All 0.61 0.83 
Table 11 Pearson’s correlation coefficients (r) as the result of the 
multivariate regression analysis 
The multivariate regression performed discerned that the best 
association between the whole organ’s mechanical properties and microCT 
images can be obtained by combining bone mass parameters (BMD,BV/TV) 
and microstructure properties (Tb.Th, and Conn.D), together with 
parameters concerning the modulus distribution (EA, EI and Fz). One must 
however consider that to achieve such a good correlation, at least 80% of 
the vertebral body had to undergo a detailed microCT assessment in 
comparison to an assessment with only one slice which was able to 
correlate with considerable success. Namely, compared to the complex 
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assessment of all contributors, the one slice assessment (Fz.OneSlice) 
showed correlations lower only by 25.2, 12.0 and 10.9 % in terms of strength 
prediction for OP, MM and mets respectively and 21.6, 32 and 17% in terms 
of stiffness prediction for OP, MM and mets respectively. Overall, one slice 
analysis correlated by 30.4% less in terms of strength of all samples, and by 
31.1% less in terms of stiffness of all samples. 
 Morphology assessment in bone with cancer and OP - 4.1.4
Discussion 
The BMD values presented in this work are in agreement with 
literature in the case of osteoporotic bone [238], although the BMD of both 
oncological pathologies was expected to be much lower [95]. The reported 
values for single vertebra were however as low as 8mgHA/cm3, suggesting 
that the area in which authors measured the BMD was extremely 
deteriorated in terms of content of the calcified bone, in fact often suggesting 
that no bone remained at all. A notably increased BMD and BV/TV in 
metastatic bone was caused by the relatively good condition of the bone 
which had been harvested from the two patients and by a lack of osteolytic 
lesions. The assumption that the bone from these patients was relatively 
healthy is supported by other morphological indices reinforcing the quality of 
the structure of the bone. In fact, a superiority of connectivity and a 
decreased number of trabeculae and separation thereof both suggest a 
much higher quality of bone when compared to the other two investigated 
pathologies. The bone volume fraction (BV/TV) presented here is in 
agreement with several studies [239-241] although values in literature do 
vary from 0.08 to 0.39. Disagreement was found towards both ends of the 
range. Ladd et al. [242] and Follet et al. [243] reported bone fractures within 
the lowest limits of the range in contrast to Ouyang et al. [244]who reported 
values twofold higher than the values which have been presented in this 
work. The osteoporotic and multiple myeloma datasets are in agreement 
with observations of oncological tissue presented by Nazarian et al. [68] who 
failed to show a significant difference between the datasets belonging to 
their two pathologies. The trabecular morphometry indices have been found 
to lie within a similar range to those reported elsewhere [239, 243] but this 
has also been opposed by several other studies [240, 243, 244]. 
The large discrepancy which exists within the literature examined is 
explained by the lack of a “gold standard” for assessing bone structure using 
the CT. Examples in which this lack existed include the geometrical 
calibration, the range of the employed density calibration phantom, the 
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resolution [239], scanning parameters, beam hardening correction [231], the 
position of the vertebra with respect to the scanner [230] etc. In addition, one 
needs to pay attention when comparing in-vivo and cadaver samples due to 
the influence of the surrounding tissue on the resulting densities [34].  
Although a biomechanical assessment with the objective of identifying 
key components in a structural assessment has been well documented for 
compression testing [69, 217, 234]  (and includes references within a review 
article by Bouxsein et al. [70]), it had yet to be validated for wedge 
compression loading. This study has however presented a correlation with 
the bone strength in a limited number of cases and a very weak or no 
correlation with its stiffness.  
This is in contrast to findings which have been presented for strictly 
compressional loading where bone mass such as BMD and BV/TV explains 
the largest measure of variation by far in both stiffness and strength [69]. For 
more complex loading it has been reported that BMD and BV/TV correlated 
only moderately with the bone strength for osteoporotic samples only, and 
only BMD correlated with strength in multiple myeloma samples. This 
indicates two possible explanations: 1) literature-based data agrees in the 
investigation of osteoporotic bone where data are not comparable to other 
pathologies; and 2) findings from compressional loading cannot be directly 
translated to loading with an excessive bending component. The first 
possible explanation was again confirmed by assessing the density of 
connectivity, which was believed by many authors to be a link explaining the 
remaining unknown variation of results when correlating bone mass with 
strength [59]. Despite high correlations for osteoporosis, this failed to be 
repeated in experiments performed with the other two pathologies. 
In fact, the second possible explanation is similar to findings 
presented by Crawford et al. [245] who suggested that an additional metric 
to account for bending rigidity is needed. In their validated FE simulation, the 
authors proposed that even the multiplication of the axial stiffness 
(effectively a product of BMD and the cross-sectional area) by the square of 
the anterio-posterior vertebral body depth gives a significantly higher 
correlation to the bone strength. Multivariate regression analysis presented 
in this study has shown that the number of trabeculae together with the 
trabecular spacing indices do not strongly improve correlation with vertebral 
strength, however this is believed to be due to the fact that they share the 
same derivation algorithm with trabecular thickness, hence are not 
independent. To account for the bending component, it has been further 
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investigated that a combination of beam theory and the morphological 
indices did account for a variation of results with correlation to strength 
ranging between 81% and 96%, and to stiffness ranging from a modest 64% 
up to 92%. 
The results presented in this study suggest that although a 
morphology assessment can help to underpin the structural properties of 
vertebral bone, the benefits of using morphology as a precursor of fracture 
may be overwhelmed by the need for a large volume of images to be 
scanned with high accuracy. Moreover, the general understanding of the 
relationship between bone structure and biomechanical performance, and 
the ways in which they correlate, may be inflated by a comparison with 
simplistic uni-modal loading and the transition to a more complex scenario 
remains unaccounted for.  
4.2 Micro-indentation of multiple myeloma bone 
 Introduction to micro properties of multiple myeloma bone 4.2.1
Multiple myeloma is a bone marrow cancer derived from aberrant 
plasma cells and is often associated with a myeloma bone disease. The 
lesions of myeloma bone disease are frequently widespread resulting from a 
tumour-induced osteoclast/osteoblast imbalance in the remodelling process 
where the bone resorption becomes dominant. Myeloma bone disease 
results in a deficiency of the load bearing capacity, resulting in significant 
morbidity and utilisation of healthcare resources. However, the nature of the 
weakening has not been adequately assessed. In particular, it remains 
unclear whether besides bone loss, the material properties of the 
neighbouring tissue also become degraded.  
Previous studies have shown that age has little or no influence on the 
mechanical properties at the tissue level [36, 184], which remains an 
important encounter in supporting the theory that a reduction in bone 
stiffness in osteoporotic patients is primarily due to changes in BV/TV and 
not in the material properties of the bone per se. However, this has not been 
proven in cancer patients who are known to be affected by an increased risk 
of fractures occurring compared to an osteoporotic population [83]. A 
comparison to a non-affected population has clearly shown the structural 
changes in patients suffering from this neo-plastic disease [91, 92], however 
there exists only limited knowledge concerning whether the multiple 
myeloma affects the bone mechanical properties at the tissue level.  
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Due to a direct link between bone density and its stiffness moduli used 
in various fracture prediction tools, an investigation of the unambiguousness 
of underlying material properties of bone is also required to prevent 
misleading predictions. A comprehensive assessment of the mechanical 
properties of vertebrae at the tissue level affected by multiple myeloma, as 
yet unreported in literature, is needed to extend the usage of tools 
developed to predict vertebral strength, such as those employing finite 
element methods. Such a methodology needs as its input a number of 
reliable mechanical properties which might be different from the normal or 
osteoporotic aspects, such as elastic modulus at the tissue level. Moreover, 
the deterioration of the bone tissue in function of its distance to the lesion 
can be modelled, if necessary. Hence the aim of this study was to 
investigate the mechanical properties of bone tissue, measured by means of 
micro-indentation in patients with myeloma bone disease, and compare the 
findings with non-affected patients.  
Therefore, the hypotheses for this study are listed as follows: 
i. Vertebral tissue indentation properties of MM bone are influenced 
by the presence of a lesion with progression of the lytic 
infiltration. 
ii. Vertebral tissue indentation properties of MM bone are different 
when compared to indentations in healthy bone tissue. 
 Methods of bone micro-properties assessment 4.2.2
4.2.2.1 Multiple myeloma bone indentation - sample selection 
Spines with a diagnosis of MM were acquired from a non-transplant 
tissue bank (GIFT, Leeds General Infirmary, UK and Science Care®, AZ, 
USA) following ethics committee approval (Ethical approval: 10/H1306/60). 
Two vertebrae (L4 and T6) were extracted from the thoracolumbar spine of 
six subjects. Specimens were divided into two groups according to a 
microCT assessment of each vertebra (voxel size 70.8x70.8x70.8 µm3, 
microCT100 [Scanco Medical, Bassersdorf]): samples without any visible 
lesion (group MM.N, example depicted in Figure 46 (A)) and specimens with 
myeloma bone disease (MBD) infiltration to the bone (groups MM.L, two 
examples depicted in Figure 46 (B) and (C)). After removing posterior 
elements, the samples were partially embedded in PMMA to allow precise 
cutting. In addition reference grooves were made in the cortical shell.  
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Figure 46: Vertebral body section cut along a plane perpendicular to 
the vertebral axis in the middle of the multiple myeloma bone 
without any visible lesion (A), moderately infiltrated sample (B) 
and sample severely affected by MBD (C) 
4.2.2.2 Nearby lesion localisation 
Repeated microCT scans with the same parameters provided 
quantitative information about the position and size of any lytic infiltration 
with respect to the reference grooves. To automatically locate the lesions, a 
distance transform algorithm was used [235]. This method is, as illustrated in 
Figure 47, based on fitting spheres of different sizes into the background of a 
segmented 3D image of the bone [57], where the segmentation threshold 
value was obtained using an iterative selection method [236] in a custom 
compiled image processing script [208].  
    
Figure 47: Visualised distance transform algorithm to estimate the 
trabecular spacings and thicknesses which highlights 
morphological changes due to lytic infiltration to bone. 
Segmented image (A.), Tb.Sp (B.) to identify a cancer lesion 
(multiple myeloma cancer) 
A.) B.) 
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4.2.2.3 Sample preparation prior to indentation testing 
According to the position of the lesions, from each sample, two to three 
5 mm thick slices were cut using a high precision diamond band 
saw [EXACT 310, Exakt Apparatebau, Norderstedt, Germany] perpendicular 
to the cranio-caudal axis. From each of these slices, one to four 15x15 mm 
samples were prepared. In particular, samples from groups infiltrated by 
cancer were cut through the lesion (MM.L) and are later depicted in Figure 
48. Moreover, a control sample was extracted from each vertebra in a region 
without any visible cancer infiltration to the bone, according to the microCT 
images (MM.L.C). In one case there was not enough trabecular bone to take 
a control sample as most of the trabecular structure was affected by the lytic 
lesions. Samples from the group without any visible lesions (MM.NL) were 
taken from the middle region of the vertebral body. Therefore, samples were 
divided into three groups as reported in Table 12, whereas the number of 
samples tested is reported in Table 13. 
 
Figure 48 Micro-indentation sample preparation: Lesion has been 
identified based on segmented microCT images superimposed by 
lesion map highlighting bone separations >3.5mm. Reference 
grooves made prior to scanning were used as a reference 
guideline for latter cutting. Figure depicts an example of a single 
coupon containing a lesion cut with respect to the cutting grooves 
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Study groups 
Group 
name 
Infiltration to the 
bone 
Details 
MM.L Myeloma bone 
disease (MBD) 
Four patients with lytic invasion to the 
vertebral bone, samples taken from 
proximity of the lesion 
MM.L.C MBD (Control) Samples from the same vertebrae of MM.L 
group but taken from the non-affected site 
MM.N MM without visible 
lesions 
Two patients with diagnosed MM cancer 
without visible lesions 
Non-MM No MM cancer Samples from thirty-two donors without 
diagnosed MM cancer (data collected 
from [36]) 
Table 12 Base group sample allocation comprising twelve samples 
from six donors with diagnosed MM cancer compared to a non-
affected population 
 MM.L MM.L.C MM.N non-MM 
Transversally-cut 
trabeculae 
1079 311 293 243 
Axially-cut trabeculae 408 76 100 243 
Number of samples N=31 N=8 N=9 N=27 
Number of vertebrae 8 7 4 27 
Number of donors 4 2 27 
Vertebral levels 2xT6, 2xL4 T6, L4 T1-L3 
Age range, gender 
(Male/Female) 
60(M), 70(F), 68(M), 
82(M) 
87(F), 
90(M) 
21-94 
(Median 
65) 
Table 13 Number of indentations and samples for each of the base 
groups, together with non-MM group acquired by Wolfram et. 
al. [36] 
To remove the bone marrow, each sample was submerged in soapy 
water for 12 hours at 37ºC following 7 minutes in an ultrasonic bath at 40kHz 
(U1250 Ultrasonic bath [Ultrawave Ltd.]). Where necessary, the residual 
- 123 - 
bone marrow was removed using a dental pick water lavage (oralB, 
professional dental care [Brown]) submerged in a warm bath so as not to 
damage the trabeculae. In some cases the cancerous tissue had to be 
carefully removed manually. The procedure was repeated until the samples 
were cleaned and free of any soft tissue.  
Afterwards, samples were left to dry for 6 hours at room temperature 
and then fully embedded in epoxy resin (EpoFix [Struers A/S, Ballerup, 
Denmark]) with a vacuum applied for 5 minutes to remove air bubbles (CCL-
31 vacuum pump [Javac, UK]).  
Embedded samples were glued to a microscopic glass and polished 
using Ethylene glycol as a lubricant. The final polished surface was achieved 
by using a range of progressively smoother silicon carbide papers (P500, 
P1000, P2400, P4000 [Struers A/S, Ballerup, Denmark]) and finished with 3 
μm and 1 μm diamond grain suspension on polishing cloth. Between every 
polishing step, the residual grinding particles were cleaned from each 
sample with water following an ultrasound bath in distilled water for 7 
minutes at 35 kHz. Summary of the sample preparation from lesion 
localisation to labelling the lesion prior to micro-indentation testing is 
illustrated in Figure 49. 
 
Figure 49: MicroCT assessment followed by sample cutting according 
to a suggested cutting path. Bone is represented as segmented 
tissue (red) whereas fitted spheres of different colours according 
to their size represent the lesion (>3.5mm), thus predicting the 
lesion position (left). A cleaned and embedded sample with rough 
demarcation of the lesion borders is annotated with a permanent 
marker (right) 
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The use of a validated experimental methodology [184, 246, 247] and 
the same apparatuses allowed comparison with previously published 
data [36]. In particular, comparisons were made between the present study 
and that study on indents performed along the cranio-caudal direction and 
located in the inner region of axial and transverse sections of trabeculae. In 
that study, 27 human vertebral samples were harvested from patients where 
medical history did not indicate any neoplastic disease. 
4.2.2.4 Indentation procedure 
Micro-indentation was performed during a secondment placement in the 
Vienna University of Technology, Institute of Lightweight Design and 
Structural Biomechanics. Indentations were performed under dry conditions 
by using a Berkovich diamond tip mounted on a CSM micro-indenter (NHT, 
CSM, Switzerland). Indents were load driven with a monotonic ramp at 
120mN/min until reaching a set depth of 2.5µm following a hold time for 30s 
with sequential monotonic unloading again at 120mN/min. Indentation 
modulus (Ei) was computed according to the procedure suggested by Oliver 
and Pharr [248].  Indentation moduli (Ei), hardness (H), elastic energy (We) 
and plastic energy (Wp) were computed for each indentation. Ductility was 
estimated as a ratio of plastic indentation energy to total indentation energy 
(Wp/(We+Wp).  
Prior to the indentation, after mounting the sample to the base of the 
indenter, the borders of each lesion were recorded using an in-build optical 
microscope(as exampled in Figure 50). Indents were placed in either axially- 
or transversally-sectioned trabeculae. Each indent was labelled as axial or 
transversal according to the nature of the cut. In both cases only the central 
region of the section was indented.  
Every sample was indented with at least 40 indents. The load-
displacement curve of each indent was carefully examined and, in case of 
observed indenter contact problems, the corresponding indent was excluded 
from the study. Temperature (τ) and humidity (κ) were constantly measured 
during the test (τ =21.62 ±0.73ºC, κ= 50.33 ±4.9%). The indentation data 
representing a non-affected population, pooled from the previous study [36], 
were adjusted to the same reference temperature and humidity by 
performing a bi-linear least square fit. The affine adjustment function 
(eq.(1.11)) and the coefficients for each of the indentation variables (Ei, H, 
Wel and Wp (eq. (1.12), (1.13), (1.14) and (1.15)respectively)) are listed in 
Appendix F.2: Humidity and temperature adjustment.  
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Figure 50 Micro-indentation: the border of the lesion has been 
quantified as the closest trabecula-intersecting indentation plane. 
In case of multiple occurrences, lesions have been labelled 
independently (as in the example), together with a record of the 
position of at least two reference markers for orientation and 
indent position/bone overlap   
4.2.2.5 Statistical analysis used in micro-indentation study 
Each hypothesis was statistically tested using repeated measures 
analysis which was performed using the computing environment R [237].  
Datasets have been freed of the outliers below the 0.5th and above the 
99.5th percentile, as such outliers are likely caused by the inconsistent slope 
of the load-displacement curve due to unforeseen micro-fracture, slippage of 
the sample or an accidently indented underlying cavity. Variances were 
tested using ANOVA with a significance level of p=0.05 and groups were 
compared using Tukey’s post-hoc method [249]. The difference between 
compared subgroups is presented as mean ± standard deviation. 
 Micro-properties of multiple myeloma and comparison to 4.2.3
non-affected population - Results 
In total 2753 indents were used in the statistics, where 2267 indents 
from MM samples were pooled together with 486 indents of non-affected 
bone. A repeated measures analysis was performed on 149 samples (47 
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MM axial, 48 MM transverse, 27 non-MM axial and 27 non-MM transverse). 
The groups’ normalities were checked using the Shapiro-Wilk test (for all 
groups p>>0.05). The average indentation modulus of the tested samples 
ranged between 10.2 and 18.4 GPa. The micro-hardness varied between 
316.1 and 572.3 MPa. The elastic indentation energy varied between 7868 
and 20147 pJ whereas the dissipated indentation energy was between 
40853 and 71170 pJ. 
4.2.3.1 Indentation properties - comparison between MM groups 
Between groups MM.L (bone in proximity of a lesion), MM.L.C (taken 
distantly from a lesion) and MM.NL (without visible lesions) the indentation 
modulus (Ei) varied between 15.51 and 16.72 GPa in the axial and 13.9 and 
14.16 GPa in the transversal direction. Indentation direction 
(axial/transverse) failed to show any significance in elastic energy (We, 
p=0.78) but was otherwise found to be significant for all other tested 
parameters (Ei/H/Wp, p>>0.01). Furthermore, no significant difference was 
found between all three multiple myeloma groups for axial or transverse 
direction (all p>>0.5, lowest significance level p=0.13 in Ei in axial direction). 
A detailed comparison of all tested indentation variables is listed in Table 14 
and the Whisker plot in Figure 51 combines all groups together with 
comparison to non-affected population.  
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Base MM groups 
 Axial
(*)
 
Indentation 
modulus Ei 
[GPa]  
Hardness H 
[MPa]  
Elastic 
energy We 
[µJ]  
Plastic 
energy Wp 
[µJ] 
Ductility 
measure 
[1] 
mean ± stdev mean ± stdev mean ± stdev mean ± stdev mean 
± stdev 
MM.L 15.51 ± 1.62 444.26 ± 45.06 14.51 ± 1.62 55.27 ± 4.38 0.79 ± 0.01 
MM.L.C 16.72 ± 1.39 469.9 ± 29.41 14.92 ± 0.76 58.15 ± 5.26 0.79 ± 0.02 
MM.NL 15.52 ± 0.93 446.55 ± 35.23 14.54 ± 1.27 55.94 ± 3.53 0.79 ± 0.01 
 Transverse
(*)
 
Indentation 
modulus Ei 
[GPa]  
Hardness H 
[MPa]  
Elastic 
energy We 
[µJ]  
Plastic 
energy Wp 
[µJ] 
Ductility 
measure 
[1] 
mean ± stdev mean ± stdev mean ±stdev mean ±stdev mean 
±stdev 
MM.L 13.93 ± 0.96 414.79 ± 33.87 14.38 ± 1.52 50.81 ± 3.18 0.78 ± 0.01 
MM.L.C 14.16 ± 0.89 424.42 ± 38.68 14.70 ± 1.87 51.65 ± 2.76 0.78 ± 0.02 
MM.NL 13.9 ± 0.98 420.64 ± 20.93 14.69 ± 0.76 51.76 ± 1.89 0.78 ± 0.01 
Table 14 Indentation moduli, hardness and indentation energies for MM 
groups for axial and transverse indents (a significant difference 
(labelled (*)) was found only between axial and transverse 
directions) 
4.2.3.2 Indentation properties - comparison between MM and non-MM 
samples 
Given the lack of statistical differences, the multiple myeloma samples 
were combined into one group (groups prefixed MM) and compared to 
samples without a neoplastic pathology (non-MM group) taken from the 
study by Wolfram. The findings were dissimilar in axial and transverse 
direction (Table 15 (in graphical form in Appendix F.3: Results – graphical 
form)). In axial direction, the bone samples from the affected population did 
not seem to be significantly divergent in terms of stiffness (Ei, p=0.06), 
hardness (H, p=0.90) or plastic energy (Wp, p=0.43), but elastic energy (We) 
was found to be higher by 24.2% in MM bone (p<0.001), which is related to 
a 4% decrease in ductility (p<0.001).  
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Multiple myeloma bone and non-cancerous bone 
Axial 
 Indentation 
modulus Ei 
[GPa]  
Hardness H 
[MPa]  
Elastic 
energy We 
[μJ]  
Plastic 
energy Wp 
[μJ] 
Ductility 
measure [1] 
  mean 
±stdev 
mean 
±stdev 
mean 
±stdev 
mean 
±stdev 
mean 
± stdev 
Myel
oma 
15.69 
± 1.52 
448.52 
± 41.66 
14.58 
± 1.44(*) 
55.83 
± 4.39 
0.79 
± 0.01(*) 
non-
MM 
14.97 
± 1.56 
449.81 
± 41.73 
11.73 
± 1.49(*) 
56.81 
± 6.11 
0.83 
± 0.02(*) 
Transverse 
  Indentation 
modulus Ei 
[GPa]  
Hardness H 
[MPa]  
Elastic 
energy We 
[μJ]  
Plastic 
energy Wp 
[μJ] 
Ductility 
measure [1] 
  mean 
±stdev 
mean 
±stdev 
mean 
±stdev 
mean 
±stdev 
mean 
±stdev 
Myel
oma 
13.97 
± 0.94(*) 
417.49 
± 32.32(*) 
14.49 
± 1.45(*) 
51.13 
± 2.90(*) 
0.78 
± 0.01(*) 
non-
MM 
11.87 
± 0.93(*) 
373.68 
± 30.5(*) 
10.96 
± 1.41(*) 
47.19 
± 4.37(*) 
0.81 
± 0.01(*) 
Table 15 Comparison between MM infiltrated samples and samples 
without MM infiltration (significant difference p<0.05, labelled (*)) 
In the transverse direction, all mechanical properties were found to differ 
(p<0.001); in particular MM was found to be higher by 17.6%, 11.7%, 32.2% 
and 8% for Ei, H, We and Wp respectively. This resulted in an 
axial/transverse anisotropy stiffness ratio of 1.2 which is 10.9% lower than 
the non-affected population in this study. Moreover, the MM was found to be 
- 129 - 
less ductile by 4.4% in the axial and 4.1% in the transverse direction, where 
the ductility of the axial/transverse ratio was found to be the same among 
the affected and non-affected populations. 
 
Figure 51 Micro-indentation of multiple myeloma bone: Indentation 
properties in form of whiskers plot. No significant difference was 
found between samples with different progression of multiple 
myeloma infiltration. Only marginal difference was found between 
myeloma-affected and unaffected population 
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4.2.3.3 Bone material properties in proximity of lesion 
In order to investigate the influence of the distance from the closest 
lesion on the material properties a total of 1482 indentations were analysed. 
The indentation modulus was expressed as a function of the shortest 
distance between the point of indentation and the border of the lesion 
(Figure 52). In both cases - axial and transversal cuts – the results showed a 
small but significant trend in modulus change from the lesion towards the 
surrounding bone. Axially cut trabeculae showed a higher trend (adjusted 
R2=0.049, p<0.001 in Figure 53 a.)). The transversally cut trabeculae 
showed a smaller, but still significant trend (R2=0.008, p=0.002 in Figure 53 
b)). In fact, only elastic energy failed to show any significant trend. In general 
the investigated correlations were found to be weak (Table 16). 
 
Figure 52 Multiple myeloma bone sample. Indent positions with respect 
to the border of the lesion are superimposed over a picture of the 
indented bone. Each indent is represented as a blue star marker, 
whereas the border coordinates are represented by a solid blue 
line 
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Axial indentation direction 
 
Transverse indentation direction 
Figure 53 Change of indentation moduli depending on the distance 
from a lesion  
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Indentation variable Adjusted R
2
 p-value 
Axial Ei  0.049 p<0.001 
H  0.015 p=0.008 
We  -0.002 p=0.584 
Wp  0.020 p=0.002 
Transverse Ei  0.008 p=0.002 
H 0.014 p<0.001 
We 0.005 p=0.013 
Wp 0.013 p<0.001 
Table 16 Coefficient of determination (adjusted R2) and its significance 
in the vicinity of the lesion 
 Underlying material properties of multiple myeloma bone - 4.2.4
Discussion 
Firstly, bone samples from patients diagnosed with MM but without 
any metastatic infiltration were compared to bone samples from patients with 
developed myeloma bone disease (MBD). According to the results 
presented here, the material properties of the bone were not found to be 
significantly altered. Furthermore the results suggest only a subtle and 
insignificant increase in the stiffness of the bone at the extremities in cases 
where the sample was taken from a non-affected site.  
When compared to a non-affected population, bone tissue from 
patients with diagnosed multiple myeloma cancer tended to be slightly but 
insignificantly stiffer in the axial direction. In the transverse direction, MM 
bone was shown to be ~17.6% stiffer and 11.4% harder, but was also found 
to be about 4% less ductile in both directions. The remainder of the tested 
indentation variables were found not to exhibit significant differences. 
Furthermore, findings from the indentation of the bone tissue in the 
vicinity of the lesion showed only a very small decrease in stiffness in terms 
of the interaction between bone and lesion, despite its measured 
significance. This could indicate an increased remodelling of the bone at the 
periphery of the lytic defects that is associated with a reduced degree of 
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mineralisation and therefore indentation stiffness. This however contradicts 
the general understanding that MM inhibits the formation of new bone and 
that the time required for a lytic lesion to develop is faster than a complete 
remodelling cycle [250]. This rather small change in indentation variables 
towards the lesion is also in the same order of magnitude of the 
measurement error of the indentation technique hence should only be 
considered as fractional. 
However, despite the indication that the bone generally tends to be 
stiffer in multiple myeloma cancer patients and considering that the increase 
in stiffness in the vicinity of a lesion is almost negligible, the relative change 
in mechanical properties at the tissue level remains consistent within the 
whole organ and is independent of how the disease propagates. A minor 
alteration in the material properties of bone tissue in multiple myeloma 
patients could be explained by increased mineralisation due to the frequent 
and prolonged use of bisphosphonates which reduces the natural bone 
turnover [251] and which then leads to increased bone mineralisation [252] 
and hence can result in an increase of the indentation properties [182]. 
Results in this study hence suggest that changes in multiple myeloma 
cancer bone, however insignificant, originate from a reduced turnover due to 
treatment methods rather than from the presence of the cancer directly.   
The values presented in this study should be re-used with care when 
comparing them to actual physiological conditions as the study was 
performed under dried conditions. However, this study has aimed to detect 
differences in the mechanical properties of bone tissue through progressing 
pathology rather than to quantify accurate values under physiological 
conditions. Secondly, the study was limited due to the low number of 
patients available and the lack of detailed patient treatment histories, which 
could have added a significant variable to the material changes in patients’ 
vertebral bone tissue. Lastly, for the following studies it is highly 
recommended to undertake additional compositional analyses such as 
mineralisation and collagen cross-linking assessments to help develop a 
better understanding of compositional changes occurring due to neoplastic 
pathology.  
Following discussion in the fracture prediction section it remains 
unclear whether this behaviour observed in this study can be translated to 
any oncological pathologies.   
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To conclude, apart from very small changes in the vicinity of the 
lesion, it appears that the alterations of mechanical properties at the bone 
tissue level are rather ubiquitous in nature. Furthermore, it can be assumed 
that these small changes in material properties alone would not be sufficient 
to modify the overall vertebral strength. This leads to the hypothesis that the 
material law used in density image-based methods should remain unaltered 
in the case of multiple myeloma when compared to normal and osteoporotic 
bone.  
4.3 Trabecular bone micro-properties assessment - Summary 
Chapter 4 presented a comparative analysis of multiple contributors to 
biomechanical properties of weakened vertebral bone while focusing on the 
underlying micro-properties. The results presented here emphasise the 
benefit of using bone density distribution alongside bone deterioration 
measurements. Thereafter, results of the beam theory approach were 
compared to a morphological assessment and one-slice analysis. As has 
been noted, a full morphological analysis together with a composite 
assessment explains up to 84% of variations in strength for all samples 
(more specifically up to 81, 96 and 94% for OP, MM and mets respectively) 
and 69% of variations in stiffness (80, 96 and 79% for OP, MM and mets 
respectively). The single slice analysis was however proved to be a good 
indicator considering the dependency on time and exposure to scanning, 
with a reduction of only one-third in the coefficient of determination 
compared to multiple variable regression using beam theory and all 
morphology parameters. 
The second section of this chapter presented the experimental testing of 
bone material properties by means of micro-indentation which was 
necessary to define more clearly the underlying properties of cancer bone. 
The aim of this section was to illustrate differences between multiple 
myeloma bone with and without lesions and to compare the material 
properties to a non-affected population. 
As shown in this part of the thesis, no significant differences in 
indentation properties were found between bone taken from proximity to the 
lesion compared to bone taken more remotely (p>0.05). Moreover, no 
differences were observed between bone taken from both of the MBD 
groups and bone taken from MM patients without the presence of lesions 
(p>0.05). Compared to the non-affected population, the MM samples were 
non-significantly stiffer in the axial direction (p=0.06) and by 18% stiffer 
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(p<0.001) in the transverse direction. Hardness was found to be higher in 
MM samples only in the transverse direction by 12% (p<0.001).  
The results presented here suggest that the weakening of the myelomic 
bone is predominantly due to structural changes which will be presented in 
the following sections. This however cannot be generalised to include all 
oncological samples due to notable differences in the metabolic 
management of different lesions depending on the identification of the 
primary cancer (such as indicated also by assessment of the bladder cancer 
samples in the preliminary study conducted in section 3.1.3.2: “Historical 
data - Collected metastatic samples”). 
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  Chapter 5
Investigation into the use of vertebroplasty for the 
augmentation of osteoporotic and metastatic lesions 
This last experimental section of the thesis focuses on optimising the 
vertebroplasty technique with subsections focusing on newly developed 
ceramic materials (section 5.1: CaP vertebroplasty: effect of filling ratio on 
biomechanics in a single vertebra study”) and a tailored PMMA bone filling 
material (section 5.2: “Low modulus PMMA vertebroplasty”). Each type of 
cement and details regarding their use have been discussed in the literature 
review (sections: 2.4 and 2.5). While CaP cement provides lower structural 
support, its main advantage comes from its biodegradable nature supporting 
newly formed bone, however the challenge lies in optimising the augmented 
volume of the cement with respect to altered biomechanical properties. 
Contrary to CaP, the PMMA cement provides fast and efficient short term 
support to the weakened vertebral bone but appears controversial due to an 
altered biomechanical imprint affecting the adjacent levels. This is believed 
to be due to its unnaturally high stiffness which will be investigated in the 
latter section of this chapter.  
5.1 CaP vertebroplasty: effect of filling ratio on biomechanics 
in a single vertebra study 
 Introduction to ceramic cement PVP 5.1.1
Since introduction of the vertebroplasty in 1984 [131], the PMMA 
augmentation has become a relatively established technique for fracture 
treatment. There are however a number of reservations associated with 
using these acrylic cements in terms of intraoperative and long-term 
complications. The exothermic reaction during polymerisation exceeds the 
biological threshold of 40 degrees Celsius and can reach as high as 
100˚C [253-255], potentially damaging the surrounding tissue including the 
spinal cord and nerve roots [254-256]. This can be exacerbated due to the 
high injection pressure, often causing extravasation and/or pulmonary 
embolization [257]. Once delivered and integrated into the bone structure, 
acrylic cement irreversibly becomes a permanent foreign body due to the 
lack of osteo-conductivity and may interfere with natural bioactivity.  
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Considering the limitations of acrylic cements, recent attempts have 
aimed to develop a bone cement that would meet the biomechanical needs 
of stabilising the fracture [258] but which would eventually be reabsorbed 
and replaced by the natural bone [259]. In this matter the calcium 
phosphates have shown good potential in comparison to the PMMA, which 
is not osteo-conductive or resorbable. Turner et al. [260] compared PMMA 
with calcium phosphate cement in an in-vivo canine model and reported that 
in the framework of 6 months, bone augmented with CaP was found to be 
stronger than bone augmented with PMMA, which in fact became marginally 
weaker. Moreover, as reported in an animal study by Urrutia et al. [261], 
acrylic cements have been found to cause osteonecrosis in almost every 
second case tested. In contrast, a new bone formed around CaP cement 
was found to have developed as soon as two weeks after the operation [262] 
and was confirmed by Ikenaga et al. [263] and Knaack et al. [264], who 
reported the development of the same or even a superior quality of bone 
within as little as 12 weeks from its administration. This said, the 
biodegradable osteo-conductive materials provide a promising alternative to 
the current state-of-the-art standard PMMA cement particularly for younger 
patients who are not treated for malignant pathologies.  
Nevertheless, the extent of any immediate biomechanical effect prior 
to the healing of the bone remains unknown. The restoration of the vertebral 
stability remains likely if both the strength and stiffness recover to the pre-
fracture state of the bone [258], but avoids an excessive increase in stiffness 
which is typical for PMMA cements [265] and is one of the factors believed 
to increase stress in adjacent levels of the bone [266].  Although recent 
studies have provided important information on the biomechanical behaviour 
of the CaP after the augmentation, only limited information is available 
relating to the mechanical effects of the volume of injected cement. Whether 
CaP cements lack volume-strength and -stiffness correlation similar to that 
reported for PMMA [29] remains unknown.     
 The study presented here aims to quantify the material properties of a 
particular biodegradable material. Three groups augmented with different 
volume-to-fill ratios have been compared in a cadaveric destructive 
experiment. The samples collected were osteoporotic only and showed no 
sign of malignant pathologies, of which in total thirty samples were allocated 
to three groups according to their structural properties. To tackle the well-
known difficulties in benchmarking the samples prior to testing, a newly 
proposed method of sample allocation has been conducted with the use of 
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non-invasive CT-based fracture prediction. Currently all studies face a 
problem in the selection of appropriate samples, using either BMD (e.g. [29, 
267, 268]) or random selection (e.g. [265, 269]). Using the non-invasive 
fracture prediction method formerly described in this work allows for the 
choice of appropriate samples for testing, such as the collection of purely 
weaker samples prone to fracture. The benchmarking proposed here is 
based on Latin rectangle design [270]. The VBs were assigned to three 
groups, each of which contained the same number of specimens from each 
donor, allocated equally according to their predicted strength relative to the 
donor. When tested, the appropriateness of the distribution was confirmed 
against initial fracture data, with an equal distribution of actual vertebral 
strength and stiffness in each of the groups.  
 Methods used in CaP PVP  5.1.2
5.1.2.1 CaP study design 
This study was designed in collaboration with SpineFX partner 
BONESUPPORT (BONESUPPORT AB, Lund, Sweden). In this study 
biocompatible alpha-tri-calcium cement developed by the company has been 
biomechanically tested. This study provides evaluation prior to the healing 
process with focus on optimisation of cement volume as described further 
and in the flowchart presented in Figure 54. 
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Figure 54: Alpha-TCP cement study flowchart. Three groups of 
different vertebral volume fill were separately tested and 
compared for difference in observed vertebral strength 
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5.1.2.2 Sample population and group allocation prior to CaP 
augmentation 
This study comprised twenty nine thoraco-lumbar vertebral samples in 
total (3 spines denote as “SpineBS” in Table 8: subsection “Cadaveric 
sample selection and preparation”). The microCT assessment discussed in 
previous sections has in addition been used to estimate vertebral body 
volume using previously employed methods in order to remain consistent. 
For comparison the mean error between the semiautomatic method used a 
vertebral body boundary segmentation and this method was found below to 
be an accepted experimental error (mean error -1.21cm3 (RMS=3.37), tested 
on 28 osteoporotic human vertebral bodies). This method was tested to 
estimate the vertebral volume calculated from the inferior, superior and 
middle vertebral body cross-sections and the vertebral height following 
equation (1.10), where VVB denotes vertebral volume, and h1 and h2 denote 
the height between slices. CSA was estimated in three subsequent slices 
and averaged to minimise the measurement error.  
 𝑉𝑉𝐵 =
(𝐶𝑆𝐴𝑖𝑛𝑓𝑒𝑟𝑖𝑜𝑟 + 𝐶𝑆𝐴𝑚𝑖𝑑𝑑𝑙𝑒 )
2
∗ ℎ1 +
(𝐶𝑆𝐴𝑠𝑢𝑝𝑒𝑟𝑖𝑜𝑟 + 𝐶𝑆𝐴𝑚𝑖𝑑𝑑𝑙𝑒 )
2
∗ ℎ2 (1.10)  
Samples were benchmarked and allocated to three equal groups (A, B, 
C) entirely based on predicted vertebral strength (discussed in section 3.3), 
while the t-test statistical analysis on initial strength and stiffness was later 
used to verify equal distribution between tested groups. Every group 
represented a different volume of augmentation fill of 10, 20 and 30% of 
vertebral body fill for groups A, B and C respectively. 
5.1.2.3 CaP PVP and repeated fracture testing  
Prior to injection all specimens were submerged in Sodium Azide 
solution (0.03 wt% concentration) and kept in a temperature regulated oven 
(37C) for 1 hour. Injection needles (gauge 11) were positioned towards the 
anterior wall of the vertebral body (Figure 55 (A)) and if needed were slightly 
retracted to allow the cement to smoothly fill the vertebral body. The cement 
was prepared following appropriate training provided by the collaborating 
company representative and immediately after mixing the cement was 
redistributed to 1mL syringes. Each fractured specimen was augmented bi-
pedicularly until reaching the desired fill according to group allocation. When 
augmented the sample was again submerged in Sodium Azide solution 
(0.03 wt% concentration) and kept in a temperature regulated oven at 37C 
for an additional 72 hours to simulate physiological conditions and allow 
adequate time for cement curing. The Sodium Azide solution was renewed 
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on the second day of curing. The importance of the curing lies in the on-
going conversion from α−TCP to calcium deficient hydroxyapatite (CDHA), 
which results in a strength enhancement. Here, both the time of curing as 
well as the temperature is important as both contribute to an enhancement 
of the quality of the crystallinity of the forming apatite.  
After 72 hours samples were taken out of the oven, rinsed in soapy 
water followed by thorough rinsing in purified water, wrapped in moist tissue 
and left frozen at -20˚C until scanning. The freezing of specimens prior to 
scanning permitted a prolongation of the handling time and the processing of 
all samples under considerably consistent protocols. Although curing at low 
temperatures is detrimental for CaP cements [259], it has been shown that 
freezing to temperatures of -80˚C together with cement retarding additives 
are actually needed to prevent the beginning of the setting reaction [271]. 
Every sample underwent microCT scanning to verify correct placement of 
the injected cement. As depicted in Figure 55 (B), example samples were 
later processed in data visualisation software [272] for presentation 
purposes to illustrate the positioning of the cement bolus within the vertebral 
body. 
  
Figure 55: -TCP cement augmentation: Needle is inserted via pedicles 
(A) similarly to clinical application. When positioned to anterior 
middle region of VB, cannula is inserted to inject an appropriate 
volume of cement in order to create two symmetrically placed 
boluses (represented in the rendered bone/cement model depicted 
in B, red representing cement, yellow representing bone)  
Repeated mechanical testing was conducted as per protocol for wedge 
compression fracture following the thawing period overnight. The outcome of 
the mechanical testing was processed in a custom-build program (discussed 
in subsection “Single vertebra Wedge Compression Fracture rig”) to 
determine strength and stiffness during the testing.  
A.) B.) 
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Data were analysed in statistical computing language R [237]. The 
augmentation effects prior and after augmentation were tested using a 
paired t-test with significance level p=0.05.  
 Volume optimisation in CaP vertebroplasty - Results 5.1.3
The allocation of samples to groups has been statistically tested and it 
has been established that the vertebrae were distributed sufficiently without 
significant difference in mean strength and stiffness among the groups 
(ANOVA, student’s t-test for strength G1 vs G2: p>0.9, G1 vs G3: p>0.37 
and G2 vs G3: p>0.31, and for stiffness G1 vs G2: p>0.91, G1 vs G3: p>0.52 
and G2 vs G3: p>0.49). 
The group’s annotated G1 (10% VB fill), G2 (20% VB fill) and G3 (30% 
VB fill) were injected according to the measured VB volumes which 
corresponded to 2.1 ±0.7, 4.3 ±1.2 and 6.4 ±2.0 mL of the cement 
respectively. Here, the gross measurement before and after the injection did 
not show any restoration of the vertebral height. 
Later, all the samples underwent a re-fracture compression test resulting 
in a typical augmentation-amended load/displacement profile (Figure 56). 
Compared to the initial compression test of non-augmented vertebrae, the 
reinforced vertebrae showed a typical behaviour of continuous fracturing of 
trabecular bone which remained unaugmented. Later however, once the 
weaker bone is fractured, the stiffness of the cement becomes apparent, 
rapidly increasing the resilience. Such reinforced material results in a 
relatively linear load-displacement curve until fracture, which is typically 
followed by a drop in force. Under these circumstances the ratio between 
strength and stiffness becomes the most informative. 
Comparing the samples pre- and post-augmentation has shown that the 
augmentation more than doubled the vertebral strength (Figure 57); only 
group 1 failed to reach the significance level of 0.05 (G1: p=0.053, G2: 
p=0.023 and G3: p=0.007). As shown in Figure 58 the stiffness was 
significantly lower than its initial value, specifically less than half of the initial 
stiffness in all three tested groups (p=0.005, p=0.02 and p=0.004 for G1, G2 
and G3 respectively). Specifically, vertebral strength has increased 
compared to its initial values by 99.52%, 166.91% and 111.3% for groups 
G1, G2 and G3 respectively. The stiffness was restored by the augmentation 
only to 43.99%, 31.98% and 44.92% for groups G1, G2 and G3 respectively. 
Both the strength and stiffness improvements are listed in Table 17. 
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Figure 56  A representative experimental read-out of augmented 
vertebra during the re-fracture experiment. Here raw testing data 
(in (A)) represent displacement data (dashed red) coupled by 
readout frequency with the load read-out data (green). The re-
fracture experiment follows the same protocol as for the initial 
fracture (Figure 29). The augmented vertebra is represented by 
increased resilience where cement enhances the load-bearing 
capabilities of the vertebra (load displacement curve in B) 
Furthermore, there no influence was shown by the different filling ratios 
of 10%, 20% and 30% (denoted groups G1,G2 and G3 respectively) as both 
post augmentation strength and stiffness failed to show any difference 
(p>>0.05) 
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When compared with a statistical population of 29 samples, the CaP 
cement augmentation has been shown to increase the strength compared to 
the intact sample by 121% and restore the stiffness to 41% of the state 
before the fracture. 
 
Figure 57 Vertebral strength after augmentation was found to be 
significantly higher in 20 and 30% VB fill (significance level p<0.05 
indicated by *) 
 Strength (kN) Stiffness (kN/mm) 
VB fill of 10% (G1) 1.1(p=0.053) 0.94(p=0.005) 
VB fill of 20% (G2) 1.4(p=0.023) 0.58(p=0.021) 
VB fill of 30% (G3) 1.2(p=0.007) 0.93(p=0.004) 
Table 17 Vertebral strength and stiffness enhancement after VB 
augmentation (mean difference pre- and post-augmentation), 
significance level of p=0.05 shows that a statistical difference was 
found in vertebral strength pre- and post-augmentation fracture in 
the group filled with 10% of vertebral body volume 
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Figure 58 Vertebral stiffness of augmented vertebrae where no 
difference was found in osteoporotic samples p>0.05, but the 
stiffness has decreased in both oncological groups (p<0.05) Short 
term biomechanical effect when using CaP PVP - Discussion 
In order to obtain a structural assessment of wedge compression 
fracture treatment, a clinical calcium phosphate vertebroplasty has been 
simulated under laboratory conditions. It consisted of the controlled 
administration of cement with a subsequent compression test. This study 
performed on human cadaver vertebrae evaluated the mechanical effect of 
newly developed calcium cement. Contrary to PMMA, the calcium 
phosphate cement is designed to support the natural growth and hence 
recovery of the fractured bone. Here, the introduced cement is primarily an 
agent to trigger the natural healing process [124], which should support the 
bone only up to point at which it is healed.  The optimal amount of material 
which needs to be injected however remains unknown and the exact amount 
required may cause considerable issues during the surgical planning.  
This study demonstrated that increasing the volume of the injected 
calcium phosphate cement from 10% to 30% of VB fill only showed a limited 
impact in terms of the vertebral biomechanical properties. Although the 
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volume fill has not statistically been found to be an impacting factor, the 
biomechanical properties of all tested samples have been found to 
significantly change following the vertebroplasty. In particular, the ceramic 
cement almost doubled the strength of the cadaveric vertebrae, while 
stiffness was almost halved when compared to pre-augmentation values. 
This indicates that while the strength has been fully restored to its initial 
value, the stiffness remained below its initial values.  
Regarding the effects of different volumes of cement, this study 
concludes that even smaller volumes (~2mL, 10% of vertebral body volume) 
may be sufficient to stabilise the fracture, suggesting that the volume of 
introduced cement is not crucial in terms of biomechanical improvement. 
Although some degree of recovery of the stiffness is needed to prevent 
extensive micro-motion, it remains unknown whether a full restoration would 
in fact be beneficial for the healing process. The complexity of the healing 
process has long been studied by, among others, Claes et al. [273]who 
showed in an in-vivo ovine experiment that in fact, a substantial amount of 
micro-motion is required in order to trigger it. Whether human osteoporotic 
bone reacts in a similar pattern remains an open question and whether this 
then links to the use of low stiffness cements would need a thorough clinical 
investigation. 
Nonetheless, these findings imply that volumes below 30% of VB fill 
are not a crucial factor in enhancing vertebral strength and stiffness. Hence, 
there results could be used if the volume of augmented cement needs to be 
adjusted instead according to the bioactive character of the cement to 
achieve the optimal conditions for healing of the bone without affecting the 
resultant mechanical properties of the augmented vertebra. 
A similar trend to the results here has been shown by previous 
investigators [29, 30, 258, 267], i.e. that calcium phosphate cements have 
also been shown to restore or even increase the initial strength without 
restoring the initial stiffness, which was also presented for PMMA cements 
such as one used in clinical application with positive outcomes [274]  
Conversely, Bai et al. [265]and Heini et al. [268]reported that both the 
strength and stiffness had been increased. In Bai’s study, stiffness was 
restored to its initial values prior to the fracture (increasing from 0.08kN/mm 
to 0.1kN/mm), while Heini reported a greater than twofold increase in the 
initial stiffness after the augmentation (2kN/mm to 4.4kN/mm). A discrepancy 
in the measured stiffnesses is believed to occur due to different loading 
protocols. Here, Bai used the wedge compression fracture approach 
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although the pivot point was positioned posteriorly to laminas, contrary to 
Heini’s pure compression where both endplates were firmly embedded and 
compressed to failure.  
Moreover, the increased stiffness observed by Heini’s contradictory 
study could be explained by a significantly higher augmentation ratio 
obtained when a fixed amount of cement has been augmented in vertebrae 
of different bone quality. Graphs from the author’s paper also suggest a 
possible increase of strength above >40% fill but did not present data for 
stiffness, causing it to remain in doubt whether a similar effect would occur. 
The study presented here is limited to an assessment of biomechanical 
behaviour in a relatively short time after the operation. The cadaver-based 
nature of the study hence limits any conclusions to the immediate behaviour 
of cement after three days of curing, and although temperature and humidity 
have been controlled, the cement has been left to cure without any natural 
preloading which could also potentially affect the setting and creeping of the 
material.  
Clearly, a biomechanical evaluation during the later phases of the 
CaP/bone reabsorption needs to be conducted in order to confirm the 
findings from the pre-clinical animal studies [261, 263, 264]. 
Although some minor issues have been noticed due to the granulation 
effect of the mixture, only manual injection has been used which was 
considered to be much easier when compared to administration of a 
standard PMMA. The cases reported here were carefully examined with the 
intention of preventing the filter-pressing phenomena such as those reported 
by other investigators working with phosphate cements [275, 276], and in all 
cases was determined to be a typical clogging reaction of the calcium 
phosphate cement as reported by e.g. Montufar et al. [277]. A bias in the 
results due to filter-pressing phenomena has always been avoided by 
injecting the entire contents of the syringe and in case of observed 
granulation the batch was immediately discarded and the test repeated. 
Despite demonstrating only partial extravasation and no case of spinal canal 
extravasation, fluoroscopy guidance is strongly recommended due to the low 
viscosity of the cement. 
The major limitation of this study proved to be the storage of samples 
which, although fully reported and monitored, needed to include freezing 
after the three day period of curing. The freezing of samples has however 
remained consistent within the study and allowed systematic logistical 
- 148 - 
handling without any unnecessary decay of the samples. Additionally, by 
freezing the cement the setting reaction is merely slowed down [259] and as 
Grover et al. [278] reported further, temperatures in excess of -80˚C and 
over a month of storage would be required to significantly degrade the 
compression strength of the cement. 
Yet it has been reported here that these fill volumes appear to have no 
effect on the restoration of stiffness before the commencement of the 
healing process. Although the resulting changes in strength and stiffness 
due to augmentation with the α-TCP cement presented here are similar to 
the conclusions obtained using a commercially available PMMA 
cement [258] which has been used clinically for many years, a clinical trial 
will need to be conducted to confirm this. 
5.2 Low modulus PMMA vertebroplasty 
 Introduction to acrylic cement augmentation in OP and 5.2.1
metastatic bone 
Numerous studies have shown promising results in vertebral body 
fracture treatment using acrylic cements. Such treatment is recommended in 
many studies where conservative treatment is no longer effective. Despite 
large numbers of PVP operations worldwide, very little is known about the 
biomechanical contribution of the cement used.  
One of the controversies of PVP comes from recent findings which 
show that administering this very hard cement (compressive strength 
˜0.1 GPa, elastic modulus ˜2-4 GPa [279, 280]) might be linked to an 
increased occurrence of fractures in adjacent levels [281, 282]. When cured, 
such material exhibits stiffness exceeding up to one order of magnitude with 
strength exceeding up to two orders of magnitude [279, 280] compared to 
the bone embedded within [189, 202]. 
Although the cause of adjacent vertebral fractures is not clear, the 
material properties of the cement used are considered to be one of the 
possible causes alongside other factors such as the endplate-to-endplate 
pillaring effect [122, 282], extravasation [266], the natural progress of the 
primary disease [283, 284] or a secondary effect of the disease 
treatment [285]. Another explanation however arises from a biomechanical 
viewpoint, such as dramatic changes in boundary conditions and the 
possible displacement of the primary loading vector due to the presence of 
the fracture.  
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Historically, acrylic cement has been used to stabilise fractures and 
reinforce vertebral bone in a very short time, however recent concerns report 
an increase in adjacent vertebral fractures, which questions the material 
properties of the used cements. 
Computational modelling has suggested that the reduced strength 
can be explained by the “pillaring” effect of the cement bolus between both 
endplates [159, 266, 286, 287]. While clinical studies report, without any 
explanation, the increased occurrence of adjacent fractures (e.g. [122, 282, 
288, 289]), they agree on the fact that PMMA acts as a foreign body inside 
the vertebra thus causing these problems, which now needs further 
investigation. 
The studies mentioned above greatly succeeded in pinpointing the 
possible causes and basic science biomechanics of adjacent fractures, 
however they lack experimental confirmation and/or clinical evidence of 
suggested solutions. The studies mutually concluded that future 
investigation into the issue of reduced strength in adjacent levels should be 
conducted 1) using osteo-conductive (biodegradable) cement; 2) using low 
modulus cement. Where (1), in terms of pillaring effect investigations, 
requires long term follow-up studies exceeding cadaveric testing capabilities, 
the latter is presented here in a quasi-static biomechanical comparison of a 
standard off-the-shelf and low modulus PMMA cement. 
 Methods used in assessing low-modulus PMMA cement 5.2.2
5.2.2.1 PMMA PVP - Study design  
This study was designed in collaboration with the University of Uppsala. 
The intention of this work was to investigate the mechanical properties of an 
enhanced cement formula which was tailored to address the increased 
occurrence of fractures due to the high stiffness of the injected cement in 
adjacent levels to those in which vertebroplasty is performed.  
The enhanced cement which is from less stiff material was tested 
against the base PMMA commercially available cement  and each cement 
was also tested in each of two pathologies to investigate use of the cement 
in (1) osteoporotic patients, (2) patients suffering from a cancer with 
metastatic infiltration. A schematic overall flowchart of the study is depicted 
in Figure 59. 
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Figure 59: Study flowcharts for two scenarios, osteoporotic (a) and 
metastatic (b) vertebral augmentation studies comparing two 
cements: non-modified cement (G1) and one with enhanced 
formula (G2) 
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5.2.2.2 Sample population and group allocation prior to augmentation 
This study comprised twenty-four osteoporotic thoraco-lumbar samples 
(samples denoted as “SpineGO” in Table 8: subsection “Cadaveric sample 
selection and preparation”) together with twenty-four metastatic thoraco-
lumbar samples (samples denoted as “Spine mets” in Table 8: subsection 
“Cadaveric sample selection and preparation”, levels T6-L5). Injection 
volumes were calculated based on the microCT assessment using equation 
(1.10). Initial fracture data together with fracture prediction data remain 
identical to those discussed in section 3.2: Commissioning of cadaveric 
Wedge Compression Fracture testing. 
Based on the predicted strength each of the samples were 
benchmarked and allocated to one of two equal groups (G1 and G2). Here 
the group G1 represented base cement (non-modified Osteopal) whereas 
the group G2 represented modified cement (Osteopal 1.5%).  
5.2.2.3 PMMA PVP and refracturing experiment 
Prior to the injection all needles (gauge 11) were inserted under a 
fluoroscopic guidance by a trained surgeon (Vishal Borse). Needles were 
positioned through both pedicles facing the anterior part of the vertebral 
body. The insertion depth was recorded for later repositioning prior to the 
augmentation.  
In addition all specimens were submerged in Sodium Azide solution 
(0.03 wt% concentration) and kept in a temperature regulated oven (37C) 
for 1 hour. The injection needles (gauge 11) were re-inserted to their 
appropriate position and if needed were slightly retracted to allow the 
cement to smoothly fill the vertebral body. The cement was prepared by a 
skilled material scientist (Alejandro Lopez, University of Uppsala). The 
cement was mixed and distributed to 5mL syringes used for augmentation. 
Each fractured specimen was augmented bi-pedicularly until reaching a fill of 
30% of its vertebral volume fill with cement according to the group allocation. 
Augmentation was performed without the fluoroscopy guidance due to (1) 
the requirement of mixing the cement in a ventilated fume cupboard, and (2) 
the preheating protocol required to minimise the time spent by each sample 
outside of a temperature-regulated environment. Then the augmented 
sample was again submerged in Sodium Azide solution (0.03 wt% 
concentration) and kept in a temperature regulated oven (37C) for an 
additional 24 hours to simulate physiological conditions and allow adequate 
time for cement curing.  
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After a curing period of 24 hours, the samples were taken out of the 
oven, rinsed in soapy water followed by thorough rinsing in purified water, 
wrapped in moist tissue and left to freeze until scanning. Every sample 
underwent microCT scanning to verify correct placement of the injected 
cement (microCT100, [Scanco Medical AG, Bassersdorf, CH], voxel size 
70.8x70.8x70.8 µm3, 500 projections). 
Repeated mechanical testing was conducted as per protocol following 
the thawing period overnight. The recorded load-displacement outcome of 
the mechanical testing was processed in a custom-build program to 
determine strength and stiffness during the testing.  
Data were analysed in statistical computing language R [237].To 
compare the reinforcement effect between groups A and B, the groups were 
compared using a pair t-test with significance level p=0.05 [249].  
 Augmentation results when using PMMA in augmenting OP 5.2.3
and metastatic bone 
The allocation of samples used has been statistically tested and it has 
been proved to be equally distributed in terms of the strength and stiffness 
(for osteoporotic samples G1 vs G2: p>0.4 and p>0.3 for strength and 
stiffness respectively, for metastatic samples G1 vs. G2: p>0.3 and p>0.3 for 
strength and stiffness respectively).  
Comparing the samples pre- and post-augmentation has shown that 
augmentation significantly increased vertebral strength for both pathologies 
(Figure 60), whereas stiffness (Figure 61) was restored in osteoporotic 
samples to initial values (p>0.06), however in oncological samples it was 
restored on average to 2.30 ± 0.97 kN/mm and 2.12 ± 0.35 kN/mm for 
cement 1 and cement 2 respectively. 
Tested differences showed that in osteoporotic samples, cement 1 
increased strength by 255.75% compared to an increase of 96.22% when 
cement 2 was used. In oncological samples the increase was similar for both 
cements (by 43.86% for cement 1 and 48.31% for cement 2). Whereas the 
stiffness was increased in osteoporotic samples by 17.35% in those 
instances where cement 1 was used, it decreased by 15.94% in the case of 
cement 2. In metastatic samples, it was found that stiffness was restored 
only to 45.33% and 48.26% of the pre-augmentation state for cements 1 and 
2 respectively. Improvement values are listed in Table 18. 
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Figure 60 Vertebral strength after augmentation was found to be 
significantly higher in all tested groups (p<0.05) 
 
Figure 61 Vertebral stiffness of augmented vertebrae: no difference 
was found in osteoporotic samples, but it has decreased in both 
oncological groups 
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 Osteoporosis Oncological samples 
 Strength 
(kN) 
Stiffness 
(kN/mm) 
Strength 
(kN) 
Stiffness 
(kN/mm) 
Cement 1 
(G1) 
4.69(p<0.01) 0.44(p=0.08) 1.54(p=0.04) 1.91(p<0.01) 
Cement 2 
(G2) 
1.71(p<0.01) 0.38(p=0.06) 1.65(p=0.02) 1.98(p<0.01) 
Table 18 Vertebral strength and stiffness improvement after VB 
augmentation (mean difference pre- and post-augmentation), 
significance level of p=0.05 shows that a statistical difference was 
not found in change of stiffness before or after augmentation in 
OP samples, but differences were found in all other instances 
Moreover, the results in Table 19 show that cement 1 increased the 
strength of the osteoporotic sample by 3kN more than cement 2, but also 
caused an increase in stiffness by 1kN/mm compared to cement 2. This was 
not proved in metastatic samples where in fact any significant difference 
between cements 1 and 2 has not been found. 
 Osteoporosis Oncological samples 
 Strength (kN) Stiffness 
(kN/mm) 
Strength (kN) Stiffness 
(kN/mm) 
Cement 1 vs. 
Cement 2 
3.03(p<0.01) 0.96(p<0.01) 0.004(p=0.48) 0.02(p=0.30) 
Table 19 Comparison of the effect of the augmentation between the two 
tested cements showed a significant difference in cemented 
vertebrae in oncological samples, but failed to be significantly 
disparate for neoplastic pathology 
 Biomechanical effect due to varied PMMA cement stiffness- 5.2.4
Discussion 
One osteo-conductive material has been previously presented in this 
work. The aim of the study presented here was to investigate differences 
between the two acrylic (non-biodegradable) cements in two morphologically 
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different pathologies, where in fact in metastases only non-biodegradable 
material is recommended. Two cements of different compression stiffness 
derived from the same base product were thus investigated in a 
biomechanical cadaveric study, one of which is currently utilised clinically 
and the other of which is an off-the-shelf PMMA cement tailored to lower the 
stiffness. Secondly, while one of the investigated pathologies was found to 
be related to a loss of general bone quality, the other represented a rather 
dense tissue with regional bone loss in the area where the lesion was 
present. The metastatic sample in this study comprised samples with large 
confined osteolytic lesions, which were however present only in three out of 
twenty-four specimens. Moreover, due to their relative position within the 
vertebral body in addition to a thickened cortical bone in the anterior section, 
these lesions had a relatively low impact on the wedge compression strength 
of the organ per se. These factors combined eventually resulted in a 
relatively high strength and stiffness among the tested samples, even before 
the cement was administered.  
Both groups thus substantially differed in their morphology. The first 
set of samples (metastases) was found to have inferior bone quality with 
regards to BMD (148.7 ± 35.6 mgHA/cm3), trabecular thickness (0.32± 0.02 
mm) and spacing (0.81 ± 0.12 mm) and was found to have substantially 
higher bone connectivity (Conn.D = 1.82 ± 0.7 mm-3). However, the second 
set of samples demonstrated substantially lower bone quality in terms of 
lower BMD (136.7 ± 40.5 mgHA/cm3) and marginally thinner trabeculae 
(0.30 ± 0.03 mm) together with significantly increased separation of the bone 
(1.18± 0.26 mm) and notably disconnected trabeculae (Conn.D = 1.05 
± 0.43 mm-3).  
To target the clinical relevance of using the low-modulus PMMA 
cement in non-prophylactic applications, a wedge compression fracture was 
induced to single vertebra samples followed by cement augmentation with a 
fixed relative volume fill.  This was performed for two cements (low-
modulus/non-modified) within two morphologically distinct groups of samples 
(OP/metastases). The results showed that both cements had substantially 
increased strength in both groups. While in osteoporotic samples the choice 
of cement showed a strong impact in terms of an increase in strength (the 
initial strength was increased more than threefold after augmentation with 
standard cement, and only twofold using the low modulus cement), in the 
oncological samples the choice of cement did not show a significant 
difference. Although no significant change was found between initial and re-
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fracture stiffness, the OP samples augmented by the standard cement were 
almost 1kN stiffer compared to low-modulus cement. This was however not 
found in the oncological samples where both cements failed to restore the 
initial stiffness and strength, and the stiffness was not found to be different in 
any of the investigated cements.  
 Findings in the oncological samples are therefore in agreement with 
studies conducted by Boger et al. [23] and Kinzl et al. [24] who also reported 
on osteoporotic samples that standard and low-modulus PMMA cement 
restored both the strength and stiffness to their initial values before the 
fracture. On the other hand, it is rather interesting to note that the strength of 
the osteoporotic samples in this study was found to be more receptive to the 
augmentation material used. This is in agreement with a study conducted by 
Heini et al. [268] who also reported that cement augmentation is in fact more 
effective with bone demonstrating a higher degree of deterioration which is 
represented by lower BMD values. Moreover, a similar phenomenon was 
observed in experimental studies conducted on cored samples showing that 
the material properties of bone/cement structured material are much closer 
to the cement properties [24, 290, 291]. In fact, the augmented bone exhibits 
strong composite-like mechanical properties which are determined by the 
bonding of cement and bone, where in theory the bone, particularly in case 
of the vertical trabeculae, represents a more elastic structured material [292, 
293] surrounded by a matrix of stiff and strong cement. Here, the material 
properties of low modulus cements such as the one used in this study and 
reported previously [291, 294] can be tailored in order to reinforce the 
damaged vertebra without radical changes in the stress profile transmitted to 
adjacent vertebrae [23].  
Despite a relatively high number of samples used in this work, the study 
was limited by the availability of cancer donors. Moreover, the availability of 
oncological spines was complicated by the fact that the spines were 
acquired from overseas and despite a clinically confirmed metastatic 
infiltration to the vertebral bone, the severity of the morphological imprint 
was very low. Furthermore, the limited number of donors led to it becoming 
necessary to extend the harvesting of samples additionally to those from the 
lower lumbar region in order to retain the same dataset. Here, the wider 
selection of levels in the metastatic dataset might have influenced the overall 
results, however only if results could be examined together to obtain an 
overall comparison. This limitation has however been overcome by an only 
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relative comparison of pre- and post-augmentation mechanical properties 
and also by statistical evidence in equally distributed groups. 
In conclusion, results presented in this study confirm that PMMA 
vertebroplasty can be used as a satisfactory biomechanical stabiliser of 
fractured vertebral bone. Both cements showed an increase in strength after 
reinforcement of the bone regardless of the cement used. Interestingly, a 
difference has been found in the type of cement used with relation to the 
morphological character of both groups. The metastatic group, here 
characterised by a higher bone volume fraction (BV/TV), was not as strongly 
influenced by the type of cement used resulting in less marked differences in 
both strength and stiffness.  In contrast to this finding, the second group 
(OP), characterised by lower BV/TV, exhibited a more apparent influence of 
the use of cement. Considering similarities in bone/cement contribution 
observed in core samples previously discussed, this study also suggests a 
valuable correspondence at the organ level (whole VB). Moreover, the 
results suggest that tailored low-modulus cements can decrease the 
likelihood of an unnecessary increase in stiffness, which is believed to be a 
considerable factor in the increased occurrence of adjacent fractures.  
5.3 Biomechanics of augmentation using CaP and PMMA 
cement - Summary 
Two different cement types were biomechanically tested in two 
experimental studies. Both studies used the fracture prediction tool 
developed previously as a non-invasive precursor to benchmark specimens 
for effective group comparison (p>0.05 between all groups in terms of 
strength and stiffness). Later both studies followed the same cadaveric 
testing protocol to investigate a biomechanical effect of (i) bio-degradable 
cement in the early stages following treatment and (ii) two acrylic cements of 
different stiffnesses.   
First, cement based on a calcium phosphate formula has been tested in 
29 osteoporotic samples divided into three groups with varying volumes of 
injected cement. The volume of injected cement (10, 20 and 30% of VB 
volume) has failed to show a significant influence on either improvement of 
strength (p>>0.05) or stiffness (p>>0.05). Overall, CaP cement has 
increased the strength by 121% whereas the stiffness was restored only to 
41% of that prior to the fracture. 
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The second part of this section has provided results of testing acrylic 
cement (PMMA) with a tailored formula to reduce the baseline stiffness of 
the cement. This cement has been tested against off-the-shelf cement for a 
comparative study in osteoporotic and metastatic samples. All samples 
underwent fracturing followed by injection with 30% VB volume fill.  
Compared to the initial state, augmented vertebrae exhibited an increase in 
strength and decrease in stiffness regardless of the pathology and cement 
type used. In terms of biomechanical evaluation, non-modified cement (G1) 
has shown a substantial increase in strength but, accompanied by an 
increase in stiffness, was proved in samples with lower bone mass (OP 
samples). Tailored cement (G2) has shown an increase in strength in both 
cases but has not increased stiffness in either of the morphologically 
disparate groups.  
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  Chapter 6
Conclusion and Future perspective 
This section provides the conclusions reached by the work undertaken 
as a part of this thesis compared to works presented elsewhere. The chapter 
is segmented into two main bodies: “Non-invasive predictors of fracture in 
patients with different pathologies” and “PVP use in treatment of vertebral 
compression fractures” where each section highlights a summary of this 
work, the original contribution and a future perspective.  
6.1 Non-invasive predictors of fracture in patients with 
different pathologies 
 Summary of findings in structural assessment of metastatic 6.1.1
and non-metastatic bone 
From the framework of validation and verification of image-based 
fracture prediction it has been concluded that the structural analyses based 
on composite beam theory show a relatively close association with vertebral 
compression strength in osteoporosis, multiple myeloma and metastatic 
bone. In fact, it was also shown that this “CT-to-strength” approach is 
comparatively fast and easy to use, and also provides an adequate vertebral 
strength benchmarking tool when performing experiments using wedge 
compression fracture models.  
The first objective of this thesis was met as the developed model was 
tested on more than one hundred samples retrospectively by analysing 
tomographic images of historical data comparing the in-silico predictions with 
fracture data provided by previous investigators. Here, historical data 
comprised also a scarce amount of rare samples in which extra-vertebral 
lesions have developed prior to donation of the tissue. A numerical 
assessment of these samples concluded that this tissue may or may not 
contribute to the overall resilience of the whole organ depending on whether 
it suffered from osteoporotic osteophytes or osteoblastic lesions 
respectively.  
For the latter part of the validation and for conduction of a cadaveric 
study, an enhanced fracture rig was developed on which more than one 
hundred samples of three pathologies were fractured. From this study 
relatively good predictions of vertebral body strength were obtained when 
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using this model and more interestingly, even when reducing the tested 
range to a single slice analysis. This said, it has been concluded that the 
beam theory method can be used as a precursor to a biomechanical 
assessment of selected specimens in a laboratory environment, particularly 
to allow superior experimental groupings in WCF conditions over those 
usually based on BMD or vertebral level alone.  
In a framework of investigation of the biomechanical properties of 
cancer bone tissue the second objective was met by performing a detailed 
micro-indentation study. This study was the first of its kind and highlighted 
that the tissue level deterioration in multiple myeloma results in only a limited 
impact on the underlying material properties. This hence concluded that the 
weakening process in multiple myeloma most probably results primarily due 
to structural changes occurring on the meso-scale.  
Any conclusions made based on the pathological nature of the 
infiltration are however hampered by the fact that there is a lack of 
diagnostic methods to identify combined pathologies. For example cancer 
patients tend to be older in age and are thus more likely to develop 
osteopenia or osteoporosis besides developing bone lesions. Current 
DXA/CT based testing is not suitable for the diagnosis of underlying 
osteoporotic changes and hence does not provide a clear cohort of the 
tissue donated. This study however suggests that a density image-based 
fracture prediction tool accounts for the structural deterioration of bone 
where the material model used for density-to-modulus does not need to be 
adjusted, due to the presence of the osteolytic lesion at least in multiple 
myeloma bone. This nonetheless needs to be confirmed on other neoplastic 
pathologies such as breast, lung, bladder or thyroid cancers which are 
known for increased occurrence of developed osteoblastic lesions. 
 Original contribution 6.1.2
This study has aimed to provide an assessment of oncological bone, 
particularly in order to target compression fractures caused by structural 
changes within the bone. Preliminary studies within this work highlighted the 
necessity to account for structural changes and bone distribution. For this 
purpose this work proposes to build on an approach similar to that previously 
used by Whealan et al. [2]which was shown to provide fracture predictions 
with a greater association with the experimental results, even in the case of 
samples where lytic lesions were simulated by altering the vertebral body 
integration. In this study this model was adopted for use in vertebroplasty 
and contributed to the progress of current studies by confirming that a similar 
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model can provide high levels of agreement with vertebral body strength in 
single vertebra wedge compression fracture methods. This has been 
demonstrated on a large number of samples which, pooled together with the 
retrospective analysis of historical data, exceeded two hundred samples. All 
of the samples used in this study were processed in the same university 
laboratory using the same apparatuses for the initial and post-fracture 
scanning as well as for conduction of the destructive testing. Samples were 
scanned and tested in close collaboration with Daniel Skrzypiec, particularly 
for multiple myeloma samples which were later used in another 
vertebroplasty study (results as yet unpublished). This was possible due to 
the use of the same scanning and fracturing protocol up to the initial 
destructive testing. Osteoporotic study samples (annotated as “SpineGO”) 
underwent experimental testing in close collaboration with Alejandro Lopez, 
a visiting researcher from the University of Uppsala.  
The micro-indentation study produced original results in the indentation 
testing of oncological samples which had not been tested in literature to this 
point. This study was designed in collaboration with the Initial Training 
Network (ITN), particularly with partners from the Vienna University of 
Technology and the University of Bern. Samples were collected, scanned 
and embedded in a laboratory in Leeds whilst the indentation testing was 
conducted by the author of this work in a laboratory in the University of 
Vienna as a laboratory secondment. The results obtained from bone testing 
of multiple myeloma were found to be original and were later compared to 
results conducted on osteoporotic bone in a study which was carried out by 
Uwe Wolfram [184]. 
 Future perspective in structural assessment of metastatic 6.1.3
bone 
Compared to any study previously published, the results presented 
here also show that potentially only a single vertebral slice analysis is 
needed in order to permit correlation with the strength of the organ. Despite 
reducing the amount of information gathered about whole vertebrae, it has 
proven to demonstrate at least the same level of accuracy and precision as 
alternative methods presented elsewhere. Such a discovery highlights the 
potential of reducing the X-ray exposure of the patient during the 
radiography screening to a necessary minimum. This study has deliberately 
employed representative slices which are easy to identify from a fast and low 
pre-scan exposure (scout view). In fact, such a scout view is used in clinical 
CTs to select a range of axial slices, and although it does so imperfectly, 
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contains all the necessary information to preliminarily identify the weakest 
slice in relation to the rest of the vertebral body, whereas the single slice 
scan could be targeted for example at a site with strong lytic infiltration. This 
assumption is based on the principle that the scout view, similarly to DXA, 
provides a sum of densities perpendicular to each pixel of the scanning 
plane. Such a technique is however purely a theoretical assumption which 
would need to be tested and would possibly require that two scout-views 
were performed to identify any heterogeneous density violations such as 
lytic lesions.  
Proposed by findings from the preliminary study and confirmed 
elsewhere, such a technique would also be sensitive to over-mineralised but 
less stiff osteoblastic lesions that commonly occur together with lytic lesions. 
In particular, the analysis of historical samples has been complicated by the 
presence of extra-vertebral bone formations in which the contribution to the 
fracture load may be minimal, unlike the formation of osteophytes in 
osteoporosis reported in previous results which appears to significantly resist 
compressive load.  This is supported by a previous finding in which it has 
been demonstrated that the extra-vertebral lesions arising from the 
metastatic bone formation are akin to relatively immature woven bone which 
provides relatively little structural support.  This was however not confirmed 
in the main work of this thesis due to a limited availability of cancer samples 
with osteoblastic lesions. Nonetheless, this rather interesting discovery 
should be noted for future studies which aim to investigate the contribution of 
these lesions which are known to impair any attempt to perform density 
predictions in radiography screening.   
Based on this validation study, this stand-alone fracture prediction tool 
can be used as a fast and robust benchmarking tool for the relative strength 
distribution of cancer pathology. To confirm the agreement obtained by 
calibrating the material model and to improve the statistical variability of the 
cancer population, more samples should be tested in destructive 
experiments to fully prove its potential for clinical use.  
Lastly, this model is limited to a loading scheme which is however 
challenging to relate to a physiological situation in-vivo. This question is best 
addressed by multibody simulations where the loading conditions to which 
the organ is subjected can be predicted based on inverse kinematics 
measured non-invasively. A combination of the two approaches, by applying 
patient-specific loading conditions to CT-image-based predictions, could 
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allow the prevention of vertebral failures to take place during a routine 
patient screening instead of in finding them late at the ambulance services.  
6.2 PVP use in treatment of vertebral compression fractures  
 Osteo-conductive cement augmentation  6.2.1
Calcium phosphate vertebroplasty augmentation previously showed 
great potential as it enables a natural recovery of the weakened bone. The 
results of this cadaveric study show that this particular ceramic cement 
almost doubled the strength of the cadaveric vertebrae, while the stiffness 
was almost halved when compared to the stiffness of an intact vertebral 
body. On the other hand the lack of correlation between injected volume and 
strength suggests limited possibilities to improve strength to higher limits if 
necessary. 
Regarding the effect of employing a different volume of cement, the 
results reported that even smaller volumes (~2mL, 10% of the vertebral body 
volume) may be sufficient to stabilise the fracture, suggesting that the 
volume of introduced cement is not a decisive factor in terms of 
biomechanical improvement if the provisional restoration here presented is 
sufficient prior to the bone recovery. While it has been suggested that the 
volume of PMMA cements used should be kept as low as possible, osteo-
conductive cements can direct natural bone growth. Therefore the volume 
can be adjusted according to the bioactive character of the cement and 
therefore to achieve the optimal conditions for healing of the bone.  
 Low-modulus PMMA cement augmentation 6.2.2
Based on the results herein presented, this work concludes that  
undertaking vertebroplasty using PMMA cements results in an increase of 
stiffness and strength in fractured vertebrae regardless of how such 
deterioration might have occurred. The results presented in fact show a 
stabilising effect in all of the tested groups. Nonetheless, the metastatic bone 
and osteoporotic bone reacted differently to augmentation. In metastatic 
bone the effect of vertebroplasty was similar, regardless of the cement used. 
In contrast, the effect on osteoporotic samples has demonstrated that there 
is a significant difference between the two cements. Although both cements 
were proved to restore the stiffness to its initial values, low-cement was 
found to restore the stiffness closer to the values obtained prior to the 
fracture, whereas the standard cement resulted in a marginally increased 
stiffness. This in fact suggests that low modulus cement demonstrates 
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improved properties which could potentially address the worrying issue of 
adjacent fractures. 
Furthermore, it is believed that the difference in contribution is most 
likely due to a variation in morphology between the tested pathologies. This 
observation has been made based on the discovery that the contribution of 
cements’ material properties to bone strength and stiffness was more 
apparent in high-porosity osteoporotic samples, compared to less porous 
bone obtained from two metastatic patients. This said, there are a number of 
conclusions to be made: 
i. Vertebroplasty using both PMMA cements results in an increase in 
bone stiffness and strength; 
ii. The effect of vertebroplasty is related to the morphology of the bone 
prior to its augmentation; 
iii. The effect of vertebroplasty is possibly driven by a combination of 
both the cement material used and the micro-mechanical properties 
of the bone tissue embedded within the bone. 
The latter conclusion is also based on the discussion in the previous 
chapter in which the composite behaviour of augmented bone observed 
elsewhere has been emphasised. Here, based on the results obtained from 
the micro-indentation study, it is also possible to conclude that conducting 
vertebroplasty using PMMA cement would have a similar effect also on 
multiple myeloma bone, as its micromechanical properties are similar to 
osteoporotic bone. 
 Original contribution  6.2.3
Results from both studies have made an innovative contribution to the 
field of vertebroplasty. The first study encompasses the unknown 
relationship between the injected volume of cement and its biomechanical 
output when augmented into osteoporotic tissue. This work is in fact the first 
to present an augmentation of three different volumes in a laboratory 
experiment with a subsequent re-fracture experiment. These results can be 
addressed in future studies tailoring the material and biomechanical 
properties of absorbable materials. The use of fracture prediction as a 
benchmarking tool also contributes to the uniqueness of these two studies 
due to the improved Latin-square strength-based group allocation used prior 
to conducting the fracturing part of the experiment. 
PMMA augmentation was in fact conducted in two different pathologies 
of which one was related to the treatment of patients with infiltration of 
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cancer to their spine. The study was innovative in comparison to all others 
published to date in conducting a study on cement which was manufactured 
in a relatively easy process by tailoring the existing properties of currently 
available cement. Although different studies were conducted in order to 
reinforce the biomechanical effect of low-modulus cements, this study was 
conducted on a comparatively larger volume of samples comparing 
pathologies with different morphologies.  
The CaP study was conducted in collaboration with the Initial Training 
Network (ITN) partner BONESUPPORT AB. Nonetheless, the biomechanical 
experiment was conducted entirely by the author of this work in teamwork 
with ITN colleague Nicola Brandolini. The results presented in this work were 
analysed independently of any collaborating partner. 
The PMMA study was conducted in collaboration with another university, 
while the initial fracturing, scanning, fracture prediction and preparation of 
samples for augmentation were conducted by the author of this work alone 
or in collaboration with Alejandro Lopez – a visiting researcher from the 
University of Uppsala. The augmentation was performed by the surgeon 
Vishal Borse in a joint experimental session. The results were analysed 
separately in shared discussions.  
 Future perspective in CaP and PMMA augmentation 6.2.4
In agreement with other studies, the results presented here suggest that 
PMMA and CaP vertebroplasty are safe in terms of improving the 
biomechanical properties of a vertebral bone after fracture. These results 
should however be interpreted with care and only in the context of a 
biomechanical cadaveric study conducted with the intention of answering 
very specific questions. Further pre-clinical and clinical validations need to 
be conducted prior to its general use. Based on the PMMA study presented 
here it has been concluded that using normal cement compared to a low-
modulus cement risks an unnecessary increase in stiffness, which is 
believed to be a considerable factor in the increased occurrence of adjacent 
fractures. This conclusion however requires confirmation in dynamic testing 
to assess the fatigue properties of the materials used in addition to the 
quasi-static experiments presented in this work. Also, as this study was 
limited to relatively constrained loading conditions, a clearer understanding 
of boundary conditions and directional load changes is required to reinforce 
these conclusions. 
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Secondly, the most significant limitation of the calcium phosphate study 
is without any doubt the cadaveric nature of the experiment. These 
preliminary results however suggest that this material is safe in terms of 
biomechanical stiffness and strength for a short time following the 
procedure, although animal or clinical studies would need to be conducted in 
order to provide valuable information regarding bone recovery. Moreover, 
with potential bone recovery, the current cement could be also deployed in 
the burst fracture typically used in the case of younger patients. This 
however requires testing under conditions which would have a much higher 
short-term impact, possibly using a weight drop testing machine.   
The results in this work also suggest that very little is known about the 
relationship between morphology and the resulting effect of the 
augmentation. The experiment presented here should hence be conducted 
to address a larger sample population of different bone morphologies in 
order to fully deploy the potential of the augmentation treatment. 
Alternatively or alongside this, reproducing the experiment to assess the flow 
of cement would volunteer more information regarding material distribution 
and could further respond to the elementary questions which have arisen 
from this work. 
Finally, throughout this thesis a number of potential applications of the 
fracture prediction tool were shown, in particular its use in the identification 
of weakened vertebrae with sufficient accuracy and power of prediction. This 
demonstrates a strong potential for the reproduction of similarly satisfying 
outcomes for use in investigation of prophylactic augmentation.  
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List of Abbreviations 
aBMD  Areal BMD (radiographic BMD) [mg/cm2] 
ANOVA  - Analysis of variance (statistics) 
BMD or 
vBMD 
- Bone mineral density [mgHA/cm3] 
BV/TV - Bone volume fraction [1] or [%] 
CaP  - Calcium phosphate 
CDHA - Calcium deficient hydroxyapatite  
Conn.D - Bone connectivity density [mm-3] 
CS - Cross-section  
CSA - Cross-sectional area [mm2] 
CT - Computed tomography 
DXA - Dual Energy X-ray Absorbtiometry  
E - Modulus of elasticity [GPa] 
EA - Axial stiffness [N] 
EI - Bending (Flexural) stiffness [Nm2] 
Ei - Indentation modulus [GPa] 
FE - Finite element  
FRI - Fracture Risk Index 
Fz  - Theoretical strength [kN] 
GOBJ - MicroCT (Scanco) VOI 
GUI - Graphical User Interface 
H - Micro-hardness [MPa] 
HA - Hydroxyl-apatite  
ISQ - MicroCT (Scanco) reconstructed data file 
LVDT - Linear variable differential transformers  
MBD - Myeloma bone disease  
mets - Metastases from primary cancer (in this context 
any other than MM cancer) 
microCT - Pre-clinical micro-computed tomography 
MIL - Bone mean intercept of length (degree of isotropy) 
minCSA - Minimum cross-section area [mm2] 
MM - Multiple myeloma cancer 
MM.L - Micro-indentation sample group: samples with 
invasion to the vertebral bone, samples taken from 
proximity of the lesion 
MM.L.C - Micro-indentation sample group: samples with 
invasion to the vertebral bone, samples taken distantly 
from the lesion 
MM.N - Micro-indentation sample group: donors diagnosed 
with MM cancer without visible lesions 
 
Non-MM - Micro-indentation sample group: donors without 
diagnosed MM cancer 
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OP - Osteoporosis  
PKP - Percutaneous Kyphoplasty 
PMMA - Poly(methyl_methacrylate) 
p-qCT - Pre-clinical qualitative computed tomography 
PVP  - Percutaneous vertebroplasty 
qCT 
 
- Qualitative computed tomography 
R2 - Coefficient of determination (statistics)  
RCT - Randomised controlled trials 
RMS - Root mean square (statistics) 
RSQ - MicroCT (Scanco) raw data file 
SEG_CYL  - Segmented trabecular bone binary stack within the 
representative VOI  
SLA - Stereo-lithography (SLA)  
SLS - Selective Laser Sintering (SLS)  
SRE - Skeletal related event  
Tb.N - Number of trabeculae [1/mm] 
Tb.Sp - Trabecular separation 
(spacing) 
[mm] 
Tb.Th - Trabecular thickness [mm] 
TBS - Trabecular Bone Score 
VB - Vertebral body  
VCF - Vertebral compression fractures 
VOI - Volume of Interest 
VVB - Vertebral body volume 
WCF - Wedge compression fracture 
We - Elastic energy [pJ] 
WHO - World Health Organisation 
Wp - Plastic energy [pJ] 
wt% - % by weight  
α−TCP  - Alpha-tri-calcium phosphate 
ε - Bone strain [%] 
ρ - Tissue density  [mg/cm3] 
ρapp - Apparent density [mg/cm
3] 
ρash - Ash density [mg/cm
3] 
ρBMD - Bone mineral density [mgHA/cm
3] 
ρct - CT density [HU] 
ρdry - Apparent dry density [mg/cm
3] 
κ - Humidity [%] 
τ - Temperature [˚C] 
3D - 3-dimensional (volumetric) 
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Appendix A: Historical data assessment 
  Quantitative assessment Experimental 
data 
Fracture 
prediction Fz [kN] 
Specimen Extra-vertebral body 
lesion 
BMD  
[mgHA/cm
3
] 
Stiffness 
[kN/mm] 
F(zero-
slope) 
[kN] 
Entire 
VB CSA  
Extra-VB 
formations 
masked 
Bladder 
mets - T6 
enlarged 
osteoblastic lesion 
115.6 2.47 1.88 2.45 2.24 
Bladder 
mets - T7 
enlarged 
osteoblastic lesion 
95.7 2.11 1.81 2.69 2.07 
Bladder 
mets - T8 
small osteoblastic 
lesion 
78.1 1.46 1.45 2.21 2.14 
Bladder 
mets - T9 
small osteoblastic 
lesion 
93.5 2.13 1.91 4.03 2.70 
Bladder 
mets - T10 
enlarged 
osteoblastic lesion 
78.3 2.04 2.08 5.47 2.17 
Bladder 
mets - T11 
enlarged 
osteoblastic lesion 
136.1 1.16 2.00 4.87 2.19 
Bladder 
mets - T12 
no osteoblastic 
lesion 
92.7 1.43 1.52 2.09 1.81 
Bladder 
mets - L1 
small osteoblastic 
lesion 
94.0 2.92 2.59 2.81 2.78 
Bladder 
mets - L2 
no osteoblastic 
lesion 
88.4 1.04 1.73 3.47 3.35 
Bladder 
mets - L3 
very small 80.5 1.87 2.71 3.03 2.99 
Bladder 
mets - L4 
No lesion but 
fractured 
115.4 1.52 2.63 3.13 2.22 
Bladder 
mets - L5 
no osteoblastic 
lesion 
114.5 2.73 4.20 4.86 4.71 
Table 20 Historical data: Experimental, BMD and fracture prediction 
data of metastatic samples from a donor with bladder cancer 
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Figure 62 Initial fracture prediction assessment (without masking the 
CSA) 
 
Figure 63 Additional fracture prediction assessment (masking the 
Osteoblastic lesions) 
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Appendix B: Validation of vertebral body segmentation 
To validate the approach in terms of both accuracy and precision, the 
calculated volume was confirmed against measured volume.  In this study, 
volumetric measurements based on the sum of all cross-sectional areas 
obtained from the microCT measurements were directly compared to those 
experimentally obtained using a buoyancy principle.  
For this validation study seventeen porcine vertebral bodies of different 
sizes were harvested, the posterior elements were fully removed and the 
remaining vertebral body was separated from any soft tissue. Here the 
volumes were measured using the Archimedes principle [295]. In summary, 
the vertebral body was submerged into a solution and hence was subjected 
to an upwards force due to buoyancy where the force is equal to amount of 
water displaced. This force was then expressed as the change in weight of 
water before and after submerging the VB (Figure 64). 
The volumetric measurements were compared in terms of the 
percentage difference between methods, where the buoyancy method was 
taken as the reference [162]. The initial comparison of these two methods 
(blue dataset on Figure 65) uncovered a substantial but consistent difference 
in microCT measurement data (average ΔV=9.55%, RMS=9.6%). This was 
further investigated and in fact, through the application of this study, 
uncovered a faulty calibration of the microCT machine introduced by the 
manufacturer two years before this study. The manufacturer later proposed 
a re-calibration tool which was used to adjust all scans for the correct voxel 
size and were used on all scans following this final calibration.  
The corrected dataset improved in terms of volumetric bias to ΔV=-
1.59% (-0.19cm3) with precision of RMS=2.25% (0.34cm3). The remaining 
difference can be explained by residual soft tissue on the VB which is not 
visible under microCT assessment. Hence the vertebral body image 
segmentation tool has proved to be sufficiently precise and accurate in 
estimating the boundary based on microCT images.  
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Figure 64: The buoyancy principle has been used to measure the 
volume of a vertebral body. First (depicted in (A)) the experimental 
setup and the principle have been tested on a metal ball-bearing 
with known volume (ΔV<0.2%) and later used on porcine vertebral 
bone samples (in (B)). Compared to the traditional Archimedes 
principle, here the volume is not required to be measured in terms 
of displacement but can be calculated based on change of weight 
(with precision of 0.01g=0.01cm3) 
A.) 
B.) 
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Figure 65: Validation of vertebral body image segmentation script. The 
numerical approach was validated by means of compared 
volumes obtained experimentally and using the microCT 
approach. Initial results (in the graph as blue diamond markers) 
have later highlighted a discrepancy in measurements and led to 
uncovering faulty calibration of the microCT by the manufacturer. 
Corrected data (depicted as red squares) were found to possess 
volumetric differences of -1.59% (-0.19cm3) (RMS 2.25% (0.34cm3)) 
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Appendix C: Donors’ medical records available for this study 
  Primary (1) and 
secondary (2) cause 
of death 
History of (H/O) Drugs known to 
be administered 
within the last 6 
months prior to 
TOD 
SpineBS 1 1 Chronic Cardial 
Failure  
2 Peripheral Vascular 
Disease, Liver Abscess 
Arthrisis, Liver disease, Brest Cancer 
(treated) 
Information not 
available 
SpineBS 2 1 Carcinomatosis, 1b 
Gastric 
adenocarcinoma 
Information not available Information not 
available 
SpineBS 3 1 Bronchopneumonia,  
2 Adenocarcinoma of 
lung and emphysema 
Hypertensive and ischemic heart 
disease 
Information not 
available 
SpineGo 1 1 Respiratory failure 
2 Dialated 
cardiomyopathy 
Osteoporosis, mild severity 
CHF diag ~5yrs prior TOD 
Hysterectomy ~30yrs prior TOD 
Emphysema & COPD diag ~30yrs prior 
TOD 
Smoker (3 per day ~40yrs) 
Xanax, morphine, 
antibiotic, 
Antibiotics prior to 
TOD 
SpineGo 2 1 Debility with likely 
pneumonia, ESRF 
2 Persistent Cdif, R hip 
fx from fall 
Fell and Fx R femur 2mos prior TOD 
(plate input) 
Mild arthritis in knees, shoulder, hip- 
taking Celebrex; mild osteoporosis- Rx-
actonel and vit D 
Melanoma removed 20yrs-neck 
HTN 
Interstititial lung disease, resting 
capacity 92%, 
Renal failure recent 
OU Cataract Sx 15yrs ago 
UTI-amplicitin, CDIF 2 weeks ago on 
ABX and curred 
2 wks prior flu-like symptoms, ABX for 
UTI and CDIF-2 wks prior 
Social drinker(2x/week), no tabacco 
Blood transfusion 2 mths prior TOD - 3 
units after Femur Sx, 2 units a few days 
after 
 
 
 
 
Protonix, 
Oxycontin, 
Benicar, Actonel, 
Vit D, Lovonox, Fe, 
Multi-Vit,Miralax, 
Sonata, Lidoderm, 
Metanex, Sena 
… table continued on following page… 
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  Primary (1) and 
secondary (2) cause 
of death 
History of (H/O) Drugs known to 
be administered 
within the last 6 
months prior to 
TOD 
SpineGo 4 1 Aspirating pneumonia Mild arthritis in rt shoulder dx 10 prior to 
TOD, mild osteo of spine dx 10 yrs prior 
to TOD, memory loss 1yr prior to TOD, 
pneumonia 3 times w/in 4yrs prior to 
TOD, aspiration pneumonia COD, 
hearing aid 4yrs prior to TOD, UTI 
2009- abx use 1wk prior to TOD, 
Cataract sx both eyes 10-20 yrs prior to 
TOD 
Full hysterectomy 30yrs prior to TOD, 
left hip replacement 1994/1995, left 
knee sx 1996, pneumonia 3x w/in 4yrs 
prior to TOD 
Diovanm 
benzonate, abx, 
tylenol PM, iron, 
Spiriva, flu shot, 
blood transfusion  
SpineGo 5 1 Haemopericardium,  
2 Ventricular 
perforation, 1c 
Myocardial 
Infarction Information not 
available 
SpineGo 6 1 Metastatic 
oesophageal 
carcinoma 
Hysterectomy 1980’s, appendectomy 
when young, COPD, no Chemo in last 
6 months 
Information not 
available 
Spine 1 
mets 
1 Respiratory failure, 
Metastatic 
inflammatory 
carcinoma 
2 left inflammatory 
breast carcinoma, lft. 
Breast CA 
Breast CA dx 7yrs prior to TOD, 
chemotherapy and radiation for tx, 
Mets: upper spine, R hip, liver 
Hysterectomy 
No bedsores  
Bilat mastectomy 10yrs ago, lap flap 
6yrs ago, Thoracic sx 5yrs prior TOD, 
partial hysterectomy 4yrs ago, ovaries 
removed, chemo port placed 6yrs prior 
TOD  
 
Spine 2 
mets 
1 Metastatic lung 
cancer 
Ca w mets to spine, liver, ribs, no other 
bone disease 
Cancer: dx cancer 5mos prior TOD left 
lung, liver, ribs, spine, melanoma dx 
3yrs prior TOD 
CHF and irregular heartbeat, refused 
pacemaker 
Open bedsore on tailbone not sure of 
exact size (bedsores 3,4) 
Memory loss (began 10mos prior TOD) 
Traumas: fell walking down stairs at his 
home (not reported), one week prior 
getting out of bed fell- hospice 
examined after that fall no inj 
Smoker: 1ppd >20yrs 
Appendectomy 50yrs prior, hernia sx 
over 20yrs prior, endartectomy neck sx 
bilat 10yrs prior TOD 
Information not 
available 
… table continued on following page… 
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  Primary (1) and 
secondary (2) cause 
of death 
History of (H/O) Drugs known to 
be administered 
within the last 6 
months prior to 
TOD 
Spine 1 
MM 
1 Pulmonary Oedema  
2 Renal Failure and 
malignant myeloma 
87 yr old Female  
Unsure on height and weight 
Myeloma and nothing else significant, 
information from Solicitor as this lady’s 
wishes had been expressed in her will 
and we did not receive a copy of the 
GP questionnaire. Findings at autopsy 
did not find anything significant or 
intimate that the donor had had any 
other surgeries or suffered any other 
medical conditions 
 
Information not 
available 
Spine 3 
MM 
1 Mupltiple myeloma  (Material Transfer Agreement not 
available) 
 
Information not 
available 
Spine 4 
MM 
1 Multiple myeloma Myeloma, diagnosed: 05/2010, mets to 
shoulder and head 
Hypertension 
Hx of kidney stones 20y prior death 
Diabetes type II 
Hearing loss in both ears, no aids 
Smoker (15y) 
Alcohol – minimal 
Morphine, Ativan, 
(bisphosphonates 
not mentioned) 
Spine 5 
MM 
1 Cardiorespiratory 
failure 
Multiple myeloma diagnosed 08/2009 
Cirrhosis due to alcohol abuse (dx 6y 
prior) 
Cataract sx 1y prior, side unk 
Heavy alcohol use 
Smoker (15y, 1ppd) 
Morphine 
(bisphosphonates 
not mentioned) 
Spine 6 
MM 
 
1 Immunoglobulin G 
Kaapa multiple 
myeloma stage 3 
Multiple Myeloma w/o remission, unk of 
Tx if any, unk dxd 
Hernia Sx, unk location on body, 
approx. 60 years prior 
 
 
None specified 
… table continued on following page… 
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 Primary (1) and 
secondary (2) cause 
of death 
History of (H/O) Drugs known to 
be administered 
within the last 6 
months prior to 
TOD 
Spine 7 
MM 
1 Terminal multiple 
myeloma 
Fall at his home a few times and 
threshold 2 months ago 
Arthritis in knees, pain in back was 
thought to be from arthritis, pain scale 
5, self-medication (OTC Tylenol 
arthritis). No formal DX on arthritis  
Multiple Myeloma diagnosed 3y prior to 
death. Oral chemotherapy, bone 
strengthening infusions every month, 
off chemo and in remission for a year 
Quintuple bypass surgery 10y prior to 
death, veins in both legs stripped 10 y 
prior to death 
Depression 5y prior to death.  
Allergies: Seasonal, fish, NSAIDS, 
Cephalosporin 
6-8y prior to death last TB testing: 
negative 
Dialysis for the last 17y (diagnosed 17y 
prior to death) 
Acid reflux 
Loss of hearing in his left ear, dxd 10y 
prior to death 
Simvastatin 40mg 
1poqd, 
Omeprazole 20mg 
po bid, Rocatrol 
.25mcg 1poqd, 
Dexamethasone 
40mg 10tabs per 
week, Primidone 
50mg 1 pot id, 
Setraline HCL 
50mg 1poqd, 
Fludrocortisone 
Acatate .1mg po 
bid, Vitamin D 
50,000 UI 1 po 
month, Full 
spectrum B w/ Vit 
C OTC, Tylenol 
Artitis pain, 
Critical, 
Loperamide HCL 
2mg (dosage not 
known) 
Table 21 Medical history details as acquired from GIFT banks.  
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Appendix D: Morphology assessment 
Appendix D.1: Osteoporosis 
Morph.Index bmd 
[mgHA/cm
3
] 
BV/TV 
[1] 
Tb.Sp 
[mm] 
Tb.Th 
[mm] 
Tb.N 
[1/mm] 
Conn.D 
[1] 
Spine 1 BS 147.7  
(±22.8) 
0.17 
(±0.03) 
1.34  
(±0.16) 
0.32  
(±0.03) 
1.41  
(±0.14) 
0.62  
(±0.12) 
Spine 2 BS 124.9  
(±7.9) 
0.19  
(±0.02) 
1.14  
(±0.13) 
0.3  
(±0.03) 
1.21  
(±0.11) 
0.88  
(±0.09) 
Spine 3 BS 69.5  
(±9.2) 
0.11  
(±0.01) 
1.74 
(±0.17) 
0.3  
(±0.01) 
1.77  
(±0.16) 
0.37  
(±0.08) 
SpineGO 1  122.9  
(±11.2) 
0.15  
(±0.02) 
1.33 
(±0.15) 
0.3  
(±0) 
1.38  
(±0.14) 
0.69  
(±0.11) 
SpineGO 2 124.3  
(±11.5) 
0.2  
(±0.01) 
0.94 
(±0.04) 
0.27  
(±0.01) 
1.01  
(±0.04) 
1.47  
(±0.12) 
SpineGO 4 194.6 (±7.9) 0.22 (±0) 1.02 
(±0.09) 
0.31 
(±0.02) 
1.09 
(±0.07) 
1.51 
(±0.08) 
SpineGO 5 137.3 (±5.7) 0.17 
(±0.01) 
1.16 
(±0.1) 
0.3 (±0) 1.23 
(±0.09) 
0.83 
(±0.12) 
SpineGO 6 111.9 (±63.6) 0.16 
(±0.05) 
1.48 
(±0.33) 
0.33 
(±0.08) 
1.48 
(±0.32) 
0.61 
(±0.41) 
Table 22 Morphology assessment: Osteoporosis (mean ± stdev) 
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Appendix D.2: Metastases 
Morph.Index bmd 
[mgHA/cm
3
] 
BV/TV 
[1] 
Tb.Sp 
[mm] 
Tb.Th 
[mm] 
Tb.N 
[1/mm] 
Conn.D 
[1] 
Spine 1 mets 178.8  
(±26.6) 
0.31  
(±0.02) 
0.72  
(±0.03) 
0.3  
(±0.02) 
0.84  
(±0.02) 
2.53  
(±0.2) 
Spine 2 mets 125.8  
(±14.5) 
0.23  
(±0.03) 
0.89  
(±0.09) 
0.32  
(±0.03) 
0.97  
(±0.09) 
1.29  
(±0.31) 
Table 23 Morphology assessment: Metastases to spine (mean ± stdev) 
Appendix D.3: Multiple myeloma 
Morph.Index BMD 
[mgHA/cm
3
] 
BV/TV 
[1] 
Tb.Sp 
[mm] 
Tb.Th 
[mm] 
Tb.N 
[1/mm] 
Conn.D 
[1] 
Spine MM 4 111.4  
(±12.5) 
0.11  
(±0.01) 
2.56  
(±0.74) 
0.36  
(±0.08) 
2.61  
(±0.71) 
0.33  
(±0.08) 
Spine MM 5 166.8  
(±24.1) 
0.2  
(±0.01) 
1.04  
(±0.06) 
0.32  
(±0.01) 
1.13  
(±0.05) 
0.99  
(±0.1) 
Spine MM 6 107.5  
(±5.2) 
0.16  
(±0.01) 
1.18  
(±0.03) 
0.28 
(±0.01) 
1.26  
(±0.03) 
0.84  
(±0.07) 
Spine MM 7 159  0.17  1.54  0.35  1.68  0.64  
Table 24 Morphology assessment: multiple myeloma (mean ± stdev) 
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Appendix E: Cadaveric testing: Strength/stiffness per level 
Appendix E.1: Osteoporosis 
 
Figure 66 Strength and stiffness data for osteoporotic study for each 
spine and vertebral level used in the study - Spine BS 1 
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Figure 67 Strength and stiffness data for osteoporotic study for each 
spine and vertebral level used in the study - Spine BS 2 
 
Figure 68 Strength and stiffness data for osteoporotic study for each 
spine and vertebral level used in the study - Spine 3 BS 
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Figure 69 Strength and stiffness data for osteoporotic study for each 
spine and vertebral level used in the study - SpineGo 1 
 
Figure 70 Strength and stiffness data for osteoporotic study for each 
spine and vertebral level used in the study - SpineGo 2 
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Figure 71 Strength and stiffness data for osteoporotic study for each 
spine and vertebral level used in the study – SpineGo 4 
 
Figure 72 Strength and stiffness data for osteoporotic study for each 
spine and vertebral level used in the study – SpineGo 5 
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Figure 73 Strength and stiffness data for osteoporotic study for each 
spine and vertebral level used in the study – SpineGo 6 
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Appendix E.2: Multiple myeloma 
 
Figure 74 Multiple myeloma samples: Initial strength and stiffness for 
corresponding donor and spine level 
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Appendix E.3: Metastases 
 
Figure 75 Spine 1 mets: Initial strength and stiffness for corresponding 
spinal level 
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Appendix F: Micro-indentation 
Appendix F.1: Post-hoc statistical analysis 
  Indentation modulus [GPa] 
  Axial Transverse 
  diff lwr upr p-value diff lwr upr p-value 
MM.L.C-MM.L 1.2 -0.3 2.7 0.136 0.2 -0.7 1.1 0.818 
MM.NL-MM.L 0.0 -1.4 1.4 0.999 0.0 -0.9 0.8 0.996 
MM.NL-MM.L.C 1.2 -3.0 0.6 0.254 -0.3 -1.4 0.9 0.840 
  Hardness [MPa] 
  Axial Transverse 
  diff lwr upr p-value diff lwr upr p-value 
MM.L.C-MM.L 25.6 -16.6 67.8 0.313 9.6 -21.9 41.2 0.740 
MM.NL-MM.L 2.3 -35.9 40.5 0.989 5.8 -24.2 35.9 0.885 
MM.NL-MM.L.C -23.3 -74.1 27.5 0.510 -3.8 -42.4 34.8 0.969 
  Elastic Energy [pJ] 
  Axial Transverse 
  diff lwr upr p-value diff lwr upr p-value 
MM.L.C-MM.L 412 -1078 1902 0.782 328 -1091 1747 0.841 
MM.NL-MM.L 28 -1320 1376 0.999 312 -1042 1667 0.842 
MM.NL-MM.L.C -384 -2178 1410 0.862 -16 -1755 1722 0.999 
  Plastic Energy [pJ] 
  Axial Transverse 
  diff lwr upr p-value diff lwr upr p-value 
MM.L.C-MM.L 2871 -1566 7308 0.269 837 -1975 3650 0.752 
MM.NL-MM.L 667 -3346 4683 0.914 946 -1739 3631 0.672 
MM.NL-MM.L.C -2202 -7545 3141 0.581 108 -3337 3554 0.997 
  Ductility measure (Wp/(We+Wp) [1] 
  Axial Transverse 
  diff lwr upr p-value diff lwr upr p-value 
MM.L.C-MM.L 0.0 0.0 0.0 0.870 0.0 0.0 0.0 0.977 
MM.NL-MM.L 0.0 0.0 0.0 0.880 0.0 0.0 0.0 0.989 
MM.NL-MM.L.C 0.0 0.0 0.0 0.998 0.0 0.0 0.0 0.998 
Table 25 Post-hoc statistical analysis for multiple myeloma bone 
material properties 
 
 
- 206 - 
Appendix F.2: Humidity and temperature adjustment 
Adjustment to the same humidity (κ) and temperature (τ) was performed 
by using a least square fit of the indentation moduli (Ei), micro-hardness (H) 
and both indentation energies (We, Wp) to a bilinear, affine function (eq. 
(1.11) with confidents according to (1.12), (1.13), (1.14) and (1.15): 
 𝐸𝑖 , 𝐻, 𝑊𝑒𝑙𝑎𝑠𝑡 , 𝑊𝑝𝑙𝑎𝑠𝑡 = 𝑎1𝜏 + 𝑎2𝜅 +  𝑎3𝜏𝜅 +  𝑎4 (1.11)  
whereas coefficients for each adjustment were: 
 Ei: [a1, a2, a3, a4] = [-1.33, -1, 0.04, 46.92] GPa (1.12)  
 H: [a1, a2, a3, a4] = [71.9, 38.3, -1.7, -1116.8] MPa (1.13)  
 We: [a1, a2, a3, a4] = [5141, 3069, -131, -103004] pJ (1.14)  
 Wp: [a1, a2, a3, a4] = [3591, 1772, -85, -16035] pJ (1.15)  
Parameters of the fit have been provided for the purpose of this thesis 
by the author of the micro-indentation study comprising a non-affected 
population, Uwe Wolfram [36]. All four indentation variables were 
subsequently adjusted to the average humidity κref =50.33% and 
temperature τref = 21.62ºC. 
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Appendix F.3: Results – graphical form 
 
Figure 76 Graphical interpretation of means (± stdev) of micro-
indentation properties of multiple myeloma bone 
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Appendix G: Bi-axial eccentric loading  
Appendix G.1: Introduction to asymmetric beam theory 
A number of approximations has been done in this work. In one, a single 
vertebra body is taken into account as a part of long thin beam (spine) and 
hence considered as a slandered beam in which the stress distribution is 
solved using Euler-Bernoulli beam theory. In another, the bone mineral 
component, measured by means of radiation tomography, is assumed to 
stand for material properties such as Young’s modulus (E, [GPa]) and yield 
strength (ɛ, [%]).  
This section focuses on approximation that the natural vertebral body 
loading results in bending towards merely anterior direction and that the 
loading axis is located closely to the mirror neutral axis.  Such assumption 
allows neglecting the contribution of the eccentric loading with respect to the 
mirror (anterio-posterior) axis and allows considering point of the highest 
stress to be located merely anteriorly from the loading axis. This is however 
valid only when the ratio of eccentricity (moment My/Mx stress contribution) 
remains substantial with respect to primary bending moment (My). While this 
approach has been applied by number of other authors [145, 232, 296], this 
section aims to justify this approximation by providing extension of the Euler-
Bernoulli model when accounting for eccentric loading with respect to both, 
the primary (bending) and the secondary (mirror) neutral axes. This 
extension will be tested on highly asymmetric vertebral body profiles with 
simulated metastatic infiltration (from subsection 3.1.2.4) and on a human 
cadaver sample with a substantial degree of metastatic VB invasion 
(subsection 3.3.2.3), where all reanalysed data have been compared to 
those predicted as a part of the main body of this thesis and to those 
obtained experimentally.  
Appendix G.2: Theoretical consideration for asymmetric 
beam profile 
Appendix G.2.1: Bi-axial eccentric loading in asymmetric profile: 
definition  
The problem of eccentric loading arises when the load is offset from the 
modulus weighted centroid of the kern with respect to both neutral axes. 
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Such eccentric loading notably alters the stress distribution along the axial 
stress with bending introduced by a moment F*e1. This can be illustrated by 
looking at each of the stress-profiles separately. Here, the stress contribution 
due to compressional (normal) loading and additional moment can be super-
positioned to obtain the full stress profile (depicted as uni-axial eccentric 
loading in Figure 77 ). A secondary moment Mx can result in offsetting the 
modulus weighted centroid in y direction introducing additional moment due 
to significant mirror non-symmetry along the x axis.  Similarly to the situation 
depicted previously, a stress resulting from such moment is to be super-
positioned for the full stress-distribution profile.
 
 
Figure 77 stress profile due to eccentric loading considered as super-
positioned stress induced by (i) compression loading (left) and (ii) 
bending moment (right) 
This said, the strain at each point resulting from such stress profile can 
be obtained by combining contribution of each of the components in a 
general form presented in eq. (1.16). Here Mx= F*e1, My=F*e2 are the 
eccentric loading moments due to load offsets e1 and e2 with respect to the 
neutral axes; and notation of each component remains dependent on 
whether causing compression or tension. 
 ɛ(𝑥,𝑦) =
𝐹
𝐸𝐴
±
𝑀𝑦 ∗ 𝑥
𝐸𝐼𝑦
±
𝑀𝑥 ∗ 𝑦
𝐸𝐼𝑥
 (1.16)  
Appendix G.2.2: Moment notation 
While compression stress is conventionally noted as negative, this work 
aims to investigate compressional fracture load and hence compressional 
stress will be noted as positive. Whether a moment is causing positive or 
negative stress has been decided on four possible cases due to eccentricity. 
A case where the eccentricity “e1” is positioned posteriorly to the neutral axis 
is highly unlikely and will not be considered. Furthermore, as the nature of 
the loading was purely compressional (free loading plate using a ball-joint 
discussed in subsection 3.2.2.4) the tension stress due to introduced 
eccentricity becomes nil and only positive moments should be accounted for.  
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Whether a moment contributes to the compressional stress or not is 
hence depicted in Figure 78 listed for two possible cases whether the 
loading axis is located on left or right from the mirror neutral axis.  
 
 
 
 
Figure 78 Moment notation with respect to modulus weighted centroid 
(Green) in asymmetrical vertebrae where the cross-sectional 
profile has been altered due to presence of a lesion (pale blue)  
Appendix G.3: Application of asymmetric beam theory 
In total eight “fail” images of the plastic models have been reanalysed 
accounting for bi-axial eccentricity. In addition a sample with the highest 
degree of infiltration has been included in the analysis. Here, the plastic 
models represented a range of samples with a considerable VB shape 
alteration whereas the latter cadaver sample was selected due to its high 
asymmetric vertebral body cross-section profile as a result of a severe 
metastatic infiltration.  
In summary, the numerical prediction has been altered to account for:  
i. EIy next to stand-alone EIx;  
ii. Parametric form of all axes used to allow fast solution of their geometrical 
relations; 
iii. Both eccentricity moments: Mx, My; 
iv. Stress-distribution in each voxel within the vertebral body mask; 
v. Estimation of the minimal fracture load;  
vi. Visualisation of point of failure at which the threshold of 1% strain will be 
likely to breach. 
Appendix G.4:  Fracture prediction when accounting for bi-
axial eccentric loading: Results 
Values of the theoretical strength at which the VB fails (Table 26) were 
predicted in very close range to values in the main body of the thesis (y = 
0.997*x - 0.4829 [kN], R² = 0.99). Besides, the predicted values were closely 
- 211 - 
associated with the experimental values giving satisfying R² > 0.94 for plastic 
models (Figure 79), where the Bland-Altman agreement testing failed to 
indicate notable differences between error of prediction with respect to the 
position of the simulated lesion (difference between predicted and tested 
values does not highlight any outliers with respect to the VB strength 
depicted in Figure 80). As for the human sample, the results (also in Table 
26) indicate close agreement with previously presented prediction as well to 
the strength obtained experimentally.  
Sample 
type 
Lesion type Single 
moment/fixed 
point of highest 
strain [kN] 
Accounting for 
eccentric 
loading [kN] 
Experimental 
fracture 
load [kN] 
P
la
s
ti
c
 (
S
L
A
) No lesion 14.52 14.43 12.83 
Anterior lesion 4.62 4.22 3.28 
lateral lesion 7.26 7.02 4.06 
Latero-posterior 
lesion 
11.88 10.80 10.46 
P
la
s
ti
c
  
(S
L
S
) No lesion 19.58 19.60 17.63 
Anterior lesion 6.38 5.81 2.5 
lateral lesion 9.90 9.53 5.67 
Latero-posterior 
lesion 
16.06 14.65 15.73 
H
u
m
a
n
 
s
a
m
p
le
 Spine 2 mets – T8 
(Severely infiltrated 
cadaver sample) 
3.07 2.91 3.11 
Table 26 Predicted and experimental values in in-silico assessment of 
vertebral strength in simulated metastatic infiltration and a real 
sample 
As a novelty compared to the previous method used, a point of highest 
stress concentration has been identified. Here, in cases of high degree of 
asymmetry or absence of most anterior point located directly on the mid-
sagittal axis this point has been identified and although not validated 
experimentally appears to be estimated in an understandable location. This 
point has been located without user intervention as a point of highest stress 
based on point-by-point assessment (Figure 81). 
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Figure 79 Predicted strength was highly associated with values 
experimentally obtained in both cases where only uni-axial (left) or 
bi-axial eccentricity (right) has been considered 
 
 
Figure 80 No notable difference in prediction error with respect to 
overall vertebral strength has been found between the two 
methods used (left: uni-axial eccentricity used in the main body of 
the thesis, right: extension to bi-axial eccentricity) 
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Figure 81 Accounting for spatially varying point of the highest stress 
allowed to identify where is the vertebra likely to fail (yellow 
marker). Figure depicts four tested simulated lesions along a real 
metastatic sample, in all illustrating position of loading axis (green 
round marker) located on the mid-sagittal axis (red-dashed line), 
neutral axes (red-solid lines) intersecting the modulus weighted 
centroid (square green marker) 
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Appendix G.5: Conclusion when comparing uni and bi- axis 
eccentric loading with respect to fracture prediction 
Reanalysing the data while accounting for the bi-axial eccentricity 
provided enhanced robustness of the tool for analysing where the bone is 
prone to be fractured. While the approach used in the main body of the 
thesis fails to identify site of the highest stress, accounting for both 
components can point out which part of the bone is likely to fracture. On the 
other hand, qualitative results in terms of predicting the fracture strength did 
not show notable difference for the particular loading scenario. In fact, the 
correlation between predicted and experimental fracture load slightly 
decreased while remaining results in a very similar range. This was shown 
even on samples where asymmetry has been modelled to an exaggerated 
degree. In real samples, the difference between accounting for uni-axial or 
bi-axial eccentricity in the wedge compression fracture (WCF) was 5.3%. In 
all cases, these differences are at a limit generally accepted as the 
experimental error in biomechanical experimental studies. 
The section concludes that not accounting for the secondary moment in 
this thesis has not hampered validity of the values predicted due to 
predominant contribution of the primary eccentricity moment but could be 
highly beneficial for qualitative assessment of stress distribution throughout 
the entire kernel in highly degenerated bone. Furthermore the approach here 
presented should be used when adapting for complex loading scenario. 
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Appendix H: Image processing: vertebral body boundary 
estimation  
 
Figure 82 Boundaries of the vertebral body have been estimated using 
a custom-compiled script. Here, ct-images have been treated on 
slice-by-slice basis while storing the original image along the 
binary mask. Binarisation comprised of replacing any negative 
density values with background (marrow) density, followed by 
tresholding with subsequent void filling subroutine 
